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ABSTRACT 
 
 The scientific community has born witness to incredible advancements in organic 
chemistry. Exemplified by total syntheses of molecules of astonishing complexity, it is becoming 
more clear that the conquest of a molecular target is less a question of overall feasibility, and 
more a question of practical resources. This has consequently provoked the need for 
transformations that allow for the rapid generation of molecular complexity with high efficiency 
and practicality. Selective C–H activation reactions provide a novel approach for synthesizing 
complex small molecules, which traditionally have been designed with sites of pre-incorporated 
oxidation for further manipulation. The ability to introduce sites of functionality directly onto 
simple hydrocarbon precursors offers immense potential for streamlined synthetic routes and 
improved chemical efficiency. Palladium(II) / sulfoxide catalysis has demonstrated broad 
applicability toward a wide array of allylic C–H functionalizations, starting from abundant and 
simple α-olefins. The development of such transformations has been classically guided by the 
reaction’s serial ligand catalysis mechanism, requiring weakly-binding ligands for the palladium 
catalyst, and the requirement for utilizing non-basic nucleophiles. Developing advancements 
toward addressing these major challenges has been the subject of this work. 
By leveraging the serial ligand catalysis mechanism via a combination of 
palladium(II)/bis-sulfoxide C–H activation and Lewis acid co-catalysis, we have accomplished 
the synthesis of six-membered oxygenated heterocycles (chromans, isochromans, and pyrans). 
The discovery that a wide range of alcohols were competent nucleophiles under uniform reaction 
conditions (catalyst, solvent, temperature) highlighted the generality of the method. From 
mechanistic studies, we have hypothesized that the reaction proceeds via an initial C–H 
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activation, followed by chelation-assisted deprotonation and inner-sphere reductive elimination 
functionalization pathway. Consistent with this, the reaction displayed orthogonal reactivity 
trends to traditional Pd(0)–catalyzed allylic substitutions. 
Due to the weakly-coordinating nature of the bis-sulfoxide ligand, we required a different 
approach toward achieving asymmetric catalysis. Critical to the success of this goal was the 
development and utilization of a novel chiral aryl sulfoxide-oxazoline (ArSOX) ligand. We have 
reported the enantioselective synthesis of isochromans via Pd(II)-catalyzed allylic C–H oxidation 
from terminal olefin precursors. The reaction proceeds with broad scope and high levels 
asymmetric induction (avg. 92% ee). Additionally, we observed stereochemically-defined 
substitution on the isochroman to be well-tolerated, with asymmetric catalysis affording either 
enhanced diastereoselectivity or a modest turnover. Mechanistic insights indicated that 
functionalization of the π-allylpalladium intermediate is the enantiodetermining step. 
Additionally, the utility of the Pd/ArSOX platform is demonstrated with an enantioselective 
intermolecular allylic C–H alkylation reaction, which proceeds with high levels of asymmetric 
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CHAPTER ONE: TERMINAL OLEFINS TO CHROMANS, ISOCHROMANS, AND 
PYRANS VIA ALLYLIC C–H OXIDATIONa 
 
1.1 Introduction 
One of the principal objectives in modern synthetic organic chemistry is the development 
of methods for more efficient access to pharmacophoric and biologically active motifs.   
Selective C–H functionalization reactions increasingly enable the streamlining of synthetic 
routes due to their ability to directly replace traditionally inert C–H bonds with the desired 
oxygen, nitrogen, or carbon functionality, in the appropriate oxidation state and stereochemical 
configuration.1-6 Classical synthetic strategies typically necessitate the use of pre-oxidized 
fragments, often requiring functional group manipulations, protections, and deprotections that 
lengthen the synthetic sequence.  Alternatively, by directly installing the desired functional group 
onto a hydrocarbon precursor with minimal oxidation, C–H oxidations may bypass these 
material-inefficient steps.7  
Classically, palladium(II)-mediated stoichiometric transformations from terminal olefins 
to allylic products required the sequential formation and isolation of the π-allylpalladium 
intermediates, followed by nucleophilic functionalization.8-10 In 2005, White and Chen reported a 
Pd(OAc)2 / bis-sulfoxide catalyst 1, which (in combination with benzoquinone) was a competent 
catalyst for branched allylic C–H esterification.11 The establishment of a catalytic manifold for 
allylic C–H functionalization resulted from the combination of three key insights: (1) using a set 
of ligands capable of promoting both electrophilic C–H cleavage and nucleophilic π-
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
a	  This chapter and the figures herein are adapted from Ammann, S.E., Rice, G.T. and White, M. C. J. Am. Chem. 
Soc. 2014, 136, 10834-10837.  
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allylpalladium functionalization, (2) utilizing quinone oxidants to reoxidize palladium(0) to 
palladium(II), and (3) utilizing acidic nucleophiles that do not inhibit C–H cleavage, and may be 
deprotonated without the need for strong base in situ. Catalyst 1 has since been established as a 
general platform for allylic C–H oxidation,12-15 macrolactonization,16-18 amination,19-24 
alkylation,25-28 fluorination,29 and dehydrogenation30 from simple terminal olefin precursors 
(Figure 1.1 entry A). These reactions proceed with high levels of functional group tolerance, 
regioselectivity, chemoselectivity, diastereoselectivity, and E/Z olefin selectivity.	  	  
 
 
It is reasonable to argue that the success of this approach is attributable to the underlying 
mechanism by which allylic C–H functionalizations catalyzed by 1 operate, termed serial ligand 
catalysis (Figure 1.1 entry B). This mechanism starts when 1 coordinates the terminal olefin 
substrate and effects allylic C–H cleavage to produce the π-allylpalladium intermediate. In the 
absence of both a strong base to deprotonate the nucleophile and phosphine ligands to promote a 
strongly cationic palladium species, a second ligand (for example: benzoquinone) is required to 
promote formation of the product.31-32 The palladium(0) species may then be reoxidized to 





























































Figure 1.1: Allylic C–H functionalization with 1, and serial ligand catalysis mechanism 
A B 
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complete the catalytic cycle.33-35 Because each ligand is necessary to promote a different step in 
the catalytic cycle, the ligand environment surrounding palladium consists of exchanging 
weakly-binding ligands. Importantly, the reaction conditions may be tuned to improve reactivity. 
The π-allylpalladium species may be rendered more electrophilic by addition of catalytic amount 
of a Lewis acid, hypothesized to exert this effect through interaction with 1,4-benzoquinone 
(BQ).20 Additionally, addition of a catalytic amount of a bulky base has been shown to promote 
product formation, presumably by enhancing the relative concentration of the deprotonated 
nucleophile.21
 
Reactions with 1 have generally required the use of acidic (pKa <6) nucleophiles, 
and the use of classic, less-acidic nucleophiles had seemed incompatible with the reaction 
mechanism.  
  
Oxygen-containing heterocycles comprise a class of compounds that are widely utilized 
for their important biological properties.36-37 Pyrans and benzopyran motifs, including chromans 
and isochromans, are pervasive structural elements in biologically relevant small molecules 
(Figure 1.2), such as antihypertensive agents,38 opioid σ receptor antagonists,39 and natural 
products such as ficuspirolide.40 Synthetic methods that have been reported to access such 
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Figure 1.2: Oxygenated heterocycles via allylic C–H oxidation 
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materials.41-44 Specifically, significant efforts have focused on processes that proceed via Pd(II) 
oxypalladation45-48 or Pd(0) allylic substitution methods,49-52 with the requirement for 
stereochemically-defined internal olefin precursors, and in some cases with high levels of 
asymmetric induction,46-47, 50-52  
Allylic C–H functionalizations of terminal olefins catalyzed by 1 have shown broad 
applicability in synthetic methodology (vide supra). Because of their prevalence in bio-active 
compounds, we sought to apply a C–H activation strategy toward a general method for the 
synthesis of cyclic ether motifs starting from terminal olefin substrates. However, such a strategy 
would necessitate using phenol or alcohol oxygen nucleophiles instead of the previously reported 
carboxylic acids. Nucleophiles used for allylic C–H functionalization under the mild conditions 
of 1 have uniformly possessed pKas under 6. More basic nucleophiles hinder the catalytic cycle, 
either by binding and therefore deactivating the palladium catalyst or by failing to undergo 
deprotonation under the acidic reaction conditions (the only sources of base – the acetate 
counterion or dihydroquinone generated upon palladium reoxidation – are weak and catalytic).24 
These oxygen nucleophiles represented a major hurdle for allylic oxidations due to their 
relatively low acidity (pKas ranging from ~ 10 for phenol to above 15 for aliphatic alcohols). 
Indeed, exploratory intermolecular reaction between terminal olefins and excess phenols 
catalysed by 1 consistently showed no allylic products. However, we drew inspiration from 
oxidative macrolactonization and diol forming reactions previously published in the group. In 
particular, we noted a mechanistic study showing that the carboxylic acid nucleophile 
coordinates to the π-allylpalladium center prior to functionalization.16 Thus we envisioned that 
rendering the reaction intramolecular might promote alcohol complexation to the palladium in a 
similar fashion. Such coordination to palladium would acidify the alcohol, enabling 
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deprotonation under otherwise neutral conditions.53 Moreover, such an approach toward C–O 
bond formation under non-basic conditions might have orthogonal scope to classic methods that 
employ Pd(0) catalysis. 
1.2  Results and Discussion 
 
 
We initiated our studies with preliminary evaluation of standard Pd(II)/bis-sulfoxide 
conditions using commercial catalyst 1 and BQ, and we observed formation of chroman 3a in a 
modest 18% yield from phenol 2a (Table 1.1, entry 1). It was reasonable to hypothesize that 
addition of a catalytic amount of a base might assist in the deprotonation step; however, addition 
of a catalytic amount of DIPEA shut down reactivity (entry 2).21 It had been previously 
Entry Additive Catalyst Solvent Time Yield[%]a
1 none 1 THF 72 h 18
2 DIPEA 1 THF 24 h   0
3 B(C5F6)3 1 THF 16 h 22
4 Cr(salen)Cl 1 THF 16 h 48
5 Cr(salen)Cl 1 DCE 16 h 79d
9 none 1 DCE 16 h 24
10 Cr(salen)Cl Pd(OAc)2 DCE 16 h <5












a Yields determined by 1HNMR with an internal standard (nitrobenzene).
b 2,6-dimethylbenzoquinone substituted for 1,4-benzoquinone. c 5 mol% 1.
d Average of two isolated yields.  e 43% recovered starting material.
H
12c Cr(salen)Cl 1 DCE 72 h 67d
8 Mn(salen)Cl 1 DCE 16 h 45d,e
7 1 DCE 16 h 72d
6 Cr(salen)BF4 1 DCE 16 h 47d
Cr(TPP)Cl
Table 1.1: Reaction optimization 
	   6	  
demonstrated that additions of catalytic amounts of Lewis acids promote enhanced reactivity in 
allylic C–H functionalizations.15, 20 Although the inclusion of catalytic loadings of B(C6F5)3 
failed to promote the reaction (entry 3),22 inclusion of the oxophilic Lewis acid Cr(salen)Cl 
increased the reaction yield to 48% (entry 4),12, 54 The reaction was further optimized by 
changing the solvent to 1,2-dichloroethane (79% yield, entry 5). Use of a weaker-coordinating 
BF4 counterion with the Cr Lewis acid resulted in lower yield, however use of an analogous 
square planar porphyrin ligand (Cr(TPP)Cl) resulted in a nearly identical yield of 3a (entry 6,7). 
Interestingly, use of Mn(salen)Cl as a co-catalyst, also previously shown to promote 1-catalyzed 
intermolecular C–H aminations, also effected a modest enhancement in yield (entry 8).12 Lastly, 
we probed the reaction through a series of control studies. Removal of the Cr co-catalyst from 
these optimized reaction conditions resulted in a dramatic decrease in yield (entry 9). 
Substitution of catalyst 1 with Pd(OAc)2 resulted in only trace yield (< 5%) of product, showing 
that the bis-sulfoxide ligand is a critical component in the reaction, likely to promote a C–H 
cleavage/π-allylpalladium functionalization pathway (entry 10). Consistent with the hypothesis 
that a π-acidic ligand like BQ is required to bind Pd in order to access the Cr co-catalyst effect, 
substitution of BQ with the more sterically-bulky 2,6-dimethylbenzoquinone (2,6-DMBQ) 
caused the reaction to proceed with greatly diminished yield (entry 11).12, 55 It should be noted 
that 2,6-DMBQ has been shown to be a competent re-oxidant for Pd, and this control experiment 
supports the hypothesis for a dual role of BQ (both reoxidation and π-allylpalladium 
acidification) in this reaction.21 Additionally, it was found that the loading of catalyst 1 may be 
reduced by 50% (5 mol%), resulting in only a minor decrease in yield with an extended reaction 
time (entry 12).  
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With the optimized conditions in hand, we next examined the scope of this method for 2-
vinyl-chroman formation. Examination of aromatic substitution showed broad tolerance for both 
electron-donating substituents (Table 1.2, products 3b, 3c, 3j) and electron-withdrawing 
substituents (products 3d-3i, 3k 3l). It is significant to note that even the highly electron-
withdrawing trifluoromethyl and nitro groups furnished chroman products in good yields 
(products 3h, 3i). This is in contrast to what has been observed under Pd(0) allylic substitution 
conditions, where poor reactivity is observed with weakly nucleophilic phenols (vide infra).56-58 




























































Table 1.2: Substrate scope for chroman formation 
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3e-3g), and these moieties serve as handles for further manipulation by cross-coupling 
methodology. Substitution on the alkyl chain was also investigated. The bulky ketal-substituted 
product 3m, serving as a masked ketone to access chromanone motifs, was obtained in a 65% 
yield. Oxygen substitution on the alkyl chain furnishes benzodioxan 3n; analogous nitrogen 
substitution enables formation of dihydro-2,4-benzoxazine product 3o.  Additionally, we were 
pleased to discover that the reaction scale may be increased to 5-mmol (a 50-fold increase from 
0.1 mmol scale) without any diminishment in yield (product 3a). 
 
 
Noting that the reaction proceeds with unexpectedly broad electronic tolerance for phenol 
nucleophiles, we hypothesized that such a nucleophile activation strategy via chelation approach 
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Table 1.3: Substrate scope for isochroman and pyran formation 
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aliphatic alcohols (pKa = 15-16). We were pleased to discover that benzyl alcohol 4a is 
converted into 3-vinyl-2-isochroman 5a in good yield under identical reaction conditions to 
those used for chroman synthesis (Table 1.3).  Examination of aromatic substitution revealed that 
chloride- and trifluoromethyl-substituted isochromans may be furnished in good yield (products 
5b and 5d, respectively). We were also pleased to observe that bulky geminal dimethyl-
substitution is tolerated adjacent to the oxygen nucleophile, affording product 5c in 65% yield. 
We hypothesized that given the facile nature of this reaction irrespective of the electronic nature 
of the alcohol nucleophile, aliphatic alcohols might also function as nucleophiles to furnish pyran 
motifs. Gratifyingly, we found that utilization of primary alcohols 6a-c under identical 
conditions to those employed for phenols and benzyl alcohols allows for the preparation of 2-
vinylpyran products 7a-c with good yields. Examination of 1-heptenol as a substrate resulted in 
formation of product 7d in 41% yield, showing that geminal-disubstitution is beneficial for 
cyclization, yet not a requirement for reactivity (Table 1.3, product 7d). Indeed, this example 
proceeded with a significant amount of recoverable unreacted starting material. 
The unexpectedly broad nucleophile scope prompted us to examine the reaction mechanism. 
Pd(II)-mediated oxypalladation processes starting from internal olefins have been used to furnish 
benzopyrans; therefore, we sought to evaluate whether an olefin isomerization/oxypalladation 
mechanism might be operative here (Figure 1.3 entry A).46 When internal olefin 8 was subjected 
to the standard reaction conditions, minimal substrate conversion and, critically, no formation of 
chroman product 3a was observed (entry B). Previous studies support that Pd(II)/bis-sulfoxide 
promotes C–H cleavage from terminal olefins to furnish π-allylPd intermediates and we sought 
to evaluate if such a mechanism was operatative here.11, 16 Utilizing substrates with either allylic 
hydrogen or deuterium atoms, isotope labelling studies were performed by measuring the 
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independent initial rate constants. Interestingly, a range of isotope effects were observed 
depending on the nature of the alcohol (entry C). With para H– or MeO–substituted phenol 
nucleophiles (possessing weak nucleophilicity and modest acidity), isotope effects in the range 
of 1.7-1.8 were measured. However, an isotope effect of 3.3 was measured for para nitro-
substituted phenol 2i, which possesses a significantly lower pKa. This is consistent with a 
scenario where neither C–H cleavage nor deprotonation/functionalization (C–O bond formation) 
are completely rate-determining and the observed KIE reflects multiple steps.59-60 It is important 
to note that the same initial rate analysis for formation of aliphatic 7b showed a KIE of 5.2, and 
revealed that the initial rate for 7b formation is approximately twice as fast as 3a formation (k7b / 
k3a = 2.3). Thus, a trend based purely on nucleophile pKa does not provide a complete 
mechanistic picture for all oxygen nucleophiles beyond phenols. 
  
 
In considering the functionalization mechanism, we hypothesized that a metal-assisted 
alcohol deprotonation is necessary to acidify the O–H bond and enable soft deprotonation with 
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Figure 1.3: Mechanistic investigation: C–H Cleavage 
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may be determined depending on the metal that assists with deprotonation: π-allylpalladium 
coordination/deprotonation generates I, a precursor for palladium-localized inner-sphere 
functionalization,61 whereas Cr(salen)Cl assisted deprotonation would promote an outer-sphere 
delivery of a chromium phenoxide species to the π-allylpalladium via II (Figure 1.4 entry  A). To 
evaluate these possibilities, we performed two Hammett studies of the reaction. The first study 
catalyzed by both Pd(II)/bis-sulfoxide 1 and Cr(salen)Cl resulted in a ρ value of 0.55, and the 
second study of the background reaction catalyzed only by 1 resulted in a ρ value of 0.63 (Figure 
1.4 entry B). Two factors lead us to favor a mechanism whereby deprotonation and 
functionalization occur at palladium via I: (1) the outright existence of a significant background 
reaction without Cr(salen)Cl, and (2) the absence of a significant change in ρ values for what 
would presumably be a significant change in the reaction mechanism with and without 
Cr(salen)Cl. 
Finally, if the phenoxide were to dissociate from π-allylpalladium I and undergo 
functionalization by an outer-sphere model, such a mechanism should have analogous trends in 
reactivity to Pd(0)-mediated allylic substitution reactions known to proceed via outer-sphere 
phenoxide functionalization of a π-allylpalladium species.51, 56, 62 To evaluate this possibility, we 
examined the yields and initial rates of chroman formation for Pd(0)-mediated allylic substitution 
with electron-deficient and electron neutral substrates, and compared these to the allylic C–H 
oxidation reaction (Figure 1.5). When allylic carbonate substrate 9a containing an electron-
neutral phenol was subjected to standard Pd(0) allylic substitution conditions, 2-vinyl-chroman 
3a was formed in good yield (84% yield); however, when para-nitrophenol or para-
trifluoromethyl substrates (9b, 9c) were exposed to identical Pd(0) conditions, reactivity was 
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significantly retarded (7% and 11% yields, respectively, Figure 1.5). In both cases, this drop in 
reaction yield correlated with a significant decrease in reaction rate (kNO2 / kH = 0.03; kCF3 / kH = 
0.10). In contrast, chroman yields for allylic C–H oxidation do not show a significant 
dependence on the electronic properties of the phenol nucleophile, and the Hammett analysis of 
the Pd(II)/bis-sulfoxide/Cr(salen)Cl catalyzed allylic C–H oxidation reaction reveals that 




































































Figure 1.4: Mechanistic investigation: Metal-assisted deprotonation 
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nucleophile, presumably reflecting a more facile deprotonation (kNO2 / kH = 3.3; (kCF3 / kH = 2.0) 
(Figures 1.4 and 1.5).  
 
 
Such dramatic switches in reactivity and reaction rate trends are unlikely to be due to the 
different mechanisms for π-allylPd formation; therefore, we take this as further evidence of a 
major deviation from the classical outer-sphere functionalization model. Although in the absence 
of stereochemical evidence we cannot definitively rule out all outer-sphere functionalization 
pathways, on the basis of the evidence presented we view it as unlikely. Broad nucleophile scope 
is possibly a consequence of such a metal-chelation approach, serving as a “dampening effect” 
for the electronic character of the nucleophiles. We have previously speculated and provided 
evidence that 1-catalyzed C–H functionalizations with oxygen nucleophiles (e.g. carboxylates) 
proceed via an inner-sphere reductive elimination step.11, 15-16 The mechanistic findings herein 
constitute a further indication for such a pathway. 
1.3 Conclusions 
In summary, we have developed a general Pd(II)/bis-sulfoxide-catalyzed allylic oxidation 






















3i:  66% yieldb
3h: 81% yield
kNO2 / kH = 0.03
kCF3 / kH = 0.10
kNO2 / kH = 3.3







3i:  7% yielda
3h: 11% yieldb
a 80% recovered starting material.  b 78% recovered starting material.
Figure 1.5: Pd(0) allylic displacement vs. allylic C–H oxidation 
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starting from terminal olefins. This operationally simple method (open to air and moisture) 
proceeds with high substrate generality under uniform conditions (catalyst, solvent, temperature). 
Its low sensitivity to the electronic nature of the alcohol nucleophile, along with inverse 
electronic trends observed for reaction rate relative to outer-sphere Pd(0)-catalyzed allylic 
substitutions, suggest to us an allylic C–H functionalization mechanism proceeding via inner-
sphere palladium coordination/activation of the oxygen nucleophile and subsequent reductive 
elimination. We anticipate that this general strategy will help to broaden the scope of pro-
nucleophiles used in C–H functionalization reactions. 
	  
1.4 Experimental Data 
General Methods 
All commercially obtained reagents were used as received; Pd(OAc)2 (Johnson-Matthey 
Chemicals) and Pd[1,2-bis(phenylsulfinyl)ethane](OAc)2 “1” (Strem Chemicals) were stored in a 
refrigerator at 0°C and weighed out in the air at room temperature prior to use. Tetrahydrofuran 
(THF) was purified prior to use by passage through a bed of activated alumina (Glass Contour, 
Laguna Beach, California). 1,2-Dichloroethane, 1,4-benzoquinone and (R,R)-Cr(salen)Cl were 
purchased from Sigma-Aldrich, Cr(TPP)Cl, X-Phos and Pd2(dba)3 were purchased from Strem 
Chemicals and used as received. All allylic oxidation reactions were run under ambient air with 
no precautions taken to exclude moisture. All other reactions were run under an argon balloon 
unless otherwise stated. Thin-layer chromatography (TLC) was conducted with E. Merck silica 
gel 60 F254 precoated plates (0.25 mm) and visualized with UV and potassium permanganate 
stain. Flash chromatography was performed as described by Still using ZEOprep 60 ECO 43-60 
micron silica gel (American International Chemical, Inc.). 1H NMR spectra were recorded on a 
Varian Unity-400 (400 MHz), Varian Inova-500 (500 MHz), or Varian Unity-500 (500 MHz) 
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spectrometer and are reported in ppm using solvent as an internal standard (CDCl3 at 7.26 ppm). 
Data reported as: s = singlet, d = doublet, t = triplet, q = quartet, quin. = quintet, sext. = sextet, 
sept. = septet, m = multiplet, b = broad, ap = apparent; coupling constant(s) in Hz; integration. 
Proton-decoupled 13C NMR spectra were recorded on a Varian Unity-400 (100 MHz) and Varian 
Unity-500 (125 MHz) spectrometer and are reported in ppm using solvent as an internal standard 
(CDCl3). IR spectra were recorded as thin films on NaCl plates on a Perkin-Elmer Spectrum BX 
and are reported in frequency of absorption (cm-1). High-resolution mass spectra were obtained 
at the University of Illinois Mass Spectrometry Laboratory. 
Note: A more direct fragment-coupling strategy was developed to access the bis-homoallylic 
tether motif with a small amount (11%) of internal olefin by-product, starting from a 
commercially available aryl bromide and alkyl bromide precursor. The resulting anisole product 
can be readily deprotected to the desired phenol (see procedure below).  Extensive optimization 
(ligand modification, solvent, temperature) to exclude olefin isomerization was not undertaken.  
Material produced from this route was found to be almost completely competent for the reaction, 
resulting in 70% yield of 3a. 
 
Procedure: 
Under the conditions of Fu,63 a flame-dried 50 mL Schlenk flask was charged with zinc powder 
(0.98 g, 15 mmol) and heated to 70˚C under vacuum for 30 minutes. After back-filling the flask 
with argon, iodine (0.13 g, 0.5 mmol) and DMA (10 mL, freshly distilled) were added. The 




1.) Zn0, I2, DMA
2.) Pd2dba3, X-Phos, 
     DMA
OMe
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(1.18 mL, 10 mmol) was added. The mixture was stirred for 7 hours at 70˚C. After cooling to 
room temperature, the mixture was filtered (to remove excess zinc) into a dry flask under argon. 
In a separate flame-dried flask, in a glove box was added Pd2(dba)3 (73 mg, 0.08 mmol) and X-
Phos (152 mg, 0.32 mmol). The flask was removed from the glove box under argon, and DMA 
(3 mL, freshly distilled) was added. The mixture was stirred for 2 minutes, and 2-bromoanisole 
(0.5 mL, 4 mmol) was added, followed by 5 mL of the 1M alkylzinc solution prepared above. 
The mixture was stirred for 4 hours at 65˚C under argon. After conversion of the aryl bromide 
starting material (observed by TLC), the flask was cooled to 0˚C, and the mixture was slowly 
diluted with sat. aq. NH4Cl (equal volume to DMA used), transferred to an appropriate 
separatory funnel, and Et2O was added (3X volume to DMA used).  The organic layer was 
separated and washed with water (x 3).  The organic layer was dried over anhydrous MgSO4, 
filtered and concentrated under reduced pressure. The crude product was purified by column 
chromatography (1:99 EtOAc:hexanes) to afford 10 as a clear oil (426 mg, 2.42 mmol, 60% 
yield.) (11% isomerization of the terminal olefin to internal olefin isomers, determined by 1H 
NMR).  1H NMR (500MHz, CDCl3) δ 7.18 (d, J = 7.6 Hz, 1H), 7.13 (t, J = 7.3 Hz, 1H), 6.89 (t, J 
= 7.3 Hz, 1H), 6.85 (d, J = 8.0 Hz, 1H), 5.86 (ddt, J = 16.8, 10.0, 6.7 Hz, 1H), 5.04 (d, J = 17.1 
Hz, 1H), 5.97 (d, J = 10.3 Hz, 1H), 3.83 (s, 3H), 2.63 (ap. t, J = 7.6 Hz, 2H), 2.11 (q, J = 7.1 Hz, 
2H), 1.69 (quin., J = 7.8 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ 158.1, 139.6, 131.5, 130.4, 
127.5, 120.9, 115.0, 110.8, 55.8, 34.2, 30.3, 29.6; HRMS (EI) m/z calc’d for C12H16O [M]+: 
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General Synthesis of Phenol Starting Materials 
 
General Route A was used for substrates 2a, 2b, 2c, 2j, and 2k. General Route B was used for 
substrates 2a and 2i. General Route C was used for substrates 2a, 2d, 2e, 2f, 2g and 2h. 
General Route A: To a round-bottom flask (RBF) flask opened to air was added a Teflon stir 
bar, the corresponding α-tetralone starting material (1.0 equiv.) and dichloromethane (0.50 M) 
then placed on a magnetic stir plate.  mCPBA (1.8 equiv.) was then added to the stirring reaction 
flask at room temperature, and the flask was equipped with a condenser.  The temperature was 
then raised to reflux and allowed to stir until conversion by TLC analysis (24-72h).  Upon 
complete conversion, the reaction was cooled in an ice bath and quenched SLOWLY with sat. 
aq. sodium bisulfite solution.  The solution was then transferred to an appropriate separatory 
funnel.  The organic layer was washed with 10% aqueous NaOH (x 5) (wash volumes being 
equal to the organic volume).  The organic layers were combined and dried over anhydrous 
MgSO4, filtered and concentrated under reduced pressure. The crude lactone was carried forward 
with no further purification. 
 To a flame-dried RBF containing a Teflon stir bar was added the corresponding lactone 
(1.0 equiv.) and toluene (0.10 M).  The reaction was cooled to –78°C, followed by the dropwise 
mCPBA
(1.8 equiv.)

















General Starting Material Synthesis A
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addition of DIBAL-H (1.0 M in hexanes; 1.1 equiv.).  Upon complete conversion by TLC 
analysis (2h) the reaction was slowly quenched with sat. aq. Rochelle’s salt.  The quenched 
reaction was allowed to warm to room temperature at which point additional sat. aq. Rochelle’s 
salt (equal volume to the organic layer) was added.  The biphasic mixture was stirred vigorously 
overnight.  The solution was then transferred to an appropriate separatory funnel.  The aqueous 
layer was washed with EtOAc (x 3). The organic layers were combined and dried over 
anhydrous MgSO4, filtered and concentrate under reduced pressure. The crude aldehyde was 
carried forward with no further purification. 
 To a flame-dried RBF containing a Teflon stir bar was added Ph3PCH2Br (4.0 equiv.) and 
THF (0.10 M).  The flask was place in an ice bath followed by the rapid addition of solid KtBuO 
(3.9 equiv.).  The solution immediately turns bright yellow (heterogeneous mixture) and is 
allowed to stir for 30 min.  The corresponding aldehyde (1.0 equiv.) in THF (1.0 M) was then 
added via canula and stirred for an additional 2 hours.  Upon completion by TLC analysis the 
reaction was quenched with sat. aq. NH4Cl solution. The solution was transferred to an 
appropriate separatory funnel and the aqueous layer was extracted with Et2O (3 x). The organic 
layers were combined and dried over anhydrous MgSO4, filtered and concentrated under reduced 
pressure.  The crude reaction mixture was purified using flash column chromatography (7-10% 
EtOAc/Hexanes) providing the corresponding phenol starting materials.   
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General Route B: Under the Heck conditions of Jeffery,64 to a flame-dried RBF containing a 
Teflon stir bar was added aryl iodide starting material (1.0 equiv.), tetrabutylammonium chloride 
(1 equiv.), NaHCO3 (2.5 equiv.) and DMF (1.0 M). Pd(OAc)2 (2.0 mol%) was then added 
quickly in one portion followed by the addition of but-3-en-1-ol (1 equiv.).  The flask was placed 
in an 85°C oil bath and stirred until completion by TLC analysis (24-72h).  Upon complete 
conversion, the mixture was diluted with sat. aq. NH4Cl (equal volume to DMF used), 
transferred to an appropriate separatory funnel, and Et2O was added (3X volume to DMF used).  
The organic layer was separated and washed with water (x 3).  The organic layer was dried over 
anhydrous MgSO4, filtered and concentrated under reduced pressure. The crude aldehyde was 
carried forward with no further purification. 
 To a flame dried flask containing a Teflon stir bar was added Ph3PCH2Br (4.0 equiv.) and 
THF (0.10 M).  The flask was placed in an ice bath followed by the rapid addition of solid 
KtBuO (3.9 equiv.).  The solution immediately turned bright yellow (heterogeneous mixture) and 
wass allowed to stir for 30 min.  The corresponding aldehyde (1.0 equiv.) in THF (1.0 M) was 
added via canula and stirred for an additional 2 hours. Upon completion by TLC analysis the 





















THF, 0˚C, 2 h
EtSH (2.4 equiv.)
NaH (2.2 equiv.)
DMF, reflux, 2 h
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appropriate separatory funnel and the aqueous layer was extracted with Et2O (x 3). The organic 
layers were combined and dried over anhydrous MgSO4, filtered and concentrated under reduced 
pressure.  The crude reaction mixture was purified using flash column chromatography (7-10% 
EtOAc/Hexanes) to provide the corresponding olefin. 
 To a flame-dried flask fitted with a reflux condenser and containing a Teflon stir bar was 
added NaH (2.2 equiv.) and DMF (0.66 M based upon starting olefin).  The flask was then 
placed into an ice bath followed by the dropwise addition of ethanethiol (2.4 equiv.).  Upon 
complete addition the solution became clear yellow (if the solution is still heterogeneous, add 
ethanethiol dropwise until clear).  The corresponding olefin precursor (1 equiv.) in DMF (0.66 
M) was then added via canula.  The reaction was refluxed until complete conversion by TLC 
analysis (~2h).  The solution was cooled to room temperature, diluted with water (equal volume 
to DMF used), transferred to an appropriate separatory funnel and EtOAc was added (2X volume 
to DMF used). The organic layer was separated and washed with water (x 2).  The organic layer 
was dried over anhydrous MgSO4, filtered and concentrated under reduced pressure.  The crude 
reaction mixture was purified using flash column chromatography (7-10% EtOAc/Hexanes) 
providing the corresponding phenol.   
 
 
General Route C: To a flame-dried RBF was added a Teflon stir bar, magnesium turnings (4 
equiv.) and dry diethyl ether (1.0 M, relative to bromobutene) was added under nitrogen.  The 










MeNO2, 5 h, rt
OH
General Starting Material Synthesis C
R R R
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dropwise with vigorous stirring. A second flame-dried RBF was equipped with a stir bar and the 
respective salicylaldehyde.  THF (0.1 M respective to the substrate) was added to the second 
flask under nitrogen, and the flask was cooled to zero.  The Grignard reagent was added to the 
second flask via cannula, and the mixture was stirred while warming to room temperature for 4 
hours.  Upon complete conversion by TLC, the reaction was cooled in an ice bath and quenched 
SLOWLY with sat. aq. NH4Cl solution.  The solution was then transferred to an appropriate 
separatory funnel.  The organic layer was separated, and the aqueous layer was extracted with 
EtOAc (2 x).  The organic layers were combined and dried over anhydrous MgSO4, filtered and 
concentrated under reduced pressure. The crude alcohol was purified immediately using column 
chromatography. 
 Under the conditions of Wang,65 to a flame dried RBF containing a Teflon stir bar was 
added the corresponding alcohol (1.0 equiv.) and nitromethane (0.10 M) under nitrogen. 
Triethylsilane (2.2 equiv.) was added, followed by anhydrous FeCl3 (0.1 equiv.), and the reaction 
was stirred for 3 to 5 hours. The solvent was evaporated under reduced pressure, and the 
remaining contents were submitted directly to column chromatography to afford the desired 
phenol. 
General Synthesis of Benzylic Alcohol Starting Materials 


























THF, 0˚C, 2 hR
OTHPPPTS (15%)
MeOH, 45˚C, 12 hR
OH
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General Starting Material Synthesis: Using the conditions of Alper,66 to a flame-dried RBF 
with a stir bar was added the benzoic acid starting material (1 equiv.) and THF (0.5 M), and the 
solution was cooled to 0˚C under nitrogen. Borane/THF (1.1 equiv) was slowly added and the 
mixture was stirred for 5 hours.  The reaction was quenched carefully with THF/H2O (1:1) and 
the aqueous phase was saturated with K2CO3.  The organic layer was separated and the aqueous 
layer was extracted with ether (x 2).  The combined organic phases were dried with anhydrous 
MgSO4, filtered, concentrated, and subjected to column chromatography to afford the benzylic 
alcohol. 
A flask was charged with benzylic alcohol (1 equiv.), acetone (0.1 M), 3,4-dihydropyran 
(4 equiv.), and pyridinium p-toluenesulfonate (PPTS) (0.1 equiv.).  The heterogeneous solution 
was stirred 12-48 hours and monitored by TLC for complete conversion of the starting material.  
The reaction solution was concentrated under reduced pressure, the mixture was dissolved in 
CH2Cl2, washed with 1M NaOH. The organic layer was separated, and the aqueous layer further 
extracted with CH2Cl2 (x 2). The organic layers were combined, dried over anhydrous MgSO4, 
concentrated under reduced pressure, and subjected to column chromatography to afford the 
THP-protected alcohol. 
Using the conditions of Balme,67 to a flask under argon containing a Teflon stir bar was 
added aryl iodide (1.0 equiv.), triethylbenzylammonium chloride (TEBAC) (1 equiv.), NaHCO3 
(2.5 equiv.) and DMF (0.5 M).  Pd(OAc)2 (2.0 mol%) was added quickly in one portion followed 
by the addition of allyl alcohol (3 equiv.).  The flask was placed in an 65°C oil bath and stirred 
until completion by TLC analysis (22h).  Upon complete conversion, to the mixture was added 
aq. NH4Cl slowly at 0˚C (equal volume to DMF used), transferred to an appropriate separatory 
funnel and Et2O was added (3X volume to DMF used).  The organic layer was washed with 
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water (x 2).  The organic layer was dried over anhydrous MgSO4, filtered and concentrated under 
reduced pressure. The crude aldehyde was submitted to column chromatography. 
To a flame dried flask containing a Teflon stir bar was added Ph3PCH2Br (4.0 equiv.) and 
THF (0.10 M).  The flask was place in an ice bath followed by the rapid addition of solid KtBuO 
(3.9 equiv.).  The solution immediately turned bright yellow (heterogeneous mixture) and was 
allowed to stir for 30 min.  The corresponding aldehyde (1.0 equiv.) in THF (1.0 M) was added 
via canula and stirred for an additional 2 hrs. Upon completion by TLC analysis the reaction was 
quenched with sat. aq. NH4Cl solution. The solution was transferred to an appropriate separatory 
funnel and the aqueous layer was extracted with EtOAc (x 2). The organic layers were combined 
and dried over anhydrous MgSO4, filtered and concentrated under reduced pressure.  The crude 
reaction mixture was purified using flash column chromatography to provide the corresponding 
olefin. 
The olefin was added to a flask with a stir bar, to which was added MeOH (0.1 M) and 
PPTS (0.15 equiv.).  The solution was stirred at 45˚C overnight.  The solvent was evaporated 
under reduced pressure, and the mixture was purified by column chromatography to afford the 
desired benzylic alcohol product. 
 
Substrate Characterization Data 
  
2-(pent-4-en-1-yl)phenol (2a): Product is a clear oil.  1H NMR (500MHz, CDCl3) δ 7.13 (d, J = 
7.5 Hz, 1H), 7.10 (t, J = 7.5 Hz, 1H), 6.88 (t, J = 7.3 Hz, 1H), 6.77 (d, J = 8.0 Hz, 1H), 5.87 (ddt, 
J = 17.0, 10.2, 6.7 Hz, 1H), 5.06 (d, J = 17.0 Hz, 1H), 5.00 (d, J = 9.5 Hz, 1H), 4.70 (bs, 1H), 
OH
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2.63 (t, J = 7.5 Hz, 2H), 2.14 (q, J = 7.0 Hz, 2H), 1.74 (quin., J = 7.5 Hz, 2H); 13C NMR (125 
MHz, CDCl3) δ 153.5, 138.8, 130.4, 128.3, 127.3, 120.9, 115.4, 115.0, 33.5, 29.4, 29.0; IR (film, 
cm-1): 3448 (br), 2929, 2860, 1639, 1591, 1502, 1454; HRMS (EI) m/z calc’d for C11H14O [M]+: 
162.10447; found 162.10534. 
 
4-methyl-2-(pent-4-en-1-yl)phenol (2b): Product is a clear oil.  1H NMR (500MHz, CDCl3) δ 
6.92 (s, 1H), 6.88 (d, J = 8.0 Hz), 6.66 (d, J = 8.0 Hz, 1H), 5.86 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H), 
5.05 (d, J = 17.0 Hz, 1H), 4.99 (d, J = 10.0 Hz, 1H), 4.46 (s, 1H), 2.58 (t, J = 7.8 Hz, 2H), 2.26 
(s, 3H), 2.13 (q, J = 7.2 Hz, 2H), 1.72 (quin., J = 7.5 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ 
151.3, 138.8, 131.1, 130.1, 128.1, 127.6, 115.2, 33.6, 29.4, 29.2, 20.7; IR (film, cm-1): 3438 (br), 
3076, 3008, 2976, 2927, 2861, 1508; HRMS (EI) m/z calc’d for C12H16O [M]+: 176.12012; 
found 176.12041. 
  
4-methoxy-2-(pent-4-en-1-yl)phenol (2c): Product is an off-white solid.  1H NMR (500MHz, 
CDCl3) δ 6.71-6.67 (m, 2H), 6.63 (dd, J = 9.0 Hz, 3.0 Hz, 1H), 5.85 (ddt, J = 17.0, 10.0, 6.5 Hz, 
1H), 5.05 (d, J = 17.0 Hz, 1H), 5.00 (d, J = 10.0 Hz, 1H), 4.36 (s, 1H), 3.76 (s, 3H), 2.59 (ap. t, J 
= 7.8 Hz, 2H), 2.13 (q, J = 7.2 Hz, 2H), 1.72 (quin., J = 7.5 Hz, 2H); 13C NMR (125 MHz, 
CDCl3) δ 153.8, 147.6, 138.8. 129.6, 116.0, 116.0, 115.0, 111.9, 55.9, 33.5, 29.7, 29.0; IR (film, 
cm-1): 3402 (br), 2935, 2860, 2835, 1506, 1434; HRMS (EI) m/z calc’d for C12H16O2 [M]+: 
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4-fluoro-2-(pent-4-en-1-yl)phenol (2d): Product is a yellow oil. 1H NMR (500MHz, CDCl3) δ 
6.83 (dd, J = 9.0, 2.9 Hz, 1H), 6.76 (ddd, J = 8.5, 8.5, 3.2 Hz, 1H), 6.69 (dd, J = 8.5, 4.6 Hz, 1H), 
5.85 (ddt, J = 16.8, 10.3, 6.2 Hz, 1H), 5.05 (d, J = 17.3 Hz, 1H), 5.01 (d, J = 10.3 Hz, 1H), 4.59 
(bs, 1H), 2.59 (t, J = 7.6 Hz, 2H), 2.13 (q, J = 7.1 Hz, 2H), 1.72 (quin., J = 7.8 Hz, 2H); 13C NMR 
(125 MHz, CDCl3) δ 157.7 (d, J = 237.1 Hz), 150.0, 139.0, 130.5 (d, J = 6.3 Hz), 117.0 (d, J = 
23.4 Hz), 116.5 (d, J = 7.8 Hz), 115.6, 113.7 (d, J = 23.3 Hz), 33.8, 29.8, 29.2; IR (film, cm-1): 
3410 (br), 3078, 2933, 2862, 1639, 1504, 1437; HRMS (EI) m/z calc’d for C11H13OF [M]+: 
180.0950; found 180.0949. 
 
4-chloro-2-(pent-4-en-1-yl)phenol (2e): Product is a yellow oil. 1H NMR (500MHz, CDCl3) δ 
7.09 (d, J = 2.6 Hz, 1H) 7.03 (dd, J = 8.6, 2.6 Hz, 1H), 6.68 (d, J = 8.6 Hz, 1H), 5.84 (ddt, J = 
16.9, 10.1, 6.4, 1H), 5.06 (d, J = 17.1 Hz, 1H), 5.01 (d, J = 10.1 Hz, 1H), 4.74 (bs, 1H), 2.58 (t, J 
= 7.4 Hz, 2H), 2.12 (q, J = 7.1, 2H), 1.71 (quin., J = 7.5 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ 
152.6, 138.9, 130.7, 130.5, 127.4, 126.0, 117.0, 115.7, 33.8, 29.7, 29.2; IR (film, cm-1): 3442 
(br), 3077, 2931, 2862, 1639, 1606, 1495, 1416; HRMS (EI) m/z calc’d for C11H13OCl [M]+: 
196.0655; found 196.0652. 
 
4-bromo-2-(pent-4-en-1-yl)phenol (2f): Product is a yellow oil. 1H NMR (500MHz, CDCl3) δ 
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16.9, 10.3, 6.6 Hz, 1H), 5.05 (d, J = 17.1 Hz, 1H), 5.01 (d, J = 10.3 Hz, 1H), 4.71 (bs, 1H), 2.58 
(t, J = 7.3 Hz, 2H), 2.12 (q, J = 7.3 Hz, 2H) 1.71 (quin., J = 7.5 Hz, 2H); 13C NMR (125 MHz, 
CDCl3) δ 153.2, 138.9, 133.4, 131.2, 130.3, 117.5, 115.7, 113.3, 33.8, 29.7, 29.2; IR (film, cm-1): 
3435 (br), 3076, 2927, 2862, 1639, 1605, 1581, 1493, 1412; HRMS (EI) m/z calc’d for 
C11H13OBr [M]+: 240.0150; found 240.0146. 
 
2,4-dichloro-6-(pent-4-en-1-yl)phenol (2g): Product is a clear oil. 1H NMR (500MHz, CDCl3) δ 
7.17 (d, J = 2.4 Hz, 1H), 7.02 (d, J = 2.4 Hz, 1H), 5.83 (ddt, J = 16.9, 10.3, 6.6 Hz, 1H), 5.53 (s, 
1H), 5.04 (d, J = 17.1 Hz, 1H), 4.99 (d, J = 10.3 Hz, 1H), 2.63 (t, J = 7.7 Hz, 2H), 2.11 (q, J = 7.3 
Hz, 2H), 1.70 (quin., J = 7.7 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ 148.7, 138.9, 132.1, 129.5, 
126.5, 125.5, 120.7, 115.5, 33.9, 30.4, 29.0; IR (film, cm-1): 3535 (br), 3080, 2931, 2862, 1641, 
1595, 1579, 1466, 1412; HRMS (EI) m/z calc’d for C11H12OCl2 [M]+: 230.0265; found 
230.0263. 
 
2-(pent-4-en-1-yl)-4-(trifluoromethyl)phenol (2h): Product is a clear oil. 1H NMR (500MHz, 
CDCl3) δ 7.37 (s, 1H), 7.34 (d, J = 8.4 Hz, 1H), 6.81 (d, J = 8.4 Hz, 1H), 5.85 (ddt, J = 16.9, 
10.1, 6.6 Hz, 1H), 5.21 (bs, 1H), 5.06 (d, J = 17.1 Hz, 1H), 5.01 (d, J = 10.1 Hz, 1H), 2.65 (t, J = 
7.7 Hz, 2H), 2.13 (q, J = 7.1 Hz, 2H), 1.74 (p, J = 7.7 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ 
156.7, 138.9, 129.4, 128.0 (q, J = 3.9 Hz), 125.1 (q, J = 3.9 Hz), 125.0 (q, J = 269.3 Hz), 123.6 
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1641, 1618,  1516, 1439; HRMS (EI) m/z calc’d for C12H13OF3 [M]+: 230.0918; found 
230.0919. 
 
4-nitro-2-(pent-4-en-1-yl)phenol (2i): Product is a light yellow solid.  1H NMR (500MHz, 
CDCl3) δ 8.06 (d, J = 3.0 Hz, 1H), 8.02 (dd, J = 9.0, 3.0 Hz, 1H), 6.85 (d, J = 9.0 Hz, 1H), 5.84 
(ddt, J = 17.0, 10.0, 6.5 Hz, 1H), 5.80 (bs, 1H), 5.07 (d, J = 17.0 Hz, 1H), 5.02 (d, J = 10.5 Hz, 
1H), 2.68 (ap. t, J = 7.8 Hz, 2H), 2.14 (q, J = 7.0 Hz, 2H), 1.76 (quin., J = 7.5 Hz, 2H); 13C NMR 
(125 MHz, CDCl3) δ 159.5, 141.7, 138.2, 129.6, 126.3, 123.8, 115.5, 115.5, 33.3, 29.2, 28.4; IR 
(film, cm-1): 3307 (br), 3078, 2997, 2956, 2929, 2887, 1637, 1587, 1489; HRMS (EI) m/z calc’d 
for C11H13O3N [M]+: 207.08955; found 207.08907. 
 
3-methoxy-2-(pent-4-en-1-yl)phenol (2j): Product is a clear oil.  1H NMR (500MHz, CDCl3) δ 
7.03 (t, J = 8.3 Hz, 1H), 6.48 (d, J = 8.5 Hz, 1H), 6.44 (d, J = 8.5 Hz, 1H) 5.88 (ddt, J = 17.5, 
10.5, 7.0 Hz, 1H), 5.06 (d, J = 17.5 Hz, 1H), 4.98 (d, J = 10.5 Hz, 1H), 4.69 (s, 1H), 3.81 (s, 3H), 
2.64 (ap. t, J = 7.8 Hz, 2H), 2.12 (q, J = 7.2 Hz, 2H), 1.64 (quin., J = 8 Hz, 2H); 13C NMR (125 
MHz, CDCl3) δ 158.8, 154.5, 139.3, 126.9, 116.9, 114.6, 108.4, 103.3, 55.8, 33.7, 28.3, 22.5; IR 
(film, cm-1): 3413 (br). 3076, 2935, 2836, 1595, 1470; HRMS (EI) m/z calc’d for C12H16O2 
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3-fluoro-2-(pent-4-en-1-yl)phenol (2k): Product is a clear oil.  1H NMR (500MHz, CDCl3) δ 
7.03 (ap. q, J = 6.5 Hz, 1H), 6.65 (t, J = 8.8 Hz, 1H), 6.58 (d, J = 8.0 Hz, 1H), 5.88 (ddt, J = 17.0, 
9.5, 6.5 Hz, 1H), 5.08 (d, J = 17.0 Hz, 1H), 5.01 (d, J = 9.5 Hz, 1H), 4.77 (s, 1H), 2.68 (t, J = 7.5 
Hz, 2H), 2.15 (q, J = 7.0 Hz, 2H), 1.71 (quin., J = 7.5 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ 
162.1 (d, J = 242.1 Hz), 154.9 (d, J = 5.4 Hz), 138.8, 127.1 (d, J = 10.8 Hz), 116.5 (d, J = 19.5 
Hz), 115.0, 111.0 (d, J = 2.9 Hz), 107.9 (d, J = 22.4 Hz), 33.5, 28.4, 22.2 (d, J = 2.9 Hz); IR 
(film, cm-1): 3438 (br), 3078, 2933, 2864, 1620, 1599, 1468; HRMS (EI) m/z calc’d for 
C11H13OF [M]+: 180.09505; found 180.09598. 
 
methyl 4-hydroxy-3-(pent-4-en-1-yl)benzoate (2l): Product is a clear oil. 1H NMR (500MHz, 
CDCl3) δ 7.84 (d, J = 1.9 Hz, 1H), 7.79 (dd, J = 8.4, 1.9 Hz, 1H), 6.78 (d, J = 8.4 Hz, 1H), 5.84 
(ddt, J = 16.9, 10.3, 6.6, 1H), 5.28 (bs, 1H), 5.05 (d, J = 17.1 Hz, 1H), 5.00 (d, J = 10.1 Hz, 1H), 
3.88 (s, 3H), 2.64 (t, J = 7.7 Hz, 2H), 2.12 (q, J = 7.2 Hz, 2H), 1.74 (quin., J = 7.7 Hz, 2H); 13C 
NMR (125 MHz, CDCl3) δ 167.8, 158.45, 139.0, 132.7, 130.0, 128.9, 123.1, 115.63, 115.58, 
52.5, 33.9, 29.7, 29.2; IR (film, cm-1): 3340 (br), 3072, 2952, 2861, 1714, 1689, 1605, 1510, 
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2-(2-(but-3-en-1-yl)-1,3-dioxolan-2-yl)phenol (2m): Product is a clear oil.  1H NMR (500MHz, 
CDCl3) δ 8.24 (bs, 1H), 7.26 (dd, J = 8, 1.5 Hz, 1H), 7.20 (td, J = 7.5, 1.5 Hz, 1H), 6.88-6.84 (m, 
2H), 5.79 (ddt, J = 17.0, 10.5, 6.5 Hz, 1H), 4.99 (d, J = 17.0 Hz, 1H), 4.92 (d, J = 10.5 Hz, 1H), 
4.09 (AA’ vicinal, J = 11.0, 4.5 Hz, 2H), 3.90 (AA’ vicinal, J = 11.0, 4.5 Hz, 2H), 2.20-2.15 (m, 
2H), 2.05-2.02 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 154.9, 138.0, 130.1, 127.1, 125.5, 120.0, 
117.2, 114.7, 111.6, 64.7, 38.7, 27.6; IR (film, cm-1): 3390 (br), 3090, 3030, 3000, 2990, 1580, 
1500; HRMS (EI) m/z calc’d for C13H16O3 [M]+: 220.10995; found 220.11058. 
 
2-(but-3-en-1-yloxy)phenol (2n): Product is a clear oil.  1H NMR (500MHz, CDCl3) δ 6.93 (d, J 
= 7.5 Hz, 1H), 6.89-6.80 (m, 3H), 5.89 (ddt, J = 16.5, 9.5, 6.4 Hz, 1H), 5.64 (bs, 1H), 5.19 (d, J = 
16.5 Hz, 1H), 5.14 (d, J = 9.5 Hz, 1H), 4.11 (t, J = 6.5 Hz, 2H), 2.57 (q, J = 6.5 Hz, 2H); 13C 
NMR (125 MHz, CDCl3) δ 146.1, 145.9, 134.3, 121.8, 120.2, 117.7, 114.7, 112.2, 68.2, 33.8; IR 
(film, cm-1): 3535 (br), 3076, 2933, 2877, 1597, 1500, 1470; HRMS (EI) m/z calc’d for C10H12O2 
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N-(but-3-en-1-yl)-N-(2-hydroxyphenyl)-4-methylbenzenesulfonamide (2o): Product is an off-
white solid. 1H NMR (500MHz, CDCl3) δ 7.52 (d, J = 8.4 Hz, 2H), 7.27 (d, J = 7.9 Hz, 2H), 7.21 
(td, J = 7.7, 1.3 Hz, 1H), 7.05 (dd, J = 8.1, 1.3 Hz, 1H), 6.70 (td, J = 7.9, 1.5 Hz, 1H) 6.52 (s, 
1H), 6.33 (dd, J = 8.1, 1.5 Hz, 1H), 5.75 (ddt, J = 16.5, 10.9, 6.6 Hz, 1H), 5.09 (d, J = 10.9 Hz, 
1H), 5.08 (d, J = 16.5 Hz, 1H), 4.07 (bs, 1H), 3.19 (bs, 1H), 2.44 (s, 3H), 2.17 (q, 6.9 Hz, 2H); 
13C NMR (125 MHz, CDCl3) δ 155.7, 144.8, 135.1, 134.2, 130.6, 130.1, 128.7, 127.7, 126.2, 
121.0, 118.4, 117.9, 51.9, 33.1, 22.2; IR (film, cm-1): 3469 (br), 3070, 2980, 2939, 1641, 1597, 
1493, 1454; HRMS (EI) m/z calc’d for C17H19NO3S [M]+: 317.1086; found 317.1087. 
 
(2-(but-3-en-1-yl)phenyl)methanol (4a): Product obtained as a clear oil.  1H NMR (500MHz, 
CDCl3) δ 7.41 (d, J = 7.1 Hz, 1H), 7.31-7.24 (m, 3H), 5.92 (ddt, J = 17.1, 10.3, 6.8 Hz, 1H), 5.10 
(d, J = 17.3 Hz, 1H), 5.04 (d, J = 10.0 Hz, 1H), 4.77 (s, 2H), 2.83 (ap. t, J = 7.6 Hz, 2H), 2.41 (q, 
J = 7.3 Hz, 2H) 1.61 (bs, 1H); 13C NMR (125 MHz, CDCl3) δ 140.5, 138.9, 138.6, 130.0, 128.9, 
128.6, 126.9, 115.7, 63.7, 35.8, 32.3; IR (film, cm-1): 3338 (br), 3074, 2976, 2927, 2873, 1639, 
1604, 1491, 1454, 1416; HRMS (EI) m/z calc’d for C11H14O [M]+: 162.1045; found 162.1051. 
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(2-(but-3-en-1-yl)-4-chlorophenyl)methanol (4b): Product obtained as a clear oil. 1H NMR 
(500MHz, CDCl3) δ 7.31 (d, J = 8.1 Hz, 1H), 7.19-7.17 (m, 2H), 5.85 (ddt, J = 17.1, 10.3, 6.6 
Hz, 1H), 5.06 (d, J = 17.0 Hz, 1H), 5.01 (d, J = 10.3, 1H), 4.68 (s, 2H), 2.74 (app. t, J = 7.6 Hz, 
2H), 2.35 (q, J = 7.4, 2H), 1.65 (bs, 1H); 13C NMR (125 MHz, CDCl3) δ 142.4, 138.0, 137.3, 
134.1, 130.1, 129.9, 126.9, 116.1, 63.0, 35.4, 32.0; IR (film, cm-1): 3340 (br), 3078, 2978, 2933, 
2875, 1641, 1597, 1570, 1485, 1452, 1402; HRMS (EI) m/z calc’d for C11H13OCl [M]+: 
196.0655; found 196.0657. 
 
2-(2-(but-3-en-1-yl)phenyl)propan-2-ol (4c): Product obtained as a clear oil. 1H NMR 
(500MHz, CDCl3) δ 7.42 (d, J = 7.8 Hz, 1H), 7.25 (d, J = 7.7 Hz, 1H), 7.21 (t, J = 7.0 Hz, 1H), 
7.15 (t, J = 7.4 Hz, 1H), 5.93 (ddt, J = 16.8, 10.3, 6.6 Hz, 1H), 5.08 (d, J = 17.1 Hz, 1H), 5.00 (d, 
J = 10.1 Hz, 1H), 3.07 (t, J = 7.0 Hz, 2H), 2.40 (q, J = 6.8 Hz, 2H), 1.7 (s, 1H), 1.67 (s, 6H); 13C 
NMR (125 MHz, CDCl3) δ 141.0, 139.2, 132.2, 127.7, 126.2, 125.9, 115.3, 74.3, 37.5, 33.9, 
32.4; IR (film, cm-1): 3369 (br), 3072, 2978, 2931, 2872, 1639, 1601, 1487, 1443; HRMS (EI) 
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(2-(but-3-en-1-yl)-4-(trifluoromethyl)phenyl)methanol (4d): Product obtained as a clear oil. 
1H NMR (500MHz, CDCl3) 7.54 (d, J = 8.1 Hz, 1H), 7.48 (d, J = 8.3 Hz, 1H), 7.45 (s, 1H), 5.86 
(ddt, J = 16.9, 10.3, 6.6 Hz, 1H), 5.06 (d, J = 17.1 Hz, 1H), 5.02 (d, J = 10.3 Hz, 1H), 4.78 (d, J = 
5.1 Hz, 2H), 2.80 (t, J = 8.0 Hz, 2H), 2.38 (q, J = 8.1 Hz, 2H), 1.68-1.67 (m, 1H); 13C NMR (125 
MHz, CDCl3) δ 142.7, 140.9, 137.9, 130.5 (q, J = 32.1 Hz), 128.5, 126.6 (q, J = 3.9 Hz), 124.8 
(q, J = 271.2), 123.7 (q, J = 3.9 Hz), 116.3, 63.0, 35.3, 32.1; IR (film, cm-1): 3338 (br), 3082, 
2980, 2925, 1643, 1622, 1421; HRMS (EI) m/z calc’d for C12H13OF3 [M]+: 230.0918; found 
230.0918. 
 
(1-(pent-4-en-1-yl)cyclobutyl)methanol (6a): Product is a clear oil.  1H NMR (500MHz, 
CDCl3) δ 5.82 (ddt, J = 16.9, 10.3, 6.6 Hz, 1H), 5.02 (d, J = 16.9 Hz, 1H), 4.95 (d, J = 10.3 Hz, 
1H), 3.54 (d, J = 5.8 Hz, 2H), 2.06 (q, J = 7.1 Hz, 2H), 1.85 (q, J = 7.5 Hz, 2H), 1.81-1.69 (m, 
4H), 1.51-1.47 (m, 2H), 1.36-1.30 (m, 2H), 1.25 (t, J = 6.0 Hz, 1H); 13C NMR (125 MHz, 
CDCl3) δ 139.2, 114.7, 68.4, 43.2, 36.5, 34.7, 28.4, 23.6, 15.5; IR (film, cm-1): 3234 (br), 3078, 







	   33	  
 
(1-(pent-4-en-1-yl)cyclohexyl)methanol (6b): Product is a clear oil.  1H NMR (500MHz, 
CDCl3) δ 5.82 (ddt, J = 16.8, 10.3, 6.6 Hz, 1H), 5.02 (d, J = 17.1 Hz, 1H), 4.96 (d, J = 10.0 Hz, 
1H), 3.42 (s, 2H), 2.06-2.00 (m, 2H), 1.47-1.41 (m, 5H), 1.35-1.26 (m, 10H) 1.10 (br. S, 1H); 13C 
NMR (125 MHz, CDCl3) δ 139.6, 115.0, 69.1, 37.6, 35.2, 34.7, 33.0, 27.0, 23.0, 22.1; IR (film, 
cm-1): 3444 (br), 3076, 2929, 2860, 1641, 1454; HRMS (EI) m/z calc’d for C12H22O [M]+: 
182.16707; found 182.16673. Spectral data is in agreement with previously reported literature.70 
 
 
 2-(2-(but-3-en-1-yl)-1,3-dioxolan-2-yl)ethanol (6c): Product is a clear oil.  1H NMR (500MHz, 
CDCl3) δ 5.82 (ddt, J = 16.9, 10.3, 6.6 Hz, 1H), 5.03 (d, J = 17.1 Hz, 1H), 4.96 (d, J = 10.1 Hz, 
1H), 4.04-3.96 (m, 4H), 3.76 (q, J = 5.6 Hz, 2 H), 2.75 (t, J = 5.8 Hz, 1H), 2.13 (qt, J = 6.4, 1.3 
Hz, 2H), 1.94 (t, J = 5.6 Hz, 2H), 1.77-1.73 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 138.4, 
114.8, 112.2, 65.1, 59.1, 38.5, 36.5, 28.3; IR (film, cm-1): 3410 (br), 3078, 2954, 2887, 1641, 
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Reaction Development, Scope 
Optimization Studies 




General Procedure for Optimization Studies (unless noted otherwise) 
To a ½ dram borosilicate vial containing a Teflon stir bar was added the corresponding phenol 
(0.10 mmol, 1 equiv.), benzoquinone (0.20 mmol, 2.0 equiv.), Pd catalyst (0.01 mmol, 0.10 
equiv.) and corresponding additive  (0.01 mmol, 0.10 equiv.). The corresponding solvent (0.3 
Entry Additive Catalyst Solvent Time Yield[%]a
1 none 1 THF 72 h 18
2 DIPEA 1 THF 24 h   0
3 B(C5F6)3 1 THF 16 h 22
4 Cr(salen)Cl 1 THF 16 h 48
5 Cr(salen)Cl 1 DCE 16 h 79d
9 none 1 DCE 16 h 24
10 Cr(salen)Cl Pd(OAc)2 DCE 16 h <5












a Yields determined by 1HNMR with an internal standard (nitrobenzene).
b 2,6-dimethylbenzoquinone substituted for 1,4-benzoquinone. c 5 mol% 1.
d Average of two isolated yields.  e 43% recovered starting material.
H
12c Cr(salen)Cl 1 DCE 72 h 67d
8 Mn(salen)Cl 1 DCE 16 h 45d,e
7 1 DCE 16 h 72d
6 Cr(salen)BF4 1 DCE 16 h 47d
Cr(TPP)Cl
13 1 16 18Ag(OTf) THF
Table 1.4: Reaction optimization 
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mL) was then added to the ½ dram vial, and the vial was sealed under air and placed to stir at 
45˚C for the given amount of time. The vial was allowed to cool, the contents transferred to a 
100 mL round bottom flask with dichloromethane, and the solvents were evaporated under 
reduced pressure. The residue was dissolved in CDCl3 and nitrobenzene (0.04 mmol, 0.4 equiv.) 
was added as an internal standard. An aliquot was taken and added directly to a NMR tube and 
diluted with CDCl3 for direct analysis. The yield was determined by integration of the olefinic 
product peaks relative to the nitrobenzene standard. 
 
General procedure for phenol and alcohol functionalization reaction (small scale, <1 
mmol): To a ½ dram borosilicate vial containing a Teflon stir bar was added the corresponding 
phenol or alcohol (1 equiv.), benzoquinone (2.0 equiv.), Cr(salen)Cl  (0.10 equiv.), and catalyst 1 
(0.10 equiv.). 1,2-Dichloroethane (0.3M) was then added. The vial was sealed under air with a 
Teflon cap and placed in an aluminum block to stir at 45˚C for 16 hours (unless otherwise 
noted). The solution was allowed to cool to room temperature and was transferred using 
dichloromethane to a 100 mL RBF flask, and the solvents were evaporated under reduced 
pressure. The crude mixture was submitted directly to flash column chromatography (10% 
EtOAc/Hexanes) to afford the desired product.  Note: Products were observed to be somewhat 
volatile when the isolated material was exposed to prolonged periods of high vacuum. 
 
General procedure for reaction (large scale ≥1 mmol): To a 150 mL Chemglass pressure 
vessel containing a Teflon stir bar was added phenol 2a (811 mg, 5 mmol, 1 equiv.) and 1,2-
Dichloroethane (12 mL).  Benzoquinone (1.08 g, 10 mmol, 2.0 equiv.) was added in one portion, 
followed by Cr(salen)Cl  (316 mg, 0.5 mmol, 0.10 equiv.) and catalyst 1 (252 mg, 0.5 mmol, 
	   36	  
0.10 equiv.). 1,2-Dichloroethane (3 mL) was then added to rinse the sides of the flask. The vial 
was sealed under air and stirred at 45˚C for 16 hours. The solution was allowed to cool to room 
temperature and was transferred using dichloromethane to a 500 mL separatory funnel.  The 
mixture was diluted up to 200 mL using dichloromethane, and the mixture was washed with 100 
mL sat. aq. NaHSO3. The aqueous layer was back-extracted with 100 mL dichloromethane, and 
the organic layers were combined and washed with brine (75 mL). The organic layer was dried 
over MgSO4, filtered through celite, and the solvents were evaporated under reduced pressure. 
The crude mixture was submitted directly to flash column chromatography (10% 
EtOAc/Hexanes) to afford the desired product 3a (654 mg, 4.08 mmol, 82% yield).  Note: 
Products were observed to be somewhat volatile when the isolated material was exposed to 
prolonged periods of high vacuum. 
 
 
2-vinylchroman (3a): 2-(pent-4-en-1-yl)phenol (2a) (16.2 mg, 0.10 mmol) was reacted 
according to the general procedure. Purification by flash column chromatography (10% 
EtOAc/hexanes) provided the vinylchroman as a clear oil. Run 1 (12.5 mg, 78% yield); Run 2 
(13.0 mg, 81% yield). Average: 79% Yield. 1H NMR (500MHz, CDCl3) δ 7.09 (t, J = 7.5 Hz, 
1H), 7.04 (d, J = 7.5 Hz, 1H), 6.82-6.86 (m, 2H), 5.99 (ddd, J = 17.5, 10.5, 5.6 Hz, 1H), 5.38 (d, 
J = 17.0 Hz, 1H), 5.23 (d, J = 10.5 Hz, 1H), 4.56 (m, 1H), 2.86 (ddd, J = 16.5, 10.5, 5.9 Hz, 1H), 
2.77 (dt, J = 16.5, 5.0 Hz, 1H), 2.05-2.10 (m, 1H), 1.81-1.89 (m, 1H); 13C NMR (125 MHz, 
CDCl3) δ 154.6, 137.7, 129.6, 127.4, 121.9, 120.3, 116.9, 116.3, 76.2, 27.6, 24.3; IR (film, cm-1): 
O
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2926, 2854, 1583, 1489, 1458; HRMS (EI) m/z calc’d for C11H12O [M]+: 160.08882; found 
160.08875. Spectral data is in agreement with previously reported literature.49 
 
6-methyl-2-vinylchroman (3b): 4-methyl-2-(pent-4-en-1-yl)phenol (2b) (17.6 mg, 0.10 mmol) 
was reacted according to the general procedure. Purification by flash column chromatography 
(10% EtOAc/hexanes) provided the vinylchroman as a clear oil. Run 1 (14.6 mg, 84% yield); 
Run 2 (14.7 mg, 85% yield). Average: 84% Yield. 1H NMR (500MHz, CDCl3) δ 6.90 (d, J = 
8.5 Hz, 1H), 6.86 (s, 1H), 6.76 (d, J = 8.5 Hz, 1H), 5.99 (ddd, J = 17.0, 10.8, 5.8 Hz, 1H), 5.38 
(d, J = 17.5 Hz, 1H), 5.23 (d, J = 10.5 Hz, 1H), 4.55-4.50 (m, 1H), 2.83 (ddd, J = 16.0, 10.8, 6.0 
Hz, 1H), 2.73 (dt, J = 16.5, 5.0 Hz, 1H), 2.25 (s, 3H), 2.08-2.03 (m, 1H), 1.88-1.80 (m, 1H); 13C 
NMR (125 MHz, CDCl3) δ 152.4, 137.8, 130.0, 129.4, 128.0, 121.6, 116.7, 116.3, 76.2, 27.7, 
24.3, 20.6; IR (film, cm-1): 3006, 2926, 2856, 1500, 1244, 1226; HRMS (EI) m/z calc’d for 
C12H14O [M]+: 174.10447; found 174.10468. Spectral data is in agreement with previously 
reported literature.51 
 
6-methoxy-2-vinylchroman (3c): 4-methoxy-2-(pent-4-en-1-yl)phenol (2c) (19.2 mg, 0.10 
mmol) was reacted according to the general procedure. Purification by flash column 
chromatography (10% EtOAc/hexanes) provided the vinylchroman as a clear oil. Run 1 (14.6 
mg, 80% yield); Run 2 (14.8 mg, 78% yield). Average: 77% Yield.  1H NMR (500MHz, CDCl3) 
δ 6.78 (d, J = 9.0 Hz, 1H), 6.68 (dd, J = 9.0, 3.0 Hz, 1H), 6.59 (d, J = 2.5 Hz, 1H), 5.98 (ddd, J = 
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3.75 (s, 3H), 2.85 (ddd, J = 16.5, 10.8, 6.1 Hz, 1H), 2.75 (dt, J = 16.5, 5.0 Hz, 1H), 2.08-2.02 (m, 
1H), 1.88-1.79 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 153.4, 148.7, 137.8, 122.4, 117.5, 116.3, 
114.2, 113.5, 76.1, 55.9, 27.7, 24.6; IR (film, cm-1): 2931, 2846, 1495, 1425; HRMS (EI) m/z 
calc’d for C12H14O2 [M]+: 190.09938; found 190.09961. Spectral data is in agreement with 
previously reported literature.51 
 
6-fluoro-2-vinylchroman (3d): 4-fluoro-2-(pent-4-en-1-yl)phenol (2d) (18.0 mg, 0.10 mmol) 
was reacted according to the general procedure. Purification by flash column chromatography 
(10% EtOAc/hexanes) provided the vinylchroman as a clear oil. Run 1 (13.0 mg, 72% yield); 
Run 2 (11.8 mg, 66% yield). Average: 69% Yield. 1H NMR (500MHz, CDCl3) δ 6.81- 6.72 (m, 
3H), 5.97 (ddd, J = 16.9, 10.7, 5.6 Hz, 1H), 5.37 (d, J = 17.3 Hz, 1H), 5.23 (d, J = 10.5 Hz, 1H), 
4.55-4.49 (m, 1H), 2.84 (ddd, J = 16.6, 10.3, 6.1 Hz, 1H), 2.73 (dt, J = 16.6, 4.9 Hz, 1H), 2.09-
2.02 (m, 1H), 1.87-1.78 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 157.3 (d, J = 157.3 Hz), 151.1, 
137.9, 123.4 (d, J = 7.8 Hz), 118.2 (d, J = 7.8Hz), 116.9, 115.8 (d, J = 22.4 Hz), 114.6 (d, J = 
23.3 Hz), 76.7, 27.7, 24.9; IR (film, cm-1): 3080, 2931, 2850, 1649, 1622, 1493, 1433; HRMS 
(EI) m/z calc’d for C11H11OF [M]+: 178.07940; found 178.07922. Spectral data is in agreement 
with previously reported literature.51 
 
6-chloro-2-vinylchroman (3e): 4-chloro-2-(pent-4-en-1-yl)phenol (2e) (19.6 mg, 0.10 mmol) 
was reacted according to the general procedure. Purification by flash column chromatography 
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Run 2 (15.9 mg, 82% yield). Average: 81% Yield. 1H NMR (500MHz, CDCl3) δ 7.04 (d, J = 
8.7 Hz, 1H), 7.02 (s, 1H), 6.77 (d, J = 8.5 Hz, 1H), 5.96 (ddd, J = 17.1, 10.7, 5.6 Hz, 1H), 5.36 
(d, J = 17.3 Hz, 1H), 5.24 (d, J = 10.7 Hz, 1H), 4.59-4.54 (m, 1H), 2.82 (ddd, J = 16.5, 10.0, 5.9 
Hz, 1H), 2.74 (dt, J = 16.5, 4.9 Hz, 1H), 2.09-2.02 (m, 1H), 1.86-1.78 (m, 1H); 13C NMR (125 
MHz, CDCl3) δ 153.7, 137.7, 129.6, 127.8, 125.4, 125.4, 123.9, 118.7, 117.1, 76.8, 27.6, 24.6; 
IR (film, cm-1): 3026, 2958, 2899, 2852, 1577, 1479; HRMS (EI) m/z calc’d for C11H11OCl 
[M]+: 194.04985; found 194.05021. 
 
6-bromo-2-vinylchroman (3f): 4-bromo-2-(pent-4-en-1-yl)phenol (2f) (24.1 mg, 0.10 mmol) 
was reacted according to the general procedure. Purification by flash column chromatography 
(10% EtOAc/hexanes) provided the vinylchroman as a clear oil. Run 1 (20.2 mg, 85% yield); 
Run 2 (20.1 mg, 84% yield). Average: 84% Yield. 1H NMR (500MHz, CDCl3) δ 7.19-7.15 (m, 
2H), 6.73 (d, J = 8.3 Hz, 1H), 5.95 (ddd, J = 17.1, 10.5, 5.6 Hz, 1H), 5.36 (d, J = 17.1 Hz, 1H), 
5.24 (d, J = 10.7 Hz, 1H), 4.56-4.50 (m, 1H), 2.82 (ddd, J = 16.4, 10.0, 6.1 Hz, 1H), 2.74 (dt, J = 
16.6, 5.1 Hz, 1H), 2.09-2.03 (m, 1H), 1.86-1.78 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 154.2, 
137.7, 132.5, 130.7, 124.5, 119.2, 117.1, 112.7, 76.8, 27.6, 24.5; IR (film, cm-1): 3080, 2949, 
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6,8-dichloro-2-vinylchroman (3g): 2,4-dichloro-6-(pent-4-en-1-yl)phenol (2g) (23.1 mg, 0.10 
mmol) was reacted according to the general procedure. Purification by flash column 
chromatography (10% EtOAc/hexanes) provided the vinylchroman as a clear oil. Run 1 (18.6 
mg, 81% yield); Run 2 (18.4 mg, 80% yield). Average: 80% Yield. 1H NMR (500MHz, CDCl3) 
δ 7.19 (s, 1H), 6.94 (s, 1H), 5.96 (ddd, J = 17.3, 10.5, 4.9 Hz, 1H), 5.40 (d, J = 17.3 Hz, 1H), 
5.26 (d, J = 10.5 Hz, 1H), 4.71-4.66 (m, 1H), 2.82 (ddd, J = 16.8, 9.0, 5.6 Hz, 1H), 2.75 (dt, J = 
16.6, 5.6 Hz, 1H), 2.13-2.06 (m, 1H), 1.88-1.81 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 149.7, 
137.1, 128.5, 128.4, 125.4, 125.3, 123.2, 117.5, 77.5, 27.5, 24.8; IR (film, cm-1): 3080, 2933, 
2854, 1649, 1568, 1462, 1427; HRMS (EI) m/z calc’d for C11H10OCl2 [M]+: 228.01088; found 
228.01049. 
 
6-(trifluoromethyl)-2-vinylchroman (3h): 2-(pent-4-en-1-yl)-4-(trifluoromethyl)phenol (2h) 
(23.0 mg, 0.10 mmol) was reacted according to the general procedure. Purification by flash 
column chromatography (10% EtOAc/hexanes) provided the vinylchroman as a clear oil. Run 1 
(18.7 mg, 82% yield); Run 2 (18.5 mg, 81% yield). Average: 81% Yield. 1H NMR (500MHz, 
CDCl3) δ 7.34 (d, J = 8.5 Hz, 1H), 7.31 (s, 1H), 6.91 (d, J = 8.5 Hz, 1H), 5.97 (ddd, J = 17.3, 
10.7, 5.6 Hz, 1H), 5.38 (d, J = 17.3 Hz, 1H), 5.26 (d, J = 10.7 Hz, 1H), 4.64-4.59 (m, 1H), 2.87 
(ddd, J = 16.4, 9.8, 5.4 Hz, 1H), 2.80 (dt, J = 16.4, 5.3 Hz, 1H), 2.11 (dddd, J = 13.8, 8.5, 5.9, 2.9 
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125.1 (q, J = 250.2 Hz), 125.1 (q, J = 3.9 Hz), 122.9 (q, J = 32.0 Hz), 122.6, 117.7, 117.2, 77.1, 
27.5, 24.5; IR (film, cm-1): 2993, 2929, 2852, 1620, 1593, 1504, 1435; HRMS (EI) m/z calc’d for 
C12H11OF3 [M]+: 228.07621; found 228.07597. 
 
6-nitro-2-vinylchroman (3i): 4-nitro-2-(pent-4-en-1-yl)phenol (2i) (20.7 mg, 0.10 mmol) was 
reacted according to the general procedure. Purification by flash column chromatography (10% 
EtOAc/hexanes) provided the vinylchroman as a yellow solid. Run 1 (13.5 mg, 66% yield); Run 
2 (13.7 mg, 67% yield). Average: 66% Yield. ( 1H NMR (500MHz, CDCl3) δ 8.02-7.96 (m, 
2H), 6.90 (d, J = 9.5 Hz, 1H), 5.96 (ddd, J = 17.0, 10.8, 5.6 Hz, 1H), 5.38 (d, J = 17.0 Hz, 1H), 
5.28 (d, J = 10.8 Hz, 1H), 4.71-4.65 (m, 1H), 2.94-2.81 (m, 2H), 2.17-2.11 (m, 1H), 1.92-1.84 
(m, 1H); 13C NMR (125 MHz, CDCl3) δ 160.2, 141.1, 136.4, 125.8, 123.8, 122.4, 117.4, 117.2, 
77.4, 26.7, 24.0; IR (film, cm-1): 2939, 2906, 1614, 1583, 1504, 1481; HRMS (EI) m/z calc’d for 
C11H11O3N [M]+: 205.07390; found 205.07465.  
 
5-methoxy-2-vinylchroman (3j): 3-methoxy-2-(pent-4-en-1-yl)phenol (2j) (19.2 mg, 0.10 
mmol) was reacted according to the general procedure. Purification by flash column 
chromatography (10% EtOAc/hexanes) provided the vinylchroman as a clear oil. Run 1 (16.7 
mg, 88% yield); Run 2 (16.7 mg, 88% yield). Average: 88% Yield. 1H NMR (500MHz, CDCl3) 
δ 7.06 (t, J = 8.3 Hz, 1H), 6.53 (d, J = 8.5 Hz, 1H), 6.42 (d, J = 8.5 Hz, 1H); 5.99 (ddd, J = 17.0, 
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3H), 2.76 (dt, J = 17.5, 5.0 Hz, 1H), 2.62 (ddd, J = 17.0, 10.5, 6.6 Hz, 1H), 2.10-2.04 (m, 1H), 
1.84-1.76 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 157.9, 155.4, 137.7, 127.0, 116.4, 111.0, 
109.8, 101.9, 75.9, 55.6, 27.1, 18.8; IR (film, cm-1): 2937, 2850, 2838, 1591, 1470; HRMS (EI) 
m/z calc’d for C12H15O2 [M]+: 191.10721; found 191.10914. 
 
5-fluoro-2-vinylchroman (3k): 3-fluoro-2-(pent-4-en-1-yl)phenol (2k) (18.0 mg, 0.10 mmol) 
was reacted according to the general procedure. Purification by flash column chromatography 
(10% EtOAc/hexanes) provided the vinylchroman as a clear oil. Run 1 (14 mg, 79% yield); Run 
2 (14.6 mg, 82% yield). Average: 80% Yield. 1H NMR (500MHz, CDCl3) δ 7.06 (q, J = 7.7 Hz, 
1H), 6.68 (d, J = 8.0 Hz, 1H), 6.61 (t, J = 8.5 Hz, 1H), 6.00 (ddd, J = 17.0, 10.5, 5.5 Hz, 1H), 
5.40 (d, J = 17.0 Hz, 1H), 5.27 (d, J = 10.5 Hz, 1H), 4.58-4.54 (m, 1H), 2.84 (dt, J = 16.5, 5.0 
Hz, 1H), 2.74 (ddd, J = 16.5, 10.8, 6.3 Hz, 1H), 2.14-2.07 (m, 1H), 1.87-1.80 (m, 1H); 13C NMR 
(125 MHz, CDCl3) δ 161.2 (d, J = 242.3 Hz), 155.9, 137.2, 127.3 (d, J = 10.3), 116.7, 112.5 (d, J 
= 2.9 Hz), 110.3 (d, J = 21.8), 106.6 (d, J = 21.6), 76.1, 26.5, 17.8 (d, J = 3.9 Hz); IR (film, cm-
1): 2927, 2854, 1624, 1587, 1468; HRMS (EI) m/z calc’d for C11H11OF [M]+: 178.07940; found 
178.07853. 
 
methyl 2-vinylchroman-6-carboxylate (3l): 4-methyl-2-(pent-4-en-1-yl)phenol (2l) (22.0 mg, 
0.10 mmol) was reacted according to the general procedure. Purification by flash column 
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mg, 72% yield); Run 2 (15.7 mg, 72% yield). Average: 72% Yield. 1H NMR (500MHz, CDCl3) 
δ 7.80-7.76 (m, 2H), 6.86 (d, J = 9.0 Hz, 1H), 5.97 (ddd, J = 17.2, 10.7, 5.6 Hz, 1H), 5.37 (d, J = 
17.1 Hz, 1H), 5.25 (d, J = 10.5 Hz, 1H), 4.65-4.60 (m, 1H), 3.88 (s, 3H), 2.91-2.78 (m, 2H), 
2.13-2.07 (m, 1H), 1.90-1.82 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 167.6, 159.2, 137.5, 132.2, 
129.8, 122.6, 122.2, 117.4, 117.2, 77.2, 52.4, 27.7, 24.5; IR (film, cm-1): 3020, 2949, 2927, 2850, 
1716, 1614, 1583, 1495, 1437; HRMS (EI) m/z calc’d for C13H14O3 [M]+: 218.09430; found 
218.09389. 
 
 2-vinylspiro[chroman-4,2'-[1,3]dioxolane] (3m): 2-(2-(but-3-en-1-yl)-1,3-dioxolan-2-
yl)phenol (2m) (22.0 mg, 0.10 mmol) was reacted according to the general procedure for 72 
hours. Purification by flash column chromatography (10% EtOAc/hexanes) provided the 
vinylchroman as a clear oil. Run 1 (14.2 mg, 65% yield); Run 2 (14.1 mg, 65% yield). Average: 
65% Yield.  1H NMR (500MHz, CDCl3) δ 7.41 (d, J = 5.0 Hz, 1H), 7.23 (t, J = 6.5 Hz, 1H), 6.94 
(t, J = 6.5 Hz, 1H), 6.87 (d, J = 8.5 Hz, 1H), 6.03 (ddd, J = 17.0, 11.0, 6.0 Hz, 1H), 5.46 (d, J = 
17.5 Hz, 1H), 5.28 (d, J = 10.5 Hz, 1H), 4.79 (dd, J = 11.5, 6.0 Hz, 1H), 4.32-4.27 (m, 1H), 4.22-
4.15 (m, 2H), 4.11-4.06 (m, 1H), 2.16-2.04 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 155.5, 
136.9, 130.6, 126.4, 123.3, 120.8, 117.0, 117.0, 104.1, 75.8, 66.3, 64.4, 38.8; IR (film, cm-1): 
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2-vinyl-2,3-dihydrobenzo[b][1,4]dioxine (3n): 2-(but-3-en-1-yloxy)phenol (2n) (16.4 mg, 0.10 
mmol) was reacted according to the general procedure for 72 hours. Purification by flash 
column chromatography (10% EtOAc/hexanes) provided the vinylchroman as a clear oil. Run 1 
(10.7 mg, 66% yield); Run 2 (11.2 mg, 69% yield). Average: 67% Yield.  1H NMR (500MHz, 
CDCl3) δ 6.84-6.93 (m, 4H), 5.91 (ddd, J = 16.5, 10.5, 5.8 Hz, 1H), 5.53 (d, J = 17.5 Hz, 1H), 
5.39 (d, J = 11.0 Hz, 1H), 4.64 (t, J = 6.5 Hz, 1H), 4.26 (dd, J = 11.5, 2.0 Hz, 1H), 3.92 (dd, J = 
10.5, 7.8 Hz, 1H), 13C NMR (125 MHz, CDCl3) δ 143.3, 132.6, 121.8, 121.6, 119.4, 117.5, 
117.2, 73.8, 67.8; IR (film, cm-1): 2926, 2870, 1593, 1493, 1261; HRMS (EI) m/z calc’d for 




hydroxyphenyl)-4-methylbenzenesulfonamide (2o) (31.7 mg, 0.10 mmol) was reacted according 
to the general procedure for 72 hours. Purification by flash column chromatography (10% 
EtOAc/hexanes) provided the vinylchroman as a colorless solid. Run 1 (18 mg, 57% yield); Run 
2 (18.3 mg, 58% yield). Average: 57% Yield. 1H NMR (500MHz, CDCl3) δ 7.85 (d, J = 8.3 Hz, 
1H), 7.53 (d, J = 8.1 Hz, 2H), 7.24 (d, J = 8.3 Hz, 2Hz), 7.09 (t, J = 7.7 Hz, 1H) 6.94 (t, J = 7.8 
Hz, 1H), 6.86 (d, J = 8.3 Hz, 1H), 5.75 (ddd, J = 17.1, 10.5, 5.9 Hz, 1H), 5.30 (d, J = 17.1 Hz, 
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14.4, 10.0 Hz, 1H), 2.39 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 147.4, 144.9, 133.9, 130.5, 
127.9, 126.9, 125.1, 124.0, 121.6, 119.3, 118.1, 110.3, 72.8, 49.0, 22.2; IR (film, cm-1): 3024, 
2983, 2945, 1651, 1599, 1489, 1464, 1410; HRMS (EI) m/z calc’d for C17H17O3NS [M]+: 
315.09292; found 315.09245. Spectral data is in agreement with previously reported literature.47 
 
3-vinylisochroman (5a): (2-(but-3-en-1-yl)phenyl)methanol (4a) (16.2 mg, 0.10 mmol) was 
reacted according to the general procedure. Purification by flash column chromatography (10% 
EtOAc/hexanes) provided the isochroman as a clear oil. Run 1 (12.5 mg, 78% yield); Run 2 
(11.8 mg, 74% yield). Average: 76% Yield. 1H NMR (500MHz, CDCl3) δ 7.20-7.15 *m, 3H), 
7.14-7.11 (m, 1H), 6.02 (ddd, J = 17.2, 10.7, 5.6 Hz, 1H), 5.39 (d, J = 17.4 Hz, 1H), 5.23 (d, J = 
10.7 Hz, 1H), 4.89 (ABq, J = 15.0, 2H), 4.23-4.19 (m, 1H), 2.87 (dd, J = 16.3, 10.5 Hz, 1H), 2.79 
(dd, J = 16.3, 3.6 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 138.9, 135.1, 133.5, 129.4, 127.0, 
126.7, 124.7, 116.4, 75.8, 68.5, 34.4; IR (film, cm-1): 3066, 3022, 2926, 2897, 2831, 1649, 1585, 
1495, 1450, 1423; HRMS (EI) m/z calc’d for C11H12O [M]+: 160.08882; found 160.08862. 
 
6-chloro-3-vinylisochroman (5b): (2-(but-3-en-1-yl)-4-chlorophenyl)methanol (4b) (19.6 mg, 
0.10 mmol) was reacted according to the general procedure. Purification by flash column 
chromatography (10% EtOAc/hexanes) provided the isochroman as a clear oil. Run 1 (16.0 mg, 
82% yield); Run 2 (13.1 mg, 67% yield). Average: 75% Yield. 1H NMR (500MHz, CDCl3) δ 
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1H), 5.37 (d, J = 17.3, 1H), 5.23 (d, J = 10.7 Hz, 1H), 4.83 (ABq, J = 15.0 Hz, 2H), 4.20-4.15 (m, 
1H), 2.82 (dd, J = 16.5, 10.5 Hz, 1H), 2.76 (dd, J = 16.3, 3.6 Hz, 1H); 13C NMR (125 MHz, 
CDCl3) δ 138.4, 135.5, 133.5, 132.6, 129.2, 126.9, 126.2, 116.7, 75.446, 68.1, 34.1; IR (film, cm-
1): 3082, 3016, 2929, 2899, 2833, 1695, 1647, 1601, 1579, 1487, 1423; HRMS (EI) m/z calc’d 
for C11H11OCl [M]+: 194.04985; found 194.04953. 
 
1,1-dimethyl-3-vinylisochroman (5c): 2-(2-(but-3-en-1-yl)phenyl)propan-2-ol (4c) (19.0 mg, 
0.10 mmol) was reacted according to the general procedure. Purification by flash column 
chromatography (10% EtOAc/hexanes) provided the isochroman as a clear oil. Run 1 (12.3 mg, 
65% yield); Run 2 (12.6 mg, 67% yield). Average: 66% Yield. 1H NMR (500MHz, CDCl3) δ 
7.22-7.08 (m, 4H), 6.02 (ddd, J = 16.8, 10.5, 5.9 Hz, 1H), 5.37 (d, J = 17.3 Hz, 1H), 5.22 (d, J = 
10.5 Hz, 1H), 4.38-4.31 (m, 1H), 2.85 (dd, J = 15.6, 10.9 Hz, 1H), 2.72 (dd, J = 15.6, 2.7 Hz, 
1H), 1.57 (s, 3H), 1.56 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 143.5, 139.7, 133.3, 129.4, 126.8, 
126.6, 125.9, 116.2, 76.1, 70.3, 35.8, 32.1, 29.3; IR (film, cm-1): 3076, 3020, 2978, 2927, 2899, 
2860, 1647, 1491, 1448, 1423; HRMS (EI) m/z calc’d for C13H16O [M]+: 188.12012; found 
188.12026. 
 
6-(trifluoromethyl)-3-vinylisochroman (5d): (2-(but-3-en-1-yl)-4-(trifluoromethyl) 
phenyl)methanol (4d) (23.0 mg, 0.10 mmol) was reacted according to the general procedure. 
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a clear oil. Run 1 (16.5 mg, 72% yield); Run 2 (15.6 mg, 68% yield). Average: 70% Yield. 1H 
NMR (500MHz, CDCl3) δ 7.42 (d, J = 8.0 Hz, 1H), 7.38 (s, 1H), 7.12 (d, J = 8.0 Hz, 1H), 6.01 
(ddd, J = 16.6, 10.7, 5.6 Hz, 1H), 5.38 (d, J = 17.3 Hz, 1H), 5.26 (d, J = 10.7 Hz, 1H), 4.91 (ABq, 
J = 15.6 Hz, 2H), 4.24-4.19 (m 1H), 2.92-2.82 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 139.2, 
138.3, 134.5, 129.5 (q, J = 32.1 Hz), 126.3 (q, J = 3.9 Hz), 125.3, 124.7 (q, J = 249.5 Hz), 123.5 
(q, J = 3.9 Hz), 116.8, 75.5, 68.2, 34.2; IR (film, cm-1): 3091, 3018, 2931, 2902, 2835, 1647, 
1622, 1591, 1508, 1429; HRMS (EI) m/z calc’d for C12H11OF3 [M]+: 228.07621; found 
228.07656. 
 
7-vinyl-6-oxaspiro[3.5]nonane (7a): (1-(pent-4-en-1-yl)cyclobutyl)methanol (6a)  (15.4 mg,  
0.10 mmol) was reacted according to the general procedure. Purification by flash column 
chromatography (10% EtOAc/hexanes) provided the vinylpyran as a clear oil. Run 1 (11.6 mg, 
76% yield); Run 2 (10.2 mg, 67% yield). Average: 72% Yield. 1H NMR (500MHz, CDCl3) δ 
5.83 (ddd, J = 17.3, 10.7, 5.6 Hz, 1H), 5.21 (d, J = 17.3 Hz, 1H), 5.09 (d, J = 10.5 Hz, 1H), 3.88 
(dd, J = 11.0, 2.4 Hz, 1H), 3.75-3.69 (m, 1H), 3.28 (dd, J = 11.2, 1.2 Hz, 1H), 2.05-1.99 (m, 1H), 
1.91-1.84 (m, 3H), 1.80-1.74 (m, 1H), 1.65-1.36 (m, 5H); 13C NMR (125 MHz, CDCl3) δ 139.4, 
115.1, 78.2, 76.3, 38.0, 35.8, 30.5, 29.3, 28.6, 15.6; IR (film, cm-1): 2925, 2885, 1653, 1635, 
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3-vinyl-2-oxaspiro[5.5]undecane (7b): (1-(pent-4-en-1-yl)cyclohexyl)methanol (6b) (18.2 mg,  
0.10 mmol) was reacted according to the general procedure. Purification by flash column 
chromatography (10% EtOAc/hexanes) provided the vinylpyran as a clear oil. Run 1 (13.5 mg, 
75% yield); Run 2 (14.8 mg, 82% yield). Average: 78% Yield. 1H NMR (500MHz, CDCl3) δ 
5.88 (ddd, J = 17.1, 10.5, 5.6 Hz, 1H), 5.23 (d, J = 17.3 Hz, 1H), 5.09 (d, J = 10.7 Hz, 1H), 3.80 
(dd, J = 11.2, 2.4 Hz, 1H), 3.74-3.70 (m, 1H), 3.14 (d, J = 11.2 Hz, 1H), 1.78 (dq, J = 13.4, 2.9 
Hz, 1H), 1.62-1.38 (m, 11H), 1.24 (td, J = 13.2, 4.6 Hz, 1H), 1.16-1.12 (m, 1H); 13C NMR (125 
MHz, CDCl3) δ 140.0, 115.3, 79.5, 77.1, 37.2, 34.6, 32.6, 31.8, 28.0, 27.4, 22.1, 22.1; IR (film, 
cm-1): 2927, 2850, 1452; HRMS (EI) m/z calc’d for C12H20O [M]+: 180.15142; found 
180.15168. Spectral data is in agreement with previously reported literature.72 
 
7-vinyl-1,4,8-trioxaspiro[4.5]decane (7c): 2-(2-(but-3-en-1-yl)-1,3-dioxolan-2-yl)ethanol (6c)  
(17.2 mg,  0.10 mmol) was reacted according to the general procedure. Purification by flash 
column chromatography (10% EtOAc/hexanes) provided the vinylpyran as a clear oil. Run 1 
(13.7 mg, 81% yield); Run 2 (15.3 mg, 90% yield). Average: 86% Yield. 1H NMR (500MHz, 
CDCl3) δ 5.80 (ddd, J = 17.3, 10.7, 5.6 Hz, 1H), 5.28 (d, J = 17.3 Hz, 1H), 5.15 (d, J = 10.7 Hz, 
1H), 4.08-4.03 (m, 2H), 4.20-3.98 (m, 4H), 3.71 (ddd, J = 12.7, 11.5, 2.4 Hz, 1H), 1.85 (td, J = 
13.2, 5.4 Hz, 1H), 1.78 (dt, J = 13.2, 2.7 Hz, 1H), 1.67-1.62 (m, 2H); 13C NMR (125 MHz, 
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2929, 2872, 1656, 1464, 1421; HRMS (EI) m/z calc’d for C9H14O3 [M]+: 170.09430; found 
170.09449. 
 
2-vinyltetrahydro-2H-pyran (7d): hept-6-en-1-ol (6d) (11.4 mg, 0.1 mmol) was reacted 
according to the general procedure, except with DCE-d4 used as the solvent, and nitrobenzene 
(0.04 mmol) was added as an internal standard. After reaction completion, a 10 µL aliquot was 
taken and diluted with CDCl3 for direct analysis, with yields determined by integration of the 
olefinic product peaks and compared to the internal standard (yield = 41%, recovered starting 




Chroman Formation Initial Rates: General Procedure for Initial Rate Analysis 
To a ½ dram borosilicate vial containing a Teflon stir bar were added the corresponding phenol 
(0.10 mmol, 1 equiv.), benzoquinone (0.20 mmol, 2.0 equiv.), and Cr(salen)Cl  (0.01 mmol, 0.10 
equiv.) where specified. 1,2-Dichloroethane-d4 (0.33M) and nitrobenzene (0.04 mmol, 0.4 
equiv.) were added to the ½ dram vial. Catalyst 1 (0.01 mmol, 0.10 equiv.) was added, and the 
vial was then sealed and placed to stir at the designated temperature. Aliquots (10 µL) were taken 
at the corresponding times from the reaction flask, added directly to an NMR tube and diluted 
with CDCl3 for direct analysis. The yield was determined by integration of the olefinic product 
peaks relative to the nitrobenzene standard using the Mnova software program (version 7.1.2-
10008). Yields are reported as the average of three runs, with error bars representing standard 
deviation.  Initial rates were then calculated and applied to the corresponding Hammett Plot. 
O
	   50	  
 
 
	    
 
	    
 
	  








y	  =	  0.1089x	  























y	  =	  0.1134x	  




















	   51	  
	    
 
	  
	    
 








y	  =	  0.0834x	  


























y	  =	  0.2147x	  






















	   52	  













y	  =	  0.3646x	  

















OH 1 (10 mol%)
BQ (2 equiv.)
nitrobenzene (40 mol%)




y	  =	  0.0837x	  













H	  (without	  Cr)	  
Figure 1.10 
Figure 1.11 
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  (without	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Figure 1.12 
Figure 1.13 
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Figure 1.14 
Figure 1.15 
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Hammett Plots of Initial Rate Data for Pd-Catalyzed Chroman Formation 
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  -­‐	  0.0063	  
















HammeC	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  without	  Cr(salen)Cl	  
Figure 1.16 
Figure 1.17 
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Reactivity of Internal Olefin Under Standard Pd(II) Conditions 
 
2-(pent-3-en-1-yl)phenol (8): (97:3 E:Z) 1H NMR (500MHz, CDCl3) δ 7.14-7.07 (m, 2H), 6.88 
(t, J = 7.3 Hz, 1H), 6.77 (d, J = 7.9 Hz, 1H), 5.56-5.46 (m, 2H), 4.74 (bs, 1H), 2.67 (ap. t, J = 7.3 
Hz, 2H), 2.32-2.28 (m, 2H), 1.67 (d, J = 4.1 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 154.0, 
131.2, 130.8, 128.6, 127.8, 126.5, 121.4, 115.9, 33.3, 30.9, 18.5; IR (film, cm-1): 3437 (br), 3026, 
2960, 2918, 2856, 1608, 1591, 1502, 1491, 1454; HRMS (EI) m/z calc’d for C11H14O [M]+: 
162,10447; found 162.10423. 
 
 
To a ½ dram borosilicate vial containing a Teflon stir bar was added 2-(pent-3-en-1-yl)phenol 8 
(0.10 mmol, 1 equiv.), benzoquinone (0.20 mmol, 2.0 equiv.), catalyst 1 (0.01 mmol, 0.10 
equiv.) and Cr(III)(salen)Cl  (0.01 mmol, 0.10 equiv.). 1,2-dichloroethane (0.3 mL) and were 
then added to the ½ dram vial. The vial was then sealed and placed in an aluminum block to stir 
at 45˚C.  After 16 hours, the solvent was removed, a nitrobenzene standard (0.04 mmol, 0.4 
equiv.) was added, and the mixture was diluted in CDCl3.  An aliquot was examined by 1H NMR 
(500MHz), and the yield was determined by integration of the olefinic product peaks relative to 





OH 1 (10 mol%)
BQ (2 equiv.)
Cr(salen)Cl (10 mol%)
DCE (0.3 M), 45˚C, 16h
O
8 3a not observed
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5-(2-hydroxyphenyl)pent-2-en-1-yl methyl carbonate (9a): 1H NMR (500MHz, CDCl3) δ 
7.11-7.06 (m, 2H), 6.87 (t, J = 7.3 Hz, 1H), 6.74 (d, J = 7.7 Hz, 1H), 5.89 (dt, J = 15.4, 6.6 Hz, 
1H), 5.61 (dt, J = 15.4, 6.5 Hz, 1H), 4.71 (bs, 1H), 4.57 (d, J = 6.4 Hz, 2H), 3.79 (s, 3H), 2.71 
(ap. t, J = 7.3 Hz, 2H), 2.38 (q, J = 7.9 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ 156.3, 154.0, 
137.1, 130.9, 128.2, 127.9, 124.4, 121.5, 115.9, 69.2, 55.3, 33.0, 30.0; IR (film, cm-1): 3446 (br), 
3033, 2956, 2858, 1745, 1726, 1674, 1609, 1593, 1504, 1454; HRMS (EI) m/z calc’d for 





5-(2-hydroxy-5-nitrophenyl)pent-2-en-1-yl methyl carbonate (9b): 1H NMR (500MHz, 
CDCl3) δ 8.04 (d, J = 2.8 Hz, 1H), 8.01 (dd, J = 8.6, 2.6 Hz, 1H), 6.83 (d, J = 8.8 Hz, 1H), 6.10 
(s, 1H), 5.86 (dt, J = 15.4, 5.8 Hz, 1H), 5.61 (dt, J = 15.4, 6.4 Hz, 1H), 4.57 (d, J = 6.4 Hz, 2H), 
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159.9, 156.4, 142.1, 136.0, 129.4, 126.8, 125.1, 124.4, 115.9, 69.0, 55.5, 32.4, 29.8; IR (film, cm-
1): 3342 (br), 3037, 2954, 1747, 1722, 1618, 1591, 1523, 1496, 1444; HRMS (EI) m/z calc’d for 




5-(2-hydroxy-5-(trifluoromethyl)phenyl)pent-2-en-1-yl methyl carbonate (9c): 1H NMR 
(500MHz, CDCl3) δ 7.38-7.34 (m, 2H), 6.80 (d, J = 7.8 Hz, 1H), 5.87 (dt, J = 15.4, 6.8 Hz, 1H), 
5.61 (dt, J = 15.4, 6.6 Hz, 1H), 5.23 (s, 1H), 4.57 (d, J = 6.3 Hz, 2H), 3.79 (s, 3H), 2.74 (ap. t, J = 
7.1 Hz, 2H), 2.38 (q, J = 7.3 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ 156.5, 156.1, 136.1, 128.6, 
127.7 (q, J = 3.6 Hz), 124.9 (q, J = 3.6 Hz), 124.7 (q, J = 249.4 Hz) 124.5, 123.3 (q, J = 32.1 Hz) 
115.6, 68.7, 55.1, 32.4, 29.6; IR (film, cm-1): 3410 (br), 2954, 1725, 1616, 1446; HRMS (EI) m/z 
calc’d for C14H15O4F3 [M]+: 304.0922; found 304.0924. 
 
In a glove box under argon, to a flame-dried 5 mL RBF containing a Teflon stir bar was added 
Pd2dba3•CHCl3 (chlorofom adduct) (2.1 mg, 0.002 mmol, 0.02 equiv.) and 1,3-
Bis(diphenylphosphino)propane (2.5 mg, 0.006 mmol, 0.06 equiv.). A septum was added and the 
vial was taken outside the glovebox. Dry CH2Cl2 (0.3 mL) was added, and the mixture was 
stirred for 10 minutes under argon at room temperature. The carbonate substrate (0.1 mmol, 1 
equiv.) as a solution in dry CH2Cl2 (0.7 mL) was added via cannula, and the mixture was stirred 
for 3 hours.  The solvent was removed under reduced pressure, and the crude mixture was 
subjected directly to column chromatography to afford the chroman products. 
Chroman 3a: Run 1: 84% yield; run 2: 83% yield; Average 84% yield. 
OH
OCO2MeF3C
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Chroman 3i: Run 1: 5% yield, 82% recovered starting material; run 2: 8% yield, recovered 
starting material: 78%; Average 7% yield, 80% RSM. 
Chroman 3h: Run 1: 12% yield, 71% recovered starting material; run 2: 10% yield, recovered 
starting material: 85%; Average 11% yield, 78% RSM. 
 
 
Pd(0) Initial Rate Determination. 
Initial rates were determined by measuring product formation via HPLC (Zorbax CN, 4.6 x 250 
nm), versus an internal nitrobenzene standard. Yields for timepoints were determined via 
comparison with a standard curve of the corresponding product versus nitrobenzene.  The 
determined rate reflects the average of three runs, with error bars representing standard 
deviation. 
kNO2 / kH = 0.0193 / 0.6438 = 0.03 




y	  =	  0.6438x	  





















y	  =	  0.0193x	  +	  0.5979	  

















y	  =	  0.0674x	  +	  1.9173	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Determination of Kinetic Isotope Effect via Initial Rates of Chroman Formation 
 
In order to obtain accurate initial rate data, all reactions in this analysis were run at room 
temperature.  To a ½ dram borosilicate vial containing a Teflon stir bar was added deuterated 2a-
d2 (0.10 mmol, 1 equiv.), benzoquinone (0.20 mmol, 2.0 equiv.), and Cr(III)(salen)Cl  (0.01 
mmol, 0.10 equiv.). 1,2-Dichloroethane-d4 (0.33M) and nitrobenzene (0.04 mmol, 0.4 equiv.) 
were added to the ½ dram vial. Catalyst 1 (0.01 mmol, 0.10 equiv.) was added, and the vial was 
sealed and placed to stir at room temperature. Aliquots (10 µL) were taken at the corresponding 
times from the reaction flask, added directly to an NMR tube and diluted with CDCl3 for direct 
analysis. The yield was determined by integration of the olefinic product peaks relative to the 
nitrobenzene standard using the Mnova software program (version 7.1.2-10008). Yields are 
reported as the average of three runs, with error bars representing standard deviation.  An initial 
rate was determined and compared to the previously determined initial rate for formation of 3a 
(Figure 1.21). Error for kinetic isotopes was calculated via propagation of the standard error of 













2a-d2: 1H NMR (500MHz, CDCl3) δ 7.12 (d, J = 7.5 Hz, 1H), 7.08 (t, J = 7.7 Hz, 1H), 6.87 (t, J = 
7.5 Hz, 1H), 6.76 (d, J = 7.9 Hz, 1H), 5.85 (dd, J = 17.2, 10.3 Hz, 1H), 5.06 (dd, J = 17.2, 1.9 Hz, 
1H), 5.00 (dd, J = 10.1, 1.9 Hz, 1H), 4.63 (bs, 1H), 2.62 (ap. t, J = 7.7 Hz, 2H), 1.71 (t, J = 7.7 
Hz, 2H). 










y	  =	  0.0599x	  -­‐	  2.88	  
























2i-d2: 1H NMR (500MHz, CDCl3) δ 8.09 (d, J = 2.7 Hz, 1H), 8.04 (dd, J = 8.5, 2.7 Hz, 1H), 6.85 
(d, J = 8.8 Hz, 1H), 5.86 (dd, J = 16.8, 10.0 Hz, 1H), 5.42 (br. s, 1H), 5.10 (dd, J = 17.1, 2.0 Hz, 
1H), 5.05 (dd, J = 10.3, 2.0 Hz, 1H), 2.69 (app. t, J = 7.8 Hz, 2H), 1.77 (t, J = 7.8 Hz, 2H). 
 
See procedure above. 
 







y	  =	  0.1107x	  -­‐	  1.6133	  
























2c-d2: 1H NMR (500MHz, CDCl3) δ 6.70 (m, 2H), 6.63 (dd, J = 8.5, 3.2 Hz, 1H), 5.84 (dd, J = 
17.1, 10.3 Hz, 1H), 5.05 (dd, J = 17.3, 2.2 Hz, 1H), 4.99 (dd, J = 10.3, 2.0 Hz, 1H), 4.31 (br. s, 
1H), 3.75 (s, 3H), 2.59 (app. t, J = 7.6, 2H), 1.71 (t, J = 7.6 Hz, 2H). 
See procedure above. 









y	  =	  0.0481x	  -­‐	  3.0761	  























6b-d2: 1H NMR (500MHz, CDCl3) δ 5.84 (dd, J = 17.1, 10.3 Hz, 1H), 5.04 (dd, J = 17.1, 2.0 Hz, 
1H), 4.97 (dd, J = 10.3, 2.2 Hz, 1H), 3.44 (d, J = 5.4 Hz, 2H), 1.48-1.30 (m, 16H). 
See procedure above. 




y	  =	  0.0475x	  

















y	  =	  0.2463x	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CHAPTER TWO: A NEW LIGAND PLATFORM FOR ALLYLIC C–H OXIDATIONa 
 
2.1 Introduction 
Enantioselective functionalization of prochiral C–H bonds represents a highly efficient 
transformation, because it installs both valuable oxidized functionality and absolute 
configuration in a single step. Asymmetric allylic C–H oxidations have persisted as challenging 
problems in the field of synthetic methodology. The copper-catalyzed Kharasch-Sosnovsky 
reaction has achieved high levels of enantioinduction; however, it is limited in scope to 
symmetrical, cyclic olefins and proceeds under synthetically undesirable conditions (excess 
equivalents of olefin, days at cryogenic temperatures) (Figure 2.1 entry A).74-75 With regard to 
enantioselective C–H desymmetrizations and kinetic resolutions, palladium has shown a broad 
scope;76-80 however, palladium-catalyzed asymmetric allylic C–H functionalizations have been 
achieved hereto with generally modest levels of asymmetric induction.12, 81-83 Additionally, Pd-
catalyzed asymmetric C–H to C–O bond-forming reactions in both areas are rare.12, 79, 82 
 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
a	  Portions of this chapter and the figures herein are adapted from Ammann, S.E., Liu, W. and White, M. C. Angew. 
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Figure 2.1: Asymmetric Allylic C–H Oxidation  
	   71	  
The catalyst Pd(II)/bis-sulfoxide 1 has been demonstrated to be a distinctly general 
platform for effecting allylic C–H oxidations, aminations, fluorinations and alkylations of 
terminal olefins with synthetically useful yields, broad scope, and good regio- and E/Z –
selectivity (vide supra). The key concept in developing these reactions has been to take 
advantage of the serial ligand catalysis mechanism, where the bis-sulfoxide ligand promotes C–
H cleavage and another ligand, such as benzoquinone (BQ)11 or dimethylsulfoxide (DMSO),25 
promotes functionalization (Figure 2.2, entry A). However, significant efforts toward adapting 
this catalytic strategy for asymmetric catalysis have been met with only limited success.12 
Several significant challenges exist, illuminated by mechanistic studies. The bis-sulfoxide ligand, 
while necessary for the initial C–H cleavage step, is only weakly associated with the palladium, 
and does not exert influence during the functionalization step. Instead, BQ in superstoichiometric 
concentrations serves to promote functionalization.11 Additionally, rapid π-σ-π isomerization 
precedes the C–O bond forming step, thus scrambles any stereochemical information that might 
be imparted by a chiral bis-sulfoxide ligand during C–H cleavage. Working under this 
mechanistic regime, it was found in the group that modest enantiomeric excess may be achieved 
with a chiral Cr Lewis acid co-catalyst that works with BQ to promote enantioinduction during 
functionalization (Figure 2.1, entry B).12 Alternatively, other reports have investigated chiral 
palladium/phosphoramidite catalysts for allylic C–H functionalizations, yet they have been 
limited by modest enantioselectivity (avg. 75% ee, 1 example ≥90% ee84-85; avg. 83% ee, 2 
examples at 90% ee82), limited olefin scope (generally doubly activated C–H bonds)82, 86 and 
high sensitivity of the ligands to O2 (Figure 2.1, entry C). We hypothesized the ideal catalytic 
platform would circumvent serial ligand catalysis, and utilize an oxidatively stable, chiral ligand 
capable of promoting both C–H cleavage and functionalization (Figure 2.2, entry B). 
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Chiral isochromans are well-represented in natural products and pharmaceuticals, and are 
classically synthesized via diasteroselective cyclizations or chiral resolution of racemates.87 
Enantioselective organocatalytic and metal-catalyzed methods to furnish this motif have 
emerged, however generally starting from pre-oxidized precursors.88-92 We had recently reported 
a strategy for the formation of racemic cyclic ethers via Pd(II)/bis-sulfoxide 1 catalyzed, BQ-
promoted allylic C–H oxidation (vide supra).93 We hypothesized that high levels of asymmetric 
induction might be accessed by a chiral ligand since pre-organization of the alcohol to palladium 
before the C–O bond forming step was postulated to be critical to enable functionalization; thus 
this would provide an efficient means to furnish these valuable motifs.  
Chiral mixed P,N-donor ligands have achieved great success in asymmetric catalysis, 
including allylic substitutions,94-95 and we hypothesized that combining a sulfoxide (to promote 
the C–H cleavage step) with the π-acidic/σ-donor properties of an oxazoline (to potentially 
promote the functionalization step and effect a rigid chiral environment at the metal) might 
effectively promote allylic C–H oxidation. Mixed S,N- ligands were known to effect asymmetric 


























































A.  Serial Ligand Catalysis B.  New Ligand for Allylic C–H Functionalization
1
Figure 2.2: Serial ligand catalysis vs. novel ligand approach for allylic functionalization  
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diphenylpropenyl acetate).96 Alkyl-substituted sulfoxide-oxazoline ligands have been shown to 
promote Pd-catalyzed aromatic C–H couplings with boronic acids,97 and racemic branched 
allylic C–H acetoxylations.98 Additionally, chiral sulfoxides have recently experienced renewed 
interest in the field of asymmetric catalysis.99-100 We report the development of a chiral diarylated 
sulfoxide-oxazoline (ArSOX) ligand/Pd(II)-catalyzed asymmetric allylic C–H oxidation system 
that proceeds with broad scope and high asymmetric induction (Figure 2.1, entry D) (avg. 92% 
ee).101  
2.2 Results and Discussion 









L1:  R1 = Ph
L3:  R1 = iPr
L4:  R1 = tBu
(S,R)





















































L9:  R3 = OMe

































































































a Reactions run under air, average of two isolated runs. b rxn run for 72 hours at [0.5M]. 
c rxn run under argon with conditions reported in ref. 82 also resulted in trace product yield. 
d p-benzoquinone used in place of 2,6-DMBQ.    2,6-DMBQ = 2,6-dimethylbenzoquinone. 
N.D. = not determined.
2,6-DMBQ (1.1 equiv.)
additive (10 mol%)








Table 2.1: Reaction optimization  
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We began our investigation by identifying ArSOX ligand L1 (Table 2.1, entry 1), which 
effectively promoted formation of isochroman 12a with a very promising 83% ee, however with 
very low reactivity. Previously, Thomas Osberger in the group had demonstrated that Brønsted 
acids (especially organic hydrogen phosphates) enhance the reactivity of Pd(II)-sulfoxide 
catalyzed allylic C–H oxidations in the context of formation of oxazolidinones.14  On the basis of 
this precedent, we surveyed Brønsted acid additives (Table 2.1, entries 2-5), and we discovered 
that while the Brønsted acid did not impart a dramatic enhancement on asymmetric induction, a 
significant increase in yield was observed, especially when diphenylphosphinic acid was utilized. 
Examination of the diastereomer L2 resulted in dramatically lowered yield and enantioinduction 
(L2, entry 6), implying that the relative stereochemistry of the sulfoxide and the oxazoline is 
important. Evaluating the previously reported97-98 alkyl-substituted sulfoxide-oxazoline ligands 
furnished the products in significantly diminished yields and enantioselectivity (L3 and L4, 
entries 7,8). We next turned to modifications at the sulfoxide: utilizing an isopropyl group 
provided similar levels of enantioinduction, but significantly diminished reactivity (L5, entry 9). 
Further examination of aryl sulfoxides with substitution in the para-position revealed that a 
methoxy- substituent was not beneficial (L6, entry 10); however, both tert-butyl- and 
trifluoromethyl substitution resulted in enantioselectivities above 90% ee (L7: “tBu-ArSOX” 
and L8: “CF3-ArSOX, entries 11,12). Examination of both electron-donating and electron-
withdrawing modifications of the aryl backbone of the ligand para- to the sulfoxide were also 
examined: installation of a methoxy-substituent diminished the enantioinduction to 80% ee (L9, 
entry 13), and installation of a trifluoromethyl-group gave 88% ee (L10, entry 14). We selected 
tBu-ArSOX for further study due to its combination of high enantioinduction and reactivity, and 
its relative ease of synthesis. However, CF3-ArSOX was optimal in cases where enantiomeric 
	   75	  
excesses fell below 90% ee, and product yields were improved by extending reaction times (vide 
infra). Notably, utilizing chiral bis-sulfoxide L11 (entry 15) or chiral oxazoline L12 (entry 16) 
ligands resulted in minimal enantioinduction. As a control experiment, we evaluated 
phosphoramidite L13 (reported to promote enantioselective formation of chromans from highly 
activated 1,4-diene precursors) under both our standard conditions and conditions previously 
reported,82 however both experiments resulted in trace formation of 12a (entry 17). We found 
that utilizing benzoquinone (BQ) as the stoichiometric oxidant in place of the sterically-bulky 
2,6-dimethylbenzoquinone (2,6-DMBQ) diminished enantioselectivity (entry 18), possibly due 





















12b 69% yield, 92% ee 12c 68% yield, 93% ee 12d  64% yield, 95% eeb
12e 76% yield, 93% eec 12f 61% yield, 91% eed 12g 64% yield, 92% ee 12h 55% yield, 92% eed




12a 70% yield, 92% ee
O







toluene [0.15M], 8h, 45˚C
Reaction conditions: alcohol 1 (0.2 mmol), Pd(OAc)2 (0.1 equiv), tBu-ArSOX (0.1 equiv), Ph2PO2H (0.1 equiv), 
2,6-DMBQ (1.1 equiv), toluene (0.15M), 45˚C.  a Yields reported are isolated, average of three runs. 
b CF3-ArSOX used in place of tBu-ArSOX. c Reaction run for 9h.  d Reaction run for 10h. e Reaction run for 48h.  
f Reaction run for 7h.  Absolute stereochemistry of 12a was determined by comparison of optical rotation to a 
reported literature value.
Table 2.2: Enantioselective isochroman formation: reaction scope 
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We examined the scope of the reaction for furnishing the isochroman motif (Table 2.2). 
We were pleased to discover aromatic substitution to be broadly tolerated, with both electron-
rich substrates (entries 12b, 12c, 12d, 12j) and electron-deficient substrates (entries 12e, 12f, 
12g, 12h, 12i, 12k) furnishing the products in good yields and high enantioselectivities. Previous 
asymmetric allylic C–H functionalization methods had suffered from a lack of broad tolerance 
for aryl electronics, either displaying decreased enantioselectivity for electron-rich aryl 
moieties,84 or inconsistent trends for aryl tolerance.82 Also, tolerance for halogens such as 
bromide and chloride furnished products with handles for further manipulation via cross-
coupling (products 12e, 12h). To improve the enaniomeric excess of products 12d and 12i to 
greater than 90%, CF3-ArSOX was used in place of tBu-ArSOX.  
 
 
Stereochemical definition at both the 3- and 4- position is well represented in many 
biologically-active isochromans. Established synthetic strategies for these compounds, including 


















meso - 1,2-bis(phenylsulfinyl)ethane (L14)
(S,R)  L7 (tBu-ArSOX)














meso - 1,2-bis(phenylsulfinyl)ethane (L14)
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Table 2.3: Catalyst vs. substrate diastereocontrol  
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A77636, have generally relied on diastereoselective substrate-controlled Pictet-Spengler 
reactions; catalyst-controlled diastereoselectivity has not been demonstrated.102-103 We initiated 
our studies by observing that allylic C–H oxidation in the presence of achiral Pd(II) / bis-
sulfoxide L14 did not proceed with high levels of substrate diastereocontrol: 14 was furnished 
with a very modest 1.5:1 d.r. favoring the cis-diastereomer 14a (Table 2.3, entry A). When the 
reaction was run with Pd(II)/(S,R) tBu-ArSOX, we discovered that the d.r. was increased to 
>20:1 favoring 14a.  When the reaction was run with the “mismatched” Pd(II)/(R,S) tBu-
ArSOX, the d.r. was overturned to 1:2.8, favoring the trans-diastereomer 14b. Importantly, the 
ability to influence diastereoselectivity under Pd(II)/tBu-ArSOX catalysis was similarly 
observed in the formation of structurally-distinct 1,4-disubstituted 16. Allylic C–H oxidation 
under substrate control in the presence of achiral Pd(II)/bis-sulfoxide L14 furnished the cis-
diastereomer in 3.6:1 d.r. Once again, the use of “matched” Pd(II)/(S,R) tBu-ArSOX increased 
the d.r. to >20:1 favoring 16a, and “mismatched” Pd(II)/(R,S) tBu-ArSOX resulted in a d.r. of 
1:1.4 favoring 16b (Table 2.3, entry B). The ability to effect diastereocontrol with a chiral Pd 




















































     oxidation
b.) nucleophilic
    displacement
Reaction conditions: (a.) 9-BBN (1.5 equiv), THF, 0˚C, then NaBO3 (5 equiv), 80% yield, 93% ee. (b.) MsCl (1.05 equiv), DMAP (5 mol%), DIPEA (2.5 equiv), 
THF, then aryl piperazine (1.5 equiv), 50% yield, 92% ee. (c.) Hoveyda-Grubbs II (7 mol%), olefin (2 equiv),CH2Cl2. (d.) Cu(OAc)2 (4 mol%), DTBM-SEGPHOS 
(4.4 mol%), amine (1.2 equiv), DEMS (2 equiv), THF. (e) 9-BBN (1.5 equiv), THF, then NaBO3 (5 equiv).
12k 70% yield, 




This route: 19% Yield
Previously reported: 16% Yield
Overall yield: 
This route: 31% Yield












Figure 2.3: Vinylisochromans as versatile chiral intermediates 
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The pharmaceutical agent PNU-109291 (18) functions as a selective 5HT1D agonist. To 
obtain enantioenriched products, previous asymmetric syntheses of this target have relied on 
chiral resolution of racemates.105 The enantioselective C–H functionalization method was 
evaluated in the context of an efficient synthesis of 18 (Figure 2.3, entry A) by Wei Liu. 
Vinylisochroman 12k was formed from amide-containing olefin 11k via C–H oxidation in good 
yield and enantioselectivity, highlighting the tolerance of an N-Boc protected amide moiety that 
might chelate palladium in the reaction.106 Hydroboration/oxidation of 12k furnished alcohol 17 
in good yield, and subsequent nucleophilic displacement of 17 with aryl piperazine yielded 
piperazine 18. This asymmetric C–H oxidation route, starting from commercial materials, 
furnished the product in a comparable overall yield to the previously reported route105. 
Additionally, because past efforts at late-stage modifications to chiral isochromans have focused 
largely on diversifications at the aryl moiety, we sought to exploit the latent reactivity of the 
conserved terminal olefin in the products and thus demonstrate the potential orthogonality of this 
method.105 We found that isochroman 12a may be combined with an α,ß-unsaturated amide via 
ruthenium-catalyzed cross-metathesis to furnish amide 19,107 transformed via copper-catalyzed 
hydroamination into aliphatic amine 20,108 and also functionalized via hydroboration oxidation 
into alcohol 21 (Figure 2.3, entry B). Significantly, the stereocenter does not undergo detectable 
epimerization under any of these processes. Additionally, 21 is a precursor to (S)-Sonepiprazole 
(22), whose synthetic route via asymmetric C–H oxidation here proceeds with a higher overall 
yield than the reported synthesis that also involves resolution of a racemic intermediate.109 
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To begin our mechanistic investigation, we again needed to distinguish between an 
oxypalladation or C–H cleavage/π-allylpalladium pathway. To test an olefin isomerization / 
oxypalladation mechanism, we synthesized and subjected internal olefin 23 to the reaction 
conditions. No formation of 12a was observed (Figure 2.4, entry A), indicating the absence of an 
oxypalladation pathway. Allylic C–H cleavage with more challenging unactivated C–H bonds 
has been demonstrated previously with Pd/bis-sulfoxide catalyst 1, and we probed the capacity of 
the Pd/SOX platform to effect a similar transformation.93 With chiral catalyst Pd/(R,S)-
tBuArSOX, pyran 25 was furnished from alcohol 24 in good yield and enhanced 
diastereoselectivity relative to achiral Pd(II)/bis-sulfoxide L14 (19:1 d.r. versus 8:1 d.r., Figure 
2.4, entry B). The “mismatched” Pd/(S,R)-tBuArSOX furnished 25 with 1.3:1 d.r.  We next 
sought to identify reaction’s enantiodetermining step. We evaluated a scenario in which 
subsequent resolution of the isochromans might enhance the product’s enantioenrichment after 
initial product formation. However, the enantioenrichment of 12a was observed to remain 
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C.  Possible Resolution Study
Figure 2.4: Mechanistic investigation  
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enantioselective reaction did not result in enantioenriched 12a (Figure 2.4, entry C). Thus, a 
resolution of products can be eliminated as a viable pathway. Finally, evaluation of the reaction 
with a deuterium-labelled olefin 11a-d furnished 12a-d with good yield and enantioinduction, but 
with complete scrambling of the deuterium at the terminal alkene (Figure 2.4, entry D). This is 
indicative of π-σ-π isomerization of the π-allylpalladium intermediate.12 Thus, from these 
experiments we conclude that C–H cleavage cannot be the enantiodetermining step, and we infer 
that the catalyst imparts asymmetric induction during the functionalization step. At this point, it 
remains unclear whether the enantiomeric preference arises from increased stability/abundance 
of one diastereomeric π-allylpalladium intermediate over the other, or the preferential reactivity 
of one π-allylpalladium intermediate toward functionalization from a Curtin-Hammett-like 
equilibrium of the two π-allylpalladium intermediates. 
Asymmetric Allylic C–H Alkylation 
Palladium-catalyzed asymmetric allylic alkylation has emerged as a powerful means of 
constructing C–C bonds in a chemo- and stereo-selective fashion.95, 110-112 Despite its prominent 
synthetic utility, one significant limitation is that a pre-installed leaving group is required on the 
electrophile in order to engage the Pd(0) catalyst. In contrast, asymmetric allylic C–H alkylation 
of simple olefins allows access to the densely-functionalized products without the requirement 
for a preoxidized starting substrate. Broadly, efforts toward achieving this transformation have 
focused primarily on adapting phosphorus ligands (i.e. phosphoramidites) to promote this Pd(II) 
reaction.84-86, 113 However, these efforts have generally suffered from several significant 
challenges: narrow substrate scope (generally limited to a single nucleophile), and the 
requirement for rigorous exclusion of O2 from the reaction conditions (freeze-pump-thaw 
protocol or iterative additions of the ligand to the reaction) (Figure 2.5, entry A). We have noted 
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the broad reactivity (with regard to both electrophile and nucleophile) demonstrated by 
Pd(II)/bis-sulfoxide 1 for allylic C–H alkylation reactions (Figure 2.5, entry B).25, 27 Wei Liu 
hypothesized that an intermolecular enantioselective alkylation reaction promoted by the 
Pd/ArSOX platform, which is oxidatively-stable and has demonstrated high asymmetric 
induction, might result in a reaction with broad scope and operationally-simple conditions. Thus, 
we have endeavoured to develop a general asymmetric allylic C–H alkylation reaction of 
terminal olefins under the Pd/ArSOX catalytic platform (Figure 2.5, entry C).   
 
 
The realization of this goal with one such β-ketoester-motif as a nucleophile is shown in 
Table 2.4. Ligand L15, possessing an electron-rich trimethoxy-substituted aryl oxazoline and a 
sterically-bulky anthracene-substituted aryl sulfoxide, effects high levels of enantioinduction and 
good reactivity in the prescence of Zn(OAc)2 as an additive,114 without any precautions to 
exclude air or moisture from the reaction. For example, alkylated product 26 is furnished from 
allylbenzene in 66% yield and 90% ee. Modifications to the nucleophile revealed that a 
thiophene moiety is well-tolerated and does not poison the electrophilic catalyst, furnishing 27 in 
83% yield and 91% ee. Additionally, a furan-substituted nucleophile furnished 28 in 67% yield 
and 93% ee, notably setting the carbon scaffold of azaspirofuran antibiotic FD-838.115 
Examination of the electrophile scope revealed that electron rich aromatics and heterocycles are 













































B.  Broad Scope under Bis-sulfoxide catalysis
A.  Enantioselective alkylation under phosphoramidite catalysis
ligand
C.  Asymmetric Pd / ArSOX catalyzed allylic C–H alkylation































Figure 2.5: Enantioselective allylic C–H alkylation  
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in good yields and high enantioselectivites (entries 29-31). Notably, products 27-31 are furnished 
from reactions run with 1:1 stoichiometries of the starting materials. 
 
 
2.3  Conclusions 
In conclusion, we have developed a novel catalytic platform for enantioselective Pd(II)-
catalyzed allylic C–H functionalizations. To accomplish this, it was necessesary to move beyond 
the serial ligand catalysis mechanism and develop novel ArSOX ligands that both promote C–H 
cleavage and effect a stable chiral environment for asymmetric induction during 
functionalization. We have demonstrated the utility of this operationally simple method (open to 
air and moisture) to furnish isochromans with broad scope, in good yields and high 
enantioselectivities (≥90% ee). We show a further application of this Pd/ArSOX platform with 
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26b: 66% yield, 90% ee
29: 90% yield, 91% ee
27c: 83% yield, 91% ee
30: 75% yield, 93% ee 31: 58% yield, 95% ee














dioxane [0.17M], 5˚C, 72h
Reaction conditions: alkene (1 equiv), nucleophile (1 equiv), Pd(OAc)2 (0.1 equiv), L14 (0.1 equiv), 
Zn(OAc)2•2H2O (0.5 equiv), 2,6-DMBQ (1.5 equiv), toluene (0.17M), 5˚C 72h.  a Yields reported are isolated, 
average of three runs. b 2 equivalents of nucleophile used. c Reaction run at 0.067M.
R
Table 2.4: Substrate scope for enantioselective allylic C–H alkylation  
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asymmetric induction (≥90% ee). Further investigations will focus on applying Pd/ArSOX to 
other challenging allylic C–H functionalizations. 
 
2.4  Experimental Data 
General Details: All commercially obtained reagents were used as received; Pd(OAc)2 (Johnson-
Matthey Chemicals) was stored in a glove box, and weighed out in the air at room temperature 
prior to use. Under our conditions, both standard grade and ultra high purity Pd(OAc)2 were able 
to be used interchangeably.116 Toluene was purified prior to use by passage through a bed of 
activated alumina (Glass Contour, Laguna Beach, California). 2,6-dimethylbenzoquinone, 1,4-
benzoquinone, dibutylphosphate, diphenylphosphate, and diphenylphosphinic acid were 
purchased from Sigma-Aldrich and used as received. All allylic oxidation reactions were run 
under ambient air with no precautions taken to exclude moisture. All other reactions were run 
under an argon balloon unless otherwise stated. Thin-layer chromatography (TLC) was 
conducted with E. Merck silica gel 60 F254 precoated plates (0.25 mm) and visualized with UV 
and potassium permanganate stain. Flash chromatography was performed using ZEOprep 60 
ECO 43-60 micron silica gel (American International Chemical, Inc.). 1H NMR spectra were 
recorded on a Varian Unity-u400nb (500 MHz), Varian Inova-500 (500 MHz), or Varian Unity-
500 (500 MHz) spectrometer and are reported in ppm using solvent as an internal standard 
(CDCl3 at 7.26 ppm). Data reported as: s = singlet, d = doublet, t = triplet, q = quartet, quin. = 
quintet, sext. = sextet, sept. = septet, o = octet, m = multiplet, b = broad, ap = apparent; coupling 
constant(s) in Hz; integration. Proton-decoupled 13C NMR spectra were recorded on a Varian 
Unity-500 (125 MHz) spectrometer and are reported in ppm using solvent as an internal standard 
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(CDCl3). 19F NMR spectra were recorded on a Varian Unity-500 (470 MHz) spectrometer and 
are reported in ppm using solvent as an internal standard (CDCl3). Chiral gas chromatographic 
(GC) analysis was performed on an Agilent 6890N Series instrument equipped with FID 
detectors using a J&W Cyclosil-B column. Chiral high pressure liquid chromatography (HPLC) 
analysis was performed on an Agilent 1100 Series instrument equipped with a UV detector, 
using a CHIRALPAK AD-RH or OJ-H column.  We thank Dr. Danielle Gray at the University 
of Illinois George L. Clark X-Ray Facility for X-ray crystallographic analysis. Optical rotations 
were measured with a sodium lamp using a 1 mL cell with a 50 mm path length on a Jasco P-
1020 polarimeter. High-resolution mass spectra were obtained at the University of Illinois Mass 
Spectrometry Laboratory. 
Ligand Synthesis 
Ligand Intermediates 32, 33, and 34. 
 
 
Ligand intermediates 32, 33, and 34 were synthesized according to the method of Stoltz 
and coworkers95 using the following general procedure: 
The appropriate amino alcohol (10 mmol, 1.0 equiv) was dissolved in CH2Cl2 (33 mL). A 
solution of Na2CO3 (30 mmol, 3 equiv) in water (25 mL) was added. To the vigorously stirring 
biphasic mixture was added 2-bromobenzoyl chloride (11.5 mmol, 1.15 equiv) dropwise. The 
















     CH2Cl2, 55˚C




32: R = Ph
33: R = iPr
34: R = tBu
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separated, and the aqueous layer was extracted with CH2Cl2 (2 x 20 mL). The combined organic 
layers were treated with KOH (6 mL, 1M methanolic solution) for 15 minutes. The solution was 
neutralized with 2M HCl, and water (20 mL) was added. The layers were separated, and the 
aqueous layer was extracted with CH2Cl2 (2 x 30 mL). The combined organic layers were dried 
over anhydrous MgSO4, filtered, and evaporated under reduced pressure. The crude mixture was 
purified via column chromatography (25 ! 35% acetone in hexanes) to afford the desired amide, 
which was used for the next step. 
To a solution of amide (9.2 mmol, 1 equiv) in CH2Cl2 (35 mL) was added tosyl chloride 
(11.96 mmol, 1.3 equiv) and triethylamine (46 mmol, 5 equiv). The reaction was refluxed at 
55˚C for 22 hours. Water (10 mL) was added, and the reaction was refluxed at 75˚C for 2 hours. 
The reaction was cooled, and the layers were separated. The aqueous layer was extracted with 
CH2Cl2 (2 x 25 mL). The combined organic layers were dried over anhydrous MgSO4, filtered, 
and evaporated under reduced pressure. The crude mixture was purified via column 
chromatography (5% EtOAc in hexanes) to afford the desired phenyloxazoline. Spectral data for 
phenyloxazolines 32,117 33,118 and 3495 were consistent with previously reported literature. 
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Ligand intermediates 35,119 36,119 37,120  38121 and 39121 were synthesized according to reported 
methods, and spectral data was consistent with previously reported literature. 35, 38, and 39 use 
D-(+)-menthol as a chiral auxiliary, 36 uses L-(–)-menthol as a chiral auxiliary, and 37 uses 
diacetone-D-glucose. 
 
Synthesis of 40.  
 
 
In a dried flask, 4-trifluoromethylthiophenol (5 g, 28 mmol, 1 equiv) was dissolved in 
DMF (20 mL). Triethylamine (3.91 mL, 28 mmol, 1 equiv) was added, and the solution was 
stirred at 80˚C under an atmosphere of oxygen (balloon) for 48 hours. The reaction was cooled, 
and the mixture was diluted with ether (100 mL). The mixture was transferred to a separatory 
funnel, and the organic layer was washed with water (3 x 40 mL). The organic layer was dried 
over anhydrous MgSO4, filtered and concentrated to afford 1,2-bis(4-
(trifluoromethyl)phenyl)disulfane as a liquid. The material was used without further purification. 
To a dried flask under argon was added the disulfane (5 g, 14 mmol, 1 equiv) and glacial 
acetic acid (1.6 mL, 28 mmol, 2 equiv), and the mixture was cooled to –20˚C with stirring. 
Sulfuryl chloride (3.54 mL, 43.7 mmol, 3.1 equiv) was added dropwise via syringe over a period 
of 30 minutes. The mixture was stirred for 3 hours at –20˚C and then allowed to slowly warm to 
room temperature over a period of 2 hours. (CAUTION: evolution of HCl gas observed) The 
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room temperature, and the acetyl chloride and excess sulfuryl chloride was evaporated under 
reduced pressure to leave 4-(trifluoromethyl)benzenesulfinyl chloride as an orange liquid, used 
without further purification. The sulfinyl chloride was observed to be stable for up to a 
month if stored at 0˚C. 
Under the method of Clayden,120 to a dried flask under argon, diacetone-D-glucose (2.26 
g, 8.67 mmol, 1 equiv) was dissolved in THF (45 mL). Pyridine (0.84 mL, 10.4 mmol, 1.2 equiv) 
was added via syringe, and the mixture was stirred and cooled to –78˚C.  4-
(trifluoromethyl)benzenesulfinyl chloride (3g, 10.4 mmol, 1.2 equiv) was added dropwise via 
syringe, and the reaction was stirred 3 hours at –78˚C. The reaction was quenched with dropwise 
addition of water, and allowed to warm to room temperature. The mixture was diluted with 
CH2Cl2 (100 mL), and the layers were separated. The organic layer was washed with 5% HCl, 
2% NaHCO3, and brine. The organic layer was dried over anhydrous MgSO4, filtered, and 
concentrated under reduced pressure. The residue was purified via column chromatography (20% 
EtOAc in hexanes) to afford a mixture of diastereomers. This mixture was further purified via 
MPLC to afford 40 as a single diastereomer. 40 was observed to slowly decompose over the 
course of a month if stored at room temperature under air. 
1H NMR (500MHz, CDCl3) δ 7.96 (d, J = 7.9 Hz, 2H), 7.81 (d, J = 8.1 Hz, 2H), 5.88 (d, J = 3.4 
Hz, 1H), 5.00 (d, J = 2.8 Hz, 1H), 4.78 (d, J = 3.6 Hz, 1H), 4.22 (dd, J = 8.6, 2.8 Hz, 1H), 4.12-
4.00 (m, 3H), 1.53 (s, 3H), 1.50 (s, 3H), 1.43 (s, 3H), 1.32 (s, 3H); 13C NMR (125 MHz, CDCl3) 
δ 149.1, 134.5 (q, J = 33.0 Hz), 126.3 (q, J = 3.6 Hz), 125.8, 123.6 (q, J = 271.1 Hz), 112.8, 
109.8, 105.6, 84.1, 84.1, 81.2, 72.5, 68.0, 27.1, 27.0, 26.4, 25.6; [α]22D = +18.40˚ (c = 0.25, 
CH2Cl2); 19F NMR (470 MHz, CDCl3) δ -63.4; HRMS (TOF MS ES+) m/z calc’d for 
C19H24O7SF3 [M+H]: 453.1195; found 453.1215. 
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SOX Ligand synthesis: General Procedure 
To a dried flask under argon was added the phenyloxazoline  (1 equiv), THF (0.1 M), and 
TMEDA (1.1 equiv). The reaction was cooled to –78˚C with stirring, and n-butyllithium (1.6M 
in hexane, 1.1 equiv) was added via syringe dropwise. The reaction was stirred 20 minutes at –
78˚C. Subsequently, the sulfinate  (1.1 equiv) was added as a solution in THF (0.5 M) dropwise 
via syringe. The reaction was stirred 1 hour at –78˚C, then 1 hour at 0˚C, then 5 hours at room 
temperature. The reaction was subsequently cooled to 0˚C, and quenched with water. The 
mixture was diluted with CH2Cl2, and the layers were separated. The aqueous layer was 
extracted with CH2Cl2. The combined organic layers were dried over anhydrous MgSO4, filtered, 
and concentrated under reduced pressure. The crude residue was purified via column 
chromatography (20 ! 30% EtOAc in hexanes) to afford the desired product. 
 
 
(S)-4-phenyl-2-(2-((R)-p-tolylsulfinyl)phenyl)-4,5-dihydrooxazole (L1): Phenyloxazoline 32 
(302 mg, 1 mmol, 1 equiv) was reacted according to the general procedure with sulfinate 35 (324 
mg, 1.1 mmol, 1.1 equiv). Purification by flash column chromatography (20 ! 30% EtOAc in 
hexanes) provided the product as a clear, viscous oil. (198 mg, 0.55 mmol, 55% Yield.) 1H NMR 
(500MHz, CDCl3) δ 8.44 (d, J = 7.9 Hz, 1H), 7.95 (d, J = 7.5 Hz, 1H), 7.78 (t, J = 7.9 Hz, 1H), 
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J = 9.6 Hz, 1H), 4.74 (dd, J = 9.9, 8.4 Hz, 1H), 4.13 (t, J = 8.4 Hz, 1H), 2.33 (s, 3H); 13C NMR 
(125 MHz, CDCl3) δ 162.3, 147.3, 143.9, 142.1, 141.3, 132.4, 130.5, 130.1, 129.8, 129.1, 127.9, 
127.2, 126.8, 125.3, 125.2, 74.9, 70.4, 21.6; [α]21D = +364.78˚ (c = 1, CH2Cl2); HRMS (TOF MS 
ES+) m/z calc’d for C22H20NO2S [M+H]: 362.1215; found 362.1212. 
 
(S)-4-phenyl-2-(2-((S)-p-tolylsulfinyl)phenyl)-4,5-dihydrooxazole (L2): Phenyloxazoline 32 
(302 mg, 1 mmol, 1 equiv) was reacted according to the general procedure with sulfinate 36 (324 
mg, 1.1 mmol, 1.1 equiv). Purification by flash column chromatography (20 ! 30% EtOAc in 
hexanes) provided the product as a white powder. (162 mg, 0.45 mmol, 45% Yield.) 1H NMR 
(500MHz, CDCl3) δ 8.47 (d, J = 8.1 Hz, 1H), 8.03 (d, J = 7.7 Hz, 1H), 7.80 (t, J = 7.5 Hz, 1H), 
7.58 (t, J = 7.7 Hz, 1H), 7.45 (d, J = 7.9 Hz, 2H), 7.30-7.25 (m, 3H), 7.02 (d, J = 7.5 Hz, 2H), 
7.00 (d, J = 8.1 Hz, 2H), 5.43 (t, J = 9.6 Hz, 1H), 4.74 (ap. t, J = 9.6, Hz, 1H), 4.21 (t, J = 8.3 Hz, 
1H), 2.32 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 162.0, 147.0, 143.7, 141.8, 141.0, 132.4, 
130.5, 130.3, 129.7, 128.8, 127.8, 127.1, 127.1, 125.5, 125.1, 74.6, 71.0, 21.6; [α]22D = –195.79˚ 
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(S)-4-isopropyl-2-(2-((R)-p-tolylsulfinyl)phenyl)-4,5-dihydrooxazole (L3): Phenyloxazoline 
33 (249 mg, 0.93 mmol, 1 equiv) was reacted according to the general procedure with sulfinate 
35 (300 mg, 1.02 mmol, 1.1 equiv). Purification by flash column chromatography (20 ! 30% 
EtOAc in hexanes) provided the product as a clear, viscous oil. (146 mg, 0.45 mmol, 48% 
Yield.) 1H NMR (500MHz, CDCl3) δ 8.38 (dd, J = 7.9, 1.1 Hz, 1H), 7.85 (dd, J = 7.7, 1.3 Hz, 
1H), 7.72 (td, J = 7.7, 1.3 Hz, 1H), 7.62 (d, J = 8.3 Hz, 2H), 7.50 (td, J = 7.7, 1.3 Hz, 1H), 7.16 
(d, J = 7.9 Hz, 2H), 4.36-4.29 (m, 1H), 4.06-3.99 (m, 2H), 2.32 (s, 3H), 1.80-1.72 (m, 1H), 1.06 
(d, J = 6.6 Hz, 3H), 0.96 (d, J = 6.9 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 160.5, 147.4, 144.3, 
141.1, 132.1, 130.4, 129.8, 129.8, 127.0, 125.6, 125.3, 73.6, 70.8, 33.5, 21.7, 19.2, 19.2; [α]22D = 
+270.80˚ (c = 0.5, CH2Cl2); HRMS (TOF MS ES+) m/z calc’d for C19H22NO2S [M+H]: 
328.1368; found 328.1371. 
 
(S)-4-(tert-butyl)-2-(2-((R)-p-tolylsulfinyl)phenyl)-4,5-dihydrooxazole (L4): Phenyloxazoline 
34 (282 mg, 1 mmol, 1 equiv) was reacted according to the general procedure with sulfinate 35 
(324 mg, 1.1 mmol, 1.1 equiv). Purification by flash column chromatography (20 ! 30% EtOAc 
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(500MHz, CDCl3) δ 8.37 (dd, J = 7.9, 1.1 Hz, 1H), 7.85 (dd, J = 7.7, 1.3 Hz, 1H), 7.72 (td, J = 
7.7, 1.1 Hz, 1H), 7.65 (d, J = 8.4 Hz, 2H), 7.50 (td, J = 7.5, 0.9 Hz, 1H), 7.16 (d, J = 8.4 Hz, 2H), 
4.25 (dd, J = 10.1, 8.8 Hz, 1H), 4.16 (t, J = 8.1, Hz, 1H), 4.03 (dd, J = 10.1, 7.9 Hz, 1H), 2.32 (s, 
3H), 0.97 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 160.4, 147.6, 144.4, 141.0, 132.1, 130.4, 
129.8, 126.8, 125.6, 125.3, 77.6, 68.9, 34.3, 26.3, 21.7; [α]23D = +224.03˚ (c = 0.25, CH2Cl2); 
HRMS (TOF MS ES+) m/z calc’d for C20H24NO2S [M+H]: 342.1528; found 342.1529. Spectral 
data (including 15 peaks observed in the 13C NMR spectrum) is consistent with data in previous 
literature.98  
 
(S)-2-(2-((R)-isopropylsulfinyl)phenyl)-4-phenyl-4,5-dihydrooxazole (L5): To a dried flask 
under argon was added phenyloxazoline  32 (302 mg, 1 mmol, 1 equiv), THF (10 mL), and 
TMEDA (0.16 mL, 1.1 mmol, 1.1 equiv). The reaction was cooled to –78˚C with stirring, and n-
butyllithium (0.69 mL, 1.6M in hexane, 1.1 equiv) was added via syringe dropwise. The reaction 
was stirred 20 minutes at –78˚C. Subsequently, sulfinate 37 (386 mg, 1.1 mmol, 1.1 equiv) was 
added as a solution in THF (2 mL) dropwise via syringe. The reaction was stirred 1 hour at –
78˚C, then 1 hour at 0˚C, then 2 hours at room temperature. The reaction was subsequently 
cooled to 0˚C, and quenched with water. The mixture was diluted with CH2Cl2, and the layers 
were separated. The aqueous layer was extracted with CH2Cl2. The combined organic layers 
were dried over anhydrous MgSO4, filtered, and concentrated under reduced pressure. The crude 
residue was purified via column chromatography (20 ! 30% EtOAc in hexanes) to afford the 
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MeOH, and PTSA was added (10 mg). The reaction was stirred 10 hours at room temperature. 
The mixture was diluted with CH2Cl2 and water. The layers were separated, and the aqueous 
layer was extracted with CH2Cl2. The combined organic layers were dried over anhydrous 
MgSO4, filtered, and concentrated under reduced pressure. The residue was purified via column 
chromatography (30% EtOAc in hexanes) to afford the product as a white powder. (73 mg, 0.23 
mmol, 23% Yield.) 1H NMR (500MHz, CDCl3) δ 8.14 (dd, J = 7.8, 1.0 Hz, 1H), 7.99 (dd, J = 
7.8, 1.0 Hz, 1H), 7.74 (td, J = 7.8, 1.2 Hz, 1H), 7.56 (td, J = 7.6, 1.2 Hz, 1H), 7.42-7.37 (m, 4H), 
7.35-7.31 (m, 1H), 5.56 (dd, J = 10.0, 8.8 Hz, 1H), 4.85 (dd, J = 10.3, 8.3 Hz, 1H), 4.23 (t, J = 
8.3 Hz, 1H), 3.52 (sept., J = 6.8 Hz, 1H), 1.43 (d, J = 7.1 Hz, 3H), 0.98 (d, J = 6.8 Hz, 3H); 13C 
NMR (125 MHz, CDCl3) δ 162.3, 145.8, 142.2, 131.7, 130.0, 129.9, 129.0, 127.9, 126.6, 126.2, 
124.8, 74.8, 70.8, 52.2, 18.8, 11.6; [α]22D = +313.19˚ (c = 0.225, CH2Cl2); HRMS (TOF MS 





Phenyloxazoline 32 (309 mg, 1.02 mmol, 1 equiv) was reacted according to the general 
procedure with sulfinate 38 (349 mg, 1.13 mmol, 1.1 equiv). Purification by flash column 
chromatography (20 ! 30% EtOAc in hexanes) provided the product as a white powder. (182 
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7.3 Hz, 1H), 7.79 (t, J = 7.3 Hz, 1H), 7.62-7.58 (m, 2H), 7.55 (t, J = 7.7 Hz, 1H), 7.38-7.28 (m, 
3H), 7.23 (d, J = 7.5 Hz, 2H), 6.85 (d, J = 8.6 Hz, 2H), 5.37 (ap. t, J = 9.9 Hz, 1H), 4.73 (dd, J = 
10.1, 8.4 Hz, 1H), 4.11 (t, J = 8.8 Hz, 1H), 3.78 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 162.3, 
161.7, 147.3, 142.1, 138.3, 132.3, 130.4, 130.2, 129.2, 129.0, 127.9, 126.7, 125.2, 125.1, 114.5, 
74.8, 70.3, 55.6; [α]21D = +357.55˚ (c = 0.25, CH2Cl2); HRMS (TOF MS ES+) m/z calc’d for 




Phenyloxazoline 32 (700 mg, 2.32 mmol, 1 equiv) was reacted according to the general 
procedure with sulfinate 39 (857 mg, 2.55 mmol, 1.1 equiv). Purification by flash column 
chromatography (20 ! 30% EtOAc in hexanes) provided the product as a white powder (400 
mg, 1 mmol, 43% Yield.) 1H NMR (500MHz, CDCl3) δ 8.45 (dd, J = 7.9, 1.1 Hz, 1H), 7.96 (dd, 
J = 7.7, 1.3 Hz, 1H), 7.78 (td, J = 7.7, 1.3 Hz, 1H), 7.65-7.61 (m, 2H), 7.55 (td, J = 7.5, 1.1 Hz, 
1H), 7.38-7.30 (m, 7H), 5.41 (ap. t, J = 9.6 Hz, 1H), 4.76 (dd, J = 10.3, 8.4 Hz, 1H), 4.15 (t, J = 
8.6 Hz, 1H), 1.26 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 162.3, 154.2, 147.4, 143.8, 142.1, 
132.4, 130.4, 130.0, 129.1, 127.9, 126.8, 126.8, 126.1, 125.3, 125.2, 74.9, 70.4, 35.1, 31.4; [α]22D 
= +371.11˚ (c = 0.25, CH2Cl2); HRMS (TOF MS ES+) m/z calc’d for C25H26NO2S [M+H]: 














Phenyloxazoline 32 (387 mg, 1.28 mmol, 1 equiv) was reacted according to the general 
procedure with sulfinate 40 (638 mg, 1.41 mmol, 1.1 equiv). Purification by flash column 
chromatography (20 ! 30% EtOAc in hexanes) provided the product as a clear, viscous oil. (132 
mg, 0.32 mmol, 25% Yield.) 1H NMR (500MHz, CDCl3) δ 8.39 (d, J = 7.9 Hz, 1H), 7.96 (d, J = 
7.7 Hz, 1H), 7.92 (d, J = 8.4 Hz, 2H), 7.79 (t, J = 7.7 Hz, 1H), 7.62-7.57 (m, 3H), 7.42-7.32 (m, 
5H), 5.45 (ap. t, J = 9.6 Hz, 1H), 4.80 (dd, J = 10.3, 9.2 Hz, 1H), 4.21 (t, J = 8.6 Hz, 1H); 13C 
NMR (125 MHz, CDCl3) δ 162.1, 151.4, 147.0, 141.9, 132.7, 132.5 (q, J = 33.0 Hz), 131.0, 
130.1, 129.2, 128.1, 127.2, 126.7, 126.0 (q, J = 3.8 Hz), 125.3, 125.3, 123.8 (q, J = 271.1 Hz), 
75.1, 70.5; 19F NMR (470 MHz, CDCl3) δ -63.3; [α]23D = +317.47˚ (c = 0.25, CH2Cl2); HRMS 
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4,4-dimethyl-2-(2-(p-tolylsulfinyl)phenyl)-4,5-dihydrooxazole (41): 
Racemic product standards (12a-12k) were prepared according to 
analogous procedures, substituting the chiral ligands for the racemic ligand 
41.  1H NMR (500MHz, CDCl3) δ 8.37 (d, J = 7.9 Hz, 1H), 7.89 (dd, J = 
7.7, 1.1 Hz, 1H), 7.73 (td, J = 7.7, 1.3 Hz, 1H), 7.60 (d, J = 8.1 Hz, 2H), 7.52 (td, J = 7.5, 1.1 Hz, 
1H), 7.18 (d, J = 8.1 Hz, 2H), 4.03 4.01 (ABq, JAB = 8.1 Hz, 2H), 2.34 (s, 3H), 1.33 (s, 3H), 1.28 
(s, 3H); 13C NMR (125 MHz, CDCl3) δ 159.5, 146.7, 143.8, 141.2, 132.0, 130.4, 129.9, 129.7, 
127.1, 125.8, 125.2, 79.1, 68.8, 28.8, 28.4, 21.6; HRMS (TOF MS ES+) m/z calc’d for 
C18H20NO2S [M+H]: 314.1215; found 314.1215. 
 
(R,R) 1,2-bis(p-tolylsulfinyl)ethane (L11) was synthesized according to a reported method, and 
spectral data matched those reported.122 
 
(S)-2-(4'-(tert-butyl)-[1,1'-biphenyl]-2-yl)-4-phenyl-4,5-dihydrooxazole (L12): 1H NMR 
(500MHz, CDCl3) δ 7.84 (dd, J = 7.7, 1.4 Hz, 1H), 7.50 (td, J = 7.4, 0.9 Hz, 1H), 7.44 – 7.31 (m, 
8H), 7.30 – 7.26 (m, 1H), 7.24 – 7.21 (m, 2H), 5.30 – 5.26 (m, 1H), 4.53 (dd, J = 10.0, 8.6 Hz, 
1H), 3.98 (t, J = 8.5 Hz, 1H), 1.36 (s, 9H). 13C NMR (126 MHz, CDCl3) δ 166.8, 150.4, 142.5, 
142.2, 138.5, 130.9, 130.7, 130.6, 128.9, 128.4, 127.7, 127.7, 127.2, 127.0, 125.3, 75.2, 70.4, 
34.8, 31.7. δ -63.3; [α]23D = –110.11˚ (c = 0.3, CH2Cl2); HRMS (TOF MS ES+) m/z calc’d for 
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(S)-L13: was synthesized according to a reported method, and spectral data matched those 
reported.82 
 
meso-1,2-bis(phenylsulfinyl)ethane (L14) was synthesized according to a reported method, and 
spectral data matched those reported.17 
 
(S)-2-(5-methoxy-2-((R)-p-tolylsulfinyl)phenyl)-4-phenyl-4,5-dihydrooxazole (L9): Product 
is a white powder.  1H NMR (500MHz, CDCl3) δ 8.30 (d, J = 9.0 Hz, 1H), 7.56 (d, J = 8.1 Hz, 
2H), 7.45 (d, J = 2.6 Hz, 1H), 7.34-7.28 (m, 3H), 7.27-7.23 (m, 3H), 7.15 (d, J = 8.4 Hz, 2H), 
5.34 (ap. t, J = 10.0 Hz, 1H), 4.74 (dd, J = 10.1, 8.4 Hz, 1H), 4.13 (t, J = 8.6 Hz, 1H), 3.88 (s, 
3H), 2.33 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 162.2, 161.3, 144.4, 142.1, 141.1, 138.1, 
129.8, 129.1, 127.9, 127.3, 126.9, 126.8, 126.6, 118.0, 115.2, 74.9, 70.4, 56.0, 21.6; [α]22D = 
+284.81˚ (c = 0.314, CH2Cl2); HRMS (TOF MS ES+) m/z calc’d for C23H22NO3S [M+H]: 
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(S)-4-phenyl-2-(2-((R)-p-tolylsulfinyl)-5-(trifluoromethyl)phenyl)-4,5-dihydrooxazole (L10): 
Product is a white powder.  1H NMR (500MHz, CDCl3) δ 8.62 (d, J = 8.3 Hz, 1H), 8.22 (s, 1H), 
8.03 (d, J = 8.3 Hz, 1H), 7.58 (d, J = 8.1 Hz, 2H), 7.42-7.33 (m, 3H), 7.29-7.26 (m, 2H), 7.18 (d, 
J = 8.1 Hz, 2H), 5.43 (ap. t, J = 9.5 Hz, 1H), 4.79 (dd, J = 10.3, 8.5 Hz, 1H), 4.19 (t, J = 8.5 Hz, 
1H), 2.35 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 161.2, 151.8, 143.2, 141.8, 141.6, 132.7 (q, J = 
33.2 Hz), 129.9, 129.2, 128.8 (q, J = 3.7 Hz), 128.1, 127.3, 127.2 (q, J = 3.6 Hz), 126.7, 126.1, 
125.9, 123.5 (q, J = 272.8 Hz), 75.1, 70.5, 21.7; 19F NMR (470 MHz, CDCl3) δ -63.2; [α]24D = 
+273.6˚ (c = 1, CHCl3); HRMS (TOF MS ES+) m/z calc’d for C23H19NO2SF3 [M+H]: 430.1089; 
found 430.1088. 
General Synthesis of Starting Materials 
General Route A was used for 11a, 11f, 11h, 11i. General Route B was used for 11b, 11c, 11d, 
11e, 11g, 11j. 
General Starting Material Synthesis A. 
 
General Route A: To a dried round-bottom flask (RBF) was added the 2-bromophenylacetic 
acid starting material and anhydrous MeOH (0.3 M). Concentrated Sulfuric acid (5 mol%) was 
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volatiles were evaporated under reduced pressure, and the remaining mixture was dissolved in 
EtOAc. The organics were washed with sat. aq. NaHCO3 (x 3), and the organic layer was dried 
over anhydrous MgSO4, filtered, and concentrated under reduced pressure. The mixture was 
purified by column chromatography to afford the desired methyl ester. 
 To a dried RBF in a glove box was added Pd(PPh3)4 (0.1 equiv), LiCl (5.0 equiv), and the 
flask was sealed and taken out of the glovebox. THF (0.1 M) was added followed by the 
corresponding methyl ester substrate (1.0 equiv) and allyltributylstannane (1.2 equiv) via 
syringe. The reaction was refluxed under argon overnight. After complete conversion of the 
starting material was observed by TLC, the flask was cooled to 0˚C and diluted slowly with 
water. The layers were separated, and the aqueous layer was extracted with EtOAc (x 2). The 
combined organic layers were dried over anhydrous MgSO4, filtered, and concentrated under 
reduced pressure. The mixture was purified by column chromatography to afford the desired 
allylated methyl ester. 
 To a dried RBF was added LiAlH4 (95%, 1 equiv) under argon. THF (0.1 M) was added, 
and the flask was cooled to 0˚C. To the mixture was added the allylated methyl ester (1.4 equiv) 
dissolved in THF (1 M) dropwise, and the mixture was warmed to room temperature and stirred 
for 2 hours under argon. After complete conversion of the starting material was observed by 
TLC, the reaction flask was cooled to 0˚C, and the reaction was quenched by dropwise addition 
of sat. aq. Rochelle’s salt. The reaction was diluted with ether, and the biphasic mixture was 
stirred until both layers became homogeneous (typically 2 hours to overnight). The layers were 
separated, and the aqueous layer was extracted with ether (x 3). The combined organic layers 
were washed once with brine, and dried over anhydrous MgSO4, filtered, and concentrated under 
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reduced pressure. The mixture was purified by column chromatography to afford the desired 
alcohol. 
General Starting Material Synthesis B. 
 
General Route B: Under the conditions of Yu,123 to a dried RBF was added PhI(OAc)2 (0.75 
equiv) and I2 (0.75 equiv). The flask was wrapped in aluminum foil to protect it from light, and 
DMF (0.16 M) was added. The reaction was capped and stirred for 5 minutes, and then 
Pd(OAc)2 (0.05 equiv) and the phenylacetic acid starting material (1.0 equiv) were added 
quickly. The flask was sealed with a glass stopper and the seal was wrapped in Teflon tape and 
parafilm and subsequently covered in aluminum foil. The reaction was stirred at 60˚C for 12 
hours. The solvent was subsequently evaporated under reduced pressure with the assistance of a 
high-vacuum, and the residue was dissolved in ether. The organic layer was extracted with sat. 
aq. NaHCO3 (x 3), and the combined aqueous layers were acidified with HCl. CH2Cl2 was 
added, and the aqueous layer was extracted with CH2Cl2 (x 2) and EtOAc (x 1). The combined 
organic layers were dried over anhydrous MgSO4, filtered, and concentrated under reduced 
pressure to afford the iodinated phenylacetic acid substrate that was taken on directly to the next 
step.  
To a dried RBF was added the 2-iodophenylacetic acid starting material and anhydrous 
MeOH (0.3 M). Concentrated Sulfuric acid (5 mol%) was added, and the reaction was refluxed 
for three hours. After cooling to room temperature, the volatiles were evaporated under reduced 
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sat. aq. NaHCO3 (x 3), and the organic layer was dried over anhydrous MgSO4, filtered, and 
concentrated under reduced pressure. The mixture was purified by column chromatography to 
afford the desired methyl ester. 
 To a dried RBF in a glove box was added Pd(PPh3)4 (0.05 equiv), CsF (2.0 equiv), CuI 
(0.1 equiv), and the flask was sealed and taken out of the glovebox. DMF (0.33 M) was added 
followed by the corresponding methyl ester substrate (1.0 equiv) and allyltributylstannane (1.2 
equiv) via syringe. The reaction was stirred at 45˚C for 6 hours under argon. After complete 
conversion of the starting material was observed by TLC, the flask was cooled to 0˚C and diluted 
slowly with water. The mixture was diluted with ether, and the layers were separated. The 
organic layer was washed with water (x 2). The organic layer was dried over anhydrous MgSO4, 
filtered, and concentrated under reduced pressure. The mixture was purified by column 
chromatography to afford the desired allylated methyl ester. 
 To a dried RBF was added LiAlH4 (95%, 1 equiv) under argon. THF (0.1 M) was added, 
and the flask was cooled to 0˚C. To the mixture was added the allylated methyl ester dissolved in 
THF (1 M) dropwise, and the mixture was warmed to room temperature and stirred for 2 hours 
under argon. After complete conversion of the starting material was observed by TLC, the 
reaction flask was cooled to 0˚C, and the reaction was quenched by dropwise addition of sat. aq. 
Rochelle’s salt. The reaction was diluted with ether, and the biphasic mixture was stirred until 
both layers became homogeneous (typically 2 hours to overnight). The layers were separated, 
and the aqueous layer was extracted with ether (x 3). The combined organic layers were washed 
once with brine, and dried over anhydrous MgSO4, filtered, and concentrated under reduced 
pressure. The mixture was purified by column chromatography to afford the desired alcohol. 
 
	   101	  
Starting Materials 
 
2-(2-allylphenyl)ethan-1-ol (11a): Product is a clear oil 1H NMR (500MHz, CDCl3) δ 7.20-7.18 
(m, 4H), 5.98 (ddt, J = 16.9, 10.1, 6.2 Hz, 1H), 5.07 (d, J = 10.1 Hz, 1H), 4.99 (d, J = 16.9 Hz, 
1H), 3.84 (app. q, J = 6.4 Hz, 2H), 3.44 (d, J = 6.2 Hz, 2H), 2.91 (t, J = 6.9 Hz, 2H), 1.46 (br. s, 
1H); 13C NMR (125 MHz, CDCl3) δ 138.6, 137.6, 136.7, 130.3, 130.3, 127.1, 126.9, 116.1, 63.5, 
37.4, 36.2; HRMS (EI) m/z calc’d for C11H13O [M]+: 161.0966; found 161.0969.  Spectral data 
is consistent with data in previous literature.28 
 
2-(2-allyl-5-methylphenyl)ethan-1-ol (11b): Product is a clear oil. 1H NMR (500 MHz, 
Chloroform-d) δ 7.07 (d, J = 7.5 Hz, 1H), 7.01 (d, J = 8.1 Hz, 2H), 5.95 (ddt, J = 17.1, 10.1, 6.3 
Hz, 1H), 5.05 (dq, J = 10.1, 1.4 Hz, 1H), 4.98 (ddd, J = 17.1, 2.3, 1.3 Hz, 1H), 3.83 (t, J = 6.9 
Hz, 2H), 3.39 (d, J = 6.3 Hz, 2H), 2.87 (t, J = 6.8 Hz, 2H), 2.31 (s, 3H); 13C NMR (126 MHz, 
CDCl3) δ 137.79, 136.42, 136.24, 135.41, 130.99, 130.17, 127.76, 115.84, 63.48, 37.00, 36.11, 
21.24; HRMS (EI) m/z calc’d for C12H16O [M]+: 176.1201; found 176.1209. 
 
2-(2-allyl-4-methylphenyl)ethan-1-ol (11c): Product is a clear oil. 1H NMR (500 MHz, 
Chloroform-d) δ 7.09 (d, J = 8.2 Hz, 1H), 7.04 – 6.98 (m, 2H), 5.96 (ddt, J = 17.2, 10.1, 6.3 Hz, 
1H), 5.06 (dq, J = 10.1, 1.6 Hz, 1H), 5.00 (dq, J = 17.1, 1.8 Hz, 1H), 3.82 (t, J = 6.9 Hz, 2H), 





	   102	  
MHz, CDCl3) δ 138.31, 137.64, 136.54, 133.47, 130.94, 130.18, 127.50, 115.98, 63.53, 37.38, 
35.71, 21.25; HRMS (EI) m/z calc’d for C12H16O [M]+: 176.1201; found 176.1201.  
 
2-(2-allyl-4,5-dimethoxyphenyl)ethan-1-ol (11d): Product is a clear oil 1H NMR (500MHz, 
CDCl3) δ 6.72 (s, 1H), 6.69 (s, 1H), 5.95 (ddt, J = 16.3, 10.1, 6.2 Hz, 1H), 5.06 (dq, J = 10.1, 1.7 
Hz, 1H), 4.98 (dq, J = 17.1, 1.7 Hz, 1H), 3.86 (s, 3H), 3.85 (s, 3H), 3.81 (app. q, J = 6.6 Hz, 2H), 
3.36 (d, J = 6.2 Hz, 2H), 2.84 (t, J = 6.9 Hz, 2H), 1.42 (t, J = 5.6 Hz, 1H); 13C NMR (125 MHz, 
CDCl3) δ 147.9, 147.7, 137.9, 130.6, 128.6, 116.0, 113.6, 113.5, 63.8, 56.3, 56.3, 37.1, 36.0; 
HRMS (EI) m/z calc’d for C13H18O3 [M]+: 222.1256; found 222.1259. 
 
2-(2-allyl-5-bromophenyl)ethan-1-ol (11e): Product is a clear oil. 1H NMR (500 MHz, 
Chloroform-d) δ 7.38 – 7.28 (m, 2H), 7.04 (d, J = 8.2 Hz, 1H), 5.92 (ddt, J = 16.4, 9.9, 6.1 Hz, 
1H), 5.08 (dd, J = 9.9, 1.8 Hz, 1H), 4.96 (dd, J = 17.2, 1.9 Hz, 1H), 3.80 (t, J = 6.8 Hz, 2H), 3.37 
(d, J = 5.7 Hz, 2H), 2.84 (t, J = 6.8 Hz, 2H), 1.91 (br, 1H); 13C NMR (126 MHz, CDCl3) δ 
139.22, 137.47, 136.83, 132.87, 131.84, 129.95, 120.38, 116.49, 63.07, 36.81, 35.80; HRMS (EI) 
m/z calc’d for C11H13OBr [M]+: 240.1050; found 240.1050. 
 
2-(2-allyl-4-fluorophenyl)ethan-1-ol (11f): Product is a clear oil 1H NMR (500MHz, CDCl3) δ 
7.18 (dd, J = 8.3, 5.9 Hz, 1H), 6.94-6.87 (m, 2H), 5.97 (ddt, J = 16.4, 10.0, 6.1 Hz, 1H), 5.14 (dq, 
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6.1 Hz, 2H), 2.89 (t, J = 6.8 Hz, 2H), 1.51 (br. s, 1H); 13C NMR (125 MHz, CDCl3) δ 161.9 (d, J 
= 244.1 Hz), 140.8 (d, J = 6.8 Hz), 136.6, 132.3 (d, J = 2.8 Hz), 131.6, 131.5, 116.3 (d, J = 21.0 
Hz), 113.4 (d, J = 20.5 Hz), 63.4, 37.3, 35.4; 19F NMR (470 MHz, CDCl3) δ -117.1; HRMS (EI) 
m/z calc’d for C11H13OF [M]+: 180.0950; found 180.0948. 
 
2-(2-allyl-6-fluorophenyl)ethan-1-ol (11g): Product is a clear oil 1H NMR (500MHz, CDCl3) δ 
7.15 (dt, J = 7.9, 5.8 Hz, 1H), 6.97 (d, J = 7.7 Hz, 1H), 6.92 (t, J = 9.6 Hz, 1H), 5.96 (ddt, J = 
16.5, 10.1, 6.2 Hz, 1H), 5.08 (dq, J = 10.1, 1.5 Hz, 1H), 4.98 (dq, J = 17.2, 1.7 Hz, 1H), 3.81 
(app. q, J = 7.1 Hz, 2H), 3.46 (dt, J = 6.2, 1.5 Hz, 2H), 2.96 (td, J = 7.1, 1.9 Hz, 2H), 1.44 (br. s, 
1H); 13C NMR (125 MHz, CDCl3) δ 162.2 (d, J = 244.0 Hz), 141.3, 137.2, 128.0 (d, J = 9.2 Hz), 
125.7 (d, J = 2.8 Hz), 124.2 (d, J = 14.7), 116.5, 113.6 (d, J = 23.0 Hz), 62.7, 37.3, 29.3; 19F 
NMR (470 MHz, CDCl3) δ -117.4; HRMS (EI) m/z calc’d for C11H13FO [M]+: 180.0950; found 
180.0955. 
 
2-(2-allyl-5-chlorophenyl)ethan-1-ol (11h): Product is a clear oil 1H NMR (500MHz, CDCl3) δ 
7.20 (d, J = 1.9 Hz, 1H), 7.16 (dd, J = 8.1, 1.9 Hz, 1H), 7.10 (d, J = 8.1 Hz, 1H), 5.93 (ddt, J = 
16.3, 10.1, 5.6 Hz, 1H), 5.08 (d, J = 10.3 Hz, 1H), 4.96 (d, J = 17.1 Hz, 1H), 3.84 (app. q, J = 6.4 
Hz, 2H), 3.38 (d, J = 6.2 Hz, 2H), 2.87 (t, J = 6.6 Hz, 2H), 1.46 (t, J = 5.6 Hz, 1H); 13C NMR 
(125 MHz, CDCl3) δ 138.8, 137.0, 132.4, 131.6, 130.1, 127.1, 127.1, 116.5, 63.2, 36.9, 35.9; 
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2-(2-allyl-4-(trifluoromethyl)phenyl)ethan-1-ol (11i): Product is a clear oil 1H NMR 
(500MHz, CDCl3) δ 7.48-7.45 (m, 2H), 7.36 (d, J = 8.3 Hz, 1H), 5.99 (ddt, J = 16.4, 10.0, 6.1 
Hz, 1H), 5.16 (dq, J = 10.3, 1.5 Hz, 1H), 5.03 (dq, J = 17.1, 1.7 Hz, 1H), 3.90 (t, J = 6.8 Hz, 2H), 
3.52 (d, J = 6.1 Hz, 2H), 2.99 (t, J = 6.6 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ 141.1, 139.3, 
136.4, 130.5, 129.2 (q, J = 32.1 Hz), 126.8 (q, J = 3.6 Hz), 124.5 (q, J = 270.1 Hz), 123.5 (q, J = 
3.6 Hz), 117.0, 63.0, 37.2, 35.9; 19F NMR (470 MHz, CDCl3) δ -62.8; HRMS (EI) m/z calc’d for 
C12H13OF3 [M]+: 230.0918; found 230.0925. 
 
2-(2-allylnaphthalen-1-yl)ethan-1-ol (11j): Product is a clear oil 1H NMR (500MHz, CDCl3) δ 
8.12 (d, J = 8.5 Hz, 1H), 7.85 (d, J = 8.1 Hz, 1H), 7.74 (d, J = 8.5 Hz, 1H), 7.55 (t, J = 6.8 Hz, 
1H), 7.48 (t, J = 7.8 Hz, 1H), 7.36 (d, J = 8.5 Hz, 1H), 6.07 (ddt, J = 16.1, 10.0, 6.1 Hz, 1H), 
5.12 (dq, J = 10.0, 1.7 Hz, 1H), 5.03 (dq, J = 17.1, 1.7 Hz, 1H), 3.97 (t, J = 7.1 Hz, 2H), 3.68 (dt, 
J = 6.1, 1.7 Hz, 2H), 3.45 (t, J = 7.3 Hz, 2H), 1.48 (br. s, 1H); 13C NMR (125 MHz, CDCl3) δ 
137.6, 136.2, 133.0, 132.9, 131.5, 128.9, 128.8, 127.4, 126.4, 125.3, 124.1, 116.0, 63.2, 38.2, 
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Reaction Optimization and Products 
 
 
Table 2.5, Entry 1: 
To a ½ dram vial was added ligand L1 (7.2 mg, 0.02 mmol, 0.1 equiv) and Pd(OAc)2 (4.4 mg, 
0.02 mmol, 0.1 equiv). Toluene (0.4 mL) was added, and the vial was capped and heated to 45˚C 
until all solids had dissolved. Separately, to a 1 dram vial with stir bar was added 11a (32.4 mg, 
0.20 mmol, 1 equiv), 2,6-dimethylbenzoquinone (30 mg, 0.22 mmol, 1.1 equiv). The catalyst 
solution was subsequently added to the reaction flask, and toluene was used to rinse up to 1.3 
































































































a Reactions run under air, average of two isolated runs. b rxn run for 72 hours at [0.5M]. 
c rxn run under argon with conditions reported in ref. 82 also resulted in trace product yield. 
d p-benzoquinone used in place of 2,6-DMBQ.    2,6-DMBQ = 2,6-dimethylbenzoquinone. 
N.D. = not determined.
Table 2.5: Reaction optimization  
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45˚C.  Afterward, the vial was allowed to cool to room temperature. The majority of the toluene 
was removed under reduced pressure, and the remaining mixture was directly subjected to flash 
column chromatography (10% EtOAc/hexanes) to provide vinylisochroman 12a as a clear oil. 
Run 1 (2.3 mg, 7% yield, 83% ee); Run 2 (3.0 mg, 9% yield, 83% ee); Average: 8% Yield, 
83% ee.  
 
Table 2.5, Entry 2: 
To a ½ dram vial was added ligand L1 (7.2 mg, 0.02 mmol, 0.1 equiv) and Pd(OAc)2 (4.4 mg, 
0.02 mmol, 0.1 equiv). Toluene (0.4 mL) was added, and the vial was capped and heated to 45˚C 
until all solids had dissolved. Separately, to a 1 dram vial with stir bar was added 11a (32.4 mg, 
0.20 mmol, 1 equiv), 2,6-dimethylbenzoquinone (30 mg, 0.22 mmol, 1.1 equiv), and benzoic 
acid (2.5 mg, 0.02 mmol, 0.1 equiv). The catalyst solution was subsequently added to the 
reaction flask, and toluene was used to rinse up to 1.3 mL toluene. The 1 dram vial was sealed 
with a Teflon cap, and allowed to stir for 8 hours at 45˚C.  Afterward, the vial was allowed to 
cool to room temperature. The majority of the toluene was removed under reduced pressure, and 
the remaining mixture was directly subjected to flash column chromatography (10% 
EtOAc/hexanes) to provide vinylisochroman 12a as a clear oil. Run 1 (4.0 mg, 13% yield, 84% 
ee); Run 2 (4.0 mg, 13% yield, 84% ee); Average: 13% Yield, 84% ee.  
 
Table 2.5, Entry 3: 
To a ½ dram vial was added ligand L1 (7.2 mg, 0.02 mmol, 0.1 equiv) and Pd(OAc)2 (4.4 mg, 
0.02 mmol, 0.1 equiv). Toluene (0.4 mL) was added, and the vial was capped and heated to 45˚C 
until all solids had dissolved. Separately, to a 1 dram vial with stir bar was added 11a (32.4 mg, 
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0.20 mmol, 1 equiv), 2,6-dimethylbenzoquinone (30 mg, 0.22 mmol, 1.1 equiv), and dibutyl 
phosphate (4 µL, 0.02 mmol, 0.1 equiv). The catalyst solution was subsequently added to the 
reaction flask, and toluene was used to rinse up to 1.3 mL toluene. The 1 dram vial was sealed 
with a Teflon cap, and allowed to stir for 8 hours at 45˚C.  Afterward, the vial was allowed to 
cool to room temperature. The majority of the toluene was removed under reduced pressure, and 
the remaining mixture was directly subjected to flash column chromatography (10% 
EtOAc/hexanes) to provide vinylisochroman 12a as a clear oil. Run 1 (15 mg, 47% yield, 87% 
ee); Run 2 (½ scale) (9.7 mg, 61% yield, 87% ee); Average: 54% Yield, 87% ee.  
 
Table 2.5, Entry 4: 
To a ½ dram vial was added ligand L1 (7.2 mg, 0.02 mmol, 0.1 equiv) and Pd(OAc)2 (4.4 mg, 
0.02 mmol, 0.1 equiv). Toluene (0.4 mL) was added, and the vial was capped and heated to 45˚C 
until all solids had dissolved. Separately, to a 1 dram vial with stir bar was added 11a (32.4 mg, 
0.20 mmol, 1 equiv), 2,6-dimethylbenzoquinone (30 mg, 0.22 mmol, 1.1 equiv), and diphenyl 
phosphate (5.0 mg, 0.02 mmol, 0.1 equiv). The catalyst solution was subsequently added to the 
reaction flask, and toluene was used to rinse up to 1.3 mL toluene. The 1 dram vial was sealed 
with a Teflon cap, and allowed to stir for 8 hours at 45˚C.  Afterward, the vial was allowed to 
cool to room temperature. The majority of the toluene was removed under reduced pressure, and 
the remaining mixture was directly subjected to flash column chromatography (10% EtOAc in 
hexanes) to provide vinylisochroman 12a as a clear oil. Run 1 (15.9 mg, 50% yield, 82% ee); 
Run 2 (½ scale) (6.9 mg, 43% yield, 82% ee); Average: 47% Yield, 82% ee.  
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Table 2.5, Entry 5: 
To a ½ dram vial was added ligand L1 (7.2 mg, 0.02 mmol, 0.1 equiv) and Pd(OAc)2 (4.4 mg, 
0.02 mmol, 0.1 equiv). Toluene (0.4 mL) was added, and the vial was capped and heated to 45˚C 
until all solids had dissolved. Separately, to a 1 dram vial with stir bar was added 11a (32.4 mg, 
0.20 mmol, 1 equiv), 2,6-dimethylbenzoquinone (30 mg, 0.22 mmol, 1.1 equiv), and 
diphenylphosphinic acid (4.4 mg, 0.02 mmol, 0.1 equiv). The catalyst solution was subsequently 
added to the reaction flask, and toluene was used to rinse up to 1.3 mL toluene. The 1 dram vial 
was sealed with a Teflon cap, and allowed to stir for 8 hours at 45˚C.  Afterward, the vial was 
allowed to cool to room temperature. The majority of the toluene was removed under reduced 
pressure, and the remaining mixture was directly subjected to flash column chromatography 
(10% EtOAc in hexanes) to provide vinylisochroman 12a as a clear oil. Run 1 (20.1 mg, 63% 
yield, 87% ee); Run 2 (20.2 mg, 63% yield, 87% ee); Average: 63% Yield, 87% ee.  
 
Under comparative conditions with L1 as a ligand, dibutyl phosphate ((nBnO)2PO2H), diphenyl 
phosphate ((PhO)2PO2H) and diphenylphosphinic acid (Ph2PO2H) all give major enhancements 
in reactivity (Entries 3,4,5, respectively). Between these organic phosphoric acids, it is possible 
the pKa of Ph2PO2H (2.30) is more optimal for this specific reaction than (nBuO)2PO2H (1.53) 
or (PhO)2PO2H (1.12). 
(pKa values obtained from SciFinder.cas.org, calculated using Advanced Chemistry 




	   109	  
Table 2.5, Entry 6: 
General procedure: To a ½ dram vial was added ligand L2 (7.2 mg, 0.02 mmol, 0.1 equiv) and 
Pd(OAc)2 (4.4 mg, 0.02 mmol, 0.1 equiv). Toluene (0.4 mL) was added, and the vial was capped 
and heated to 45˚C until all solids had dissolved. Separately, to a 1 dram vial with stir bar was 
added 11a (32.4 mg, 0.20 mmol, 1 equiv), 2,6-dimethylbenzoquinone (30 mg, 0.22 mmol, 1.1 
equiv), and diphenylphosphinic acid (4.4 mg, 0.02 mmol, 0.1 equiv). The catalyst solution was 
subsequently added to the reaction flask, and toluene was used to rinse up to 1.3 mL toluene. 
The 1 dram vial was sealed with a Teflon cap, and allowed to stir for 8 hours at 45˚C.  
Afterward, the vial was allowed to cool to room temperature. The majority of the toluene was 
removed under reduced pressure, and the remaining mixture was directly subjected to flash 
column chromatography (10% EtOAc in hexanes) to provide 12a as a clear oil. Run 1 (11.8 mg, 
37% yield, 19% ee); Run 2 (8.6 mg, 27% yield, 19% ee); Average: 32% Yield, 19% ee. 
 
Table 2.5, Entry 7: 
Reaction proceeded according to the General procedure using ligand L3 (6.5 mg, 0.02 mmol, 0.1 
equiv). Product isolated as a clear oil. Run 1 (10.4 mg, 33% yield, 78% ee); Run 2 (9.1 mg, 28% 
yield, 76% ee); Average: 31% Yield, 76% ee. 
 
Table 2.5, Entry 8: 
Reaction proceeded according to the General procedure using ligand L4 (6.8 mg, 0.02 mmol, 0.1 
equiv). Product isolated as a clear oil. Run 1 (3.1 mg, 10% yield, 29% ee); Run 2 (1.3 mg, 5% 
yield, 25% ee); Average: 8% Yield, 25% ee. 
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Table 2.5, Entry 9: 
Reaction proceeded according to the General procedure using ligand L5 (6.3 mg, 0.02 mmol, 0.1 
equiv). Product isolated as a clear oil. Run 1 (6.1 mg, 19% yield, 88% ee); Run 2 (½ scale) (4.4 
mg, 28% yield, 88% ee); Average: 24% Yield, 88% ee.  
 
Table 2.5, Entry 10: 
Reaction proceeded according to the General procedure using ligand L6 (7.5 mg, 0.02 mmol, 0.1 
equiv). Product isolated as a clear oil. Run 1 (18.6 mg, 58% yield, 88% ee); Run 2 (19.1 mg, 
61% yield, 86% ee); Average: 60% Yield, 86% ee.  
 
Table 2.5, Entry 11: 
Reaction proceeded according to the General procedure using ligand (S,R) tBu-ArSOX (L7) 
(8.1 mg, 0.02 mmol, 0.1 equiv). Product isolated as a clear oil. Run 1 (22.8 mg, 71% yield, 91% 
ee); Run 2 (22.5 mg, 70% yield, 92% ee); Average: 70% Yield, 92% ee.  
 
Table 2.5, Entry 12: 
Reaction proceeded according to the General procedure using ligand (S,R) CF3-ArSOX (L8) 
(8.3 mg, 0.02 mmol, 0.1 equiv). Product isolated as a clear oil. Run 1 (14.7 mg, 46% yield, 92% 
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Table 2.5, Entry 13: 
Reaction proceeded according to the General procedure using ligand L9 (7.8 mg, 0.02 mmol, 0.1 
equiv). Product isolated as a clear oil. Run 1 (12.4 mg, 39% yield, 80% ee); Run 2 (12.1 mg, 
38% yield, 83% ee); Average: 39% Yield, 80% ee.  
 
Table 2.5, Entry 14: 
Reaction proceeded according to the General procedure using ligand L10 (8.6 mg, 0.02 mmol, 
0.1 equiv). Product isolated as a clear oil. Run 1 (10.5 mg, 33% yield, 88% ee); Run 2 (11.3 mg, 
35% yield, 87% ee); Average: 34% Yield, 88% ee.  
 
Table 2.5, Entry 15: 
Reaction proceeded according to the General procedure for 72 hours at [0.5M] using ligand L11: 
Product isolated as a clear oil. (0.1 mmol scale) (4.9 mg, 31% yield, –6% ee) 
Reaction was also examined at standard [0.15M] concentration (72h), resulting in slightly 
diminished reactivity: Run 1 (6.2 mg, 19% yield, –7% ee); Run 2 (½ scale) (3.0 mg, 19% yield, –
6% ee); Average: 19% Yield, –6% ee.  
 
Table 2.5, Entry 16: 
Reaction proceeded according to the General procedure for 72 hours at [0.5M] using ligand L12: 
Product yield determined by 1HNMR by comparison to a nitrobenzene standard (0.1 mmol scale) 
(13% yield, 12% ee) 
Reaction was also examined at standard [0.15M] concentration (72h): 8% Yield, 5% ee.  
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Table 2.5, Entry 17: 
Substrate 11a with L13 under Table 1 conditions: 
To a ½ dram vial was added ligand L13 (9.1 mg, 0.01 mmol, 0.1 equiv) and Pd(OAc)2 (2.2 mg, 
0.01 mmol, 0.1 equiv) under air. Toluene (0.2 mL) was added, and the vial was capped and 
heated to 45˚C until all solids had dissolved. Separately, to a ½ dram vial with stir bar was added 
11a (16.2 mg, 0.10 mmol, 1 equiv), 2,6-dimethylbenzoquinone (15 mg, 0.11 mmol, 1.1 equiv) 
and diphenylphosphinic acid (2.2 mg, 0.01 mmol, 0.1 equiv) under air. The catalyst solution was 
subsequently added to the reaction flask, and toluene was used to rinse up to 0.6 mL toluene. 
The ½ dram vial was sealed with a Teflon cap, and allowed to stir for 8 hours at 45˚C.  
Afterward, the vial was allowed to cool to room temperature. The majority of the toluene was 
removed under reduced pressure, and the remaining mixture was directly subjected to flash 
column chromatography (2%–10%–20% EtOAc/hexanes). Only trace product was detected, 
and the starting material was recovered: Run 1: (15.3 mg, 95% RSM) Run 2: (15.0 mg, 93% 
RSM). 
Substrate 11a with L13 under reported air-free conditions:82 
A 10 ml Schlenk tube with stir bar was oven-dried and brought into glove box, where Pd(dba)2 
(2.9 mg, 0.005 mmol, 0.05 equiv.), ligand L13 (6.8 mg, 0.0075 mmol, 0.075 equiv.), DMBQ (16 
mg, 0.12 mmol, 1.2 equiv.) and ortho-fluorobenzoic acid (1.4 mg, 0.01 mmol, 1 equiv.) was 
added. The Schlenk tube was then sealed and removed from glove box and charged with 0.4 ml 
MTBE under argon. The mixture was stirred at 45˚C for 15 minutes. After being cooled to room 
temperature, substrate (16.2 mg, 0.1 mmol, 1 equiv.) in 0.6 ml MTBE was added under argon. 
The resulting solution was subject to three freeze-pump-thaw cycles using liquid nitrogen to 
degas the solution. Then the solution was stirred at 45˚C for 12 hours. The reaction was cooled 
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down to room temperature and concentrated under reduced pressure. The remaining mixture was 
directly subjected to flash column chromatography (2%–10%–20% EtOAc/hexanes). Only trace 
product (<5%) was detected, and the starting material was recovered (average: 79% 
recovered 11a; Run 1: 13.1 mg, 81% RSM; Run 2: 13.1 mg, 76% RSM). 
 
Table 2.5, Entry 18: 
Reaction proceeded according to the General procedure using ligand (S,R) tBu-ArSOX (8.1 mg, 
0.02 mmol, 0.1 equiv), and 1,4-benzoquinone (24mg, 0.22 mmol, 1.1 equiv) (replacing 2,6-
DMBQ). Product isolated as a clear oil. Run 1 (18.5 mg, 58% yield, 77% ee); Run 2 (18.8 mg, 
59% yield, 77% ee); Average: 59% Yield, 77% ee.  
 
Substrate Scope 
Absolute stereochemistry for compound 12a (S-enantiomer) was assigned by matching the 
rotation of compound enant-12a (R-enantiomer) to the reported literature value (see below).90 
The stereochemistry of all other compounds was assigned by analogy. 
 
(S)-1-vinylisochromane (12a): General Procedure:  To a ½ dram vial was added ligand (S,R) 
tBu-ArSOX (8.1 mg, 0.02 mmol) and Pd(OAc)2 (4.4 mg, 0.02 mmol). Toluene (0.4 mL) was 
added, and the vial was capped and heated to 45˚C until all solids had dissolved. Separately, to a 
1 dram vial with stir bar was added 11a (32.4 mg, 0.20 mmol), 2,6-dimethylbenzoquinone (30 
mg, 0.22 mmol), and diphenylphosphinic acid (4.4 mg, 0.02 mmol) with no precautions to 
exclude air or moisture. The catalyst solution was subsequently added to the reaction flask, and 
O
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toluene was used to rinse up to 1.3 mL toluene. The 1 dram vial was sealed with a Teflon cap, 
and allowed to stir for 8 hours at 45˚C, until complete conversion of the starting material was 
observed by TLC.  Afterward, the vial was allowed to cool to room temperature. The majority of 
the toluene was removed under reduced pressure, and the remaining mixture was directly 
subjected to flash column chromatography (10% EtOAc in hexanes) to provide the 
vinylisochroman as a clear oil. Run 1 (22.8 mg, 71% yield); Run 2 (22.5 mg, 70% yield); Run 3 
(22.2 mg, 70% yield). Average: 70% Yield. The enantiomeric excess was determined to be 92% 
by chiral GC analysis (Cyclosil-B, 100˚C isothermal, tR(major) = 32.78 min, tR(minor) = 35.08 
min.) [α]21D = +9.66 (c = 1, CHCl3).  1H NMR (500MHz, CDCl3) δ 7.22-7.18 (m, 2H), 7.16-7.13 
(m, 1H), 7.09-7.06 (m, 1H), 5.99 (ddd, J = 17.2, 10.1, 7.3 Hz, 1H), 5.40 (d, J = 17.2 Hz, 1H), 
5.37 (d, J = 10.1 Hz, 1H), 5.18 (d, J = 7.5 Hz, 1H), 4.19 (dt, J = 11.3, 4.9 Hz, 1H), 3.89 (ddd, J = 
11.4, 9.0, 4.1 Hz, 1H), 3.00 (ddd, J = 16.5, 8.8, 5.1 Hz, 1H), 2.78 (dt, J = 16.1, 4.1 Hz, 1H); 13C 
NMR (125 MHz, CDCl3) δ 138.3, 136.4, 133.8, 129.2, 126.9, 126.3, 126.2, 118.8, 78.4, 63.4, 
29.0; HRMS (EI) m/z calc’d for C11H12O [M]+: 160.0888; found 160.0879.  Spectral data is 
consistent with data in previous literature.90 
Note: at this time, 10 mol% catalyst loading is required for reactivity: A reaction run according 
to the general procedure (developed for 10 mol% catalyst loading) with 1 mol% Pd(OAc)2 and 1 
mol% tBuArSOX for 72 hours resulted in significantly diminished yield of 12a: 8% yield, 80% 
recovered starting material. 
 
(R)-1-vinylisochromane (enant-12a): Reaction procedure is identical to that above, except 
(R,S) tBu-ArSOX (enant-L7) was used as the ligand. 22.3 mg, 70% Yield. The enantiomeric 
O
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excess was determined to be 92% by chiral GC analysis (Cyclosil-B, 100˚C isothermal, 
tR(minor) = 33.54 min, tR(major) = 34.35 min.) [α]21D = –9.45 (c = 1, CHCl3). Rotation is 




(S)-6-methyl-1-vinylisochromane (12b): 2-(2-allyl-5-methylphenyl)ethan-1-ol (11b) (35.2 mg, 
0.20 mmol) was reacted according to the general procedure. Purification by flash column 
chromatography (2% EtOAc in hexanes) provided the vinylisochroman as a clear oil. Run 1 
(25.1 mg, 72% yield); Run 2 (23.6 mg, 68% yield); Run 3 (23.6 mg, 68% yield).  Average: 69% 
Yield. The enantiomeric excess was determined to be 92% by chiral HPLC analysis 
(CHIRALPAK AD-RH column, 0.5 mL/min, 50% MeCN in H2O, λ = 214.4 nm): tR(major) = 
18.263 min, tR(minor) = 25.081 min. [α]24D = +20.7o (c = 1, CHCl3); 1H NMR (500 MHz, 
Chloroform-d) δ 7.02 – 6.92 (m, 3H), 5.96 (ddd, J = 17.3, 10.2, 7.4 Hz, 1H), 5.38 (d, J = 17.3 
Hz, 1H), 5.34 (d, J = 10.5 Hz, 1H), 5.13 (d, J = 7.3 Hz, 1H), 4.16 (dt, J = 11.5, 4.9 Hz, 1H), 3.86 
(ddd, J = 11.3, 9.0, 4.1 Hz, 1H), 2.95 (ddd, J = 15.0, 8.9, 5.3 Hz, 1H), 2.72 (dt, J = 16.5, 4.2 Hz, 
1H), 2.32 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 138.44, 136.48, 133.64, 133.39, 129.67, 
127.08, 126.24, 118.55, 78.36, 63.48, 28.99, 21.27; HRMS (EI) m/z calc’d for C12H14O [M]+: 
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(S)-7-methyl-1-vinylisochromane (12c): 2-(2-allyl-4-methylphenyl)ethan-1-ol (11c) (35.2 mg, 
0.20 mmol) was reacted according to the general procedure. Purification by flash column 
chromatography (2% EtOAc in hexanes) provided the vinylisochroman as a clear oil. Run 1 
(24.1 mg, 69% yield); Run 2 (23.5 mg, 68% yield); Run 3 (23.9 mg, 68% yield).  Average: 68% 
Yield. The enantiomeric excess was determined to be 93% by chiral HPLC analysis 
(CHIRALPAK AD-RH column, 0.5 mL/min, 50% MeCN in H2O, λ = 214.4 nm): tR(major) = 
16.639 min, tR(minor) = 19.879 min. [α]26D = -6.4o (c = 1, CHCl3); 1H NMR (500 MHz, 
Chloroform-d) δ 7.07 – 6.98 (m, 2H), 6.87 (s, 1H), 5.97 (ddd, J = 17.3, 10.1, 7.4 Hz, 1H), 5.40 
(dt, J = 17.1, 1.3 Hz, 1H), 5.35 (ddd, J = 10.3, 1.8, 0.9 Hz, 1H), 5.12 (d, J = 7.3 Hz, 1H), 4.16 
(ddd, J = 11.4, 5.3, 4.3 Hz, 1H), 3.85 (ddd, J = 11.3, 8.9, 4.0 Hz, 1H), 2.94 (ddd, J = 15.1, 9.0, 
5.3 Hz, 1H), 2.72 (dt, J = 16.2, 4.3 Hz, 1H), 2.31 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 138.35, 
136.15, 135.75, 130.69, 129.03, 127.77, 126.76, 118.71, 78.49, 63.62, 28.64, 21.41; HRMS (EI) 
m/z calc’d for C12H14O [M]+: 174.1045; found 174.1044. 
 
 
(S)-6,7-dimethoxy-1-vinylisochromane (12d): Reaction proceeded according to a modified 
procedure:  To a ½ dram vial was added ligand (R,S) CF3-ArSOX (8.3 mg, 0.02 mmol) and 
Pd(OAc)2 (4.4 mg, 0.02 mmol). Toluene (0.4 mL) was added, and the vial was capped and 
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11d (44.4 mg, 0.20 mmol), 2,6-dimethylbenzoquinone (30 mg, 0.22 mmol), and 
diphenylphosphinic acid (4.4 mg, 0.02 mmol). The catalyst solution was subsequently added to 
the reaction flask, and toluene was used to rinse up to 1.3 mL toluene. The 1 dram vial was 
sealed with a Teflon cap, and allowed to stir for 8 hours at 45˚C. Afterward, the vial was 
allowed to cool to room temperature. The majority of the toluene was removed under reduced 
pressure, and the remaining mixture was directly subjected to flash column chromatography 
(10% EtOAc in hexanes) to provide the vinylisochroman as a clear oil. Run 1 (26.2 mg, 59% 
yield); Run 2 (29.3 mg, 67% yield); Run 3 (29.0 mg, 66% yield). Average: 64% Yield. The 
enantiomeric excess was determined to be 95% by chiral GC analysis (Cyclosil-B, 160˚C 
isothermal, tR(major) = 23.47 min, tR(minor) = 24.24 min.) [α]22D = +31.37 (c = 0.26, CH2Cl2).  
1H NMR (500MHz, CDCl3) δ 6.64 (s, 1H), 6.55 (s, 1H), 5.98 (ddd, J = 17.1, 10.0, 7.6 Hz, 1H), 
5.41 (d, J = 17.1 Hz, 1H), 5.37 (d, J = 10.1 Hz, 1H), 5.11 (d, J = 7.3 Hz, 1H), 4.17 (dt, J = 11.2, 
4.4 Hz, 1H), 3.89 (s, 3H), 3.89-3.85 (m, 1H), 3.85 (s, 3H), 2.97-2.89 (m, 1H), 2.70 (dt, J = 16.1, 
3.7 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 148.1, 147.6, 138.5, 128.1, 125.9, 118.8, 111.7, 




(S)-6-bromo-1-vinylisochromane (12e): 2-(2-allyl-5-bromophenyl)ethan-1-ol (11e) (48.2 mg, 
0.20 mmol) was reacted according to the general procedure for 9 hours. Purification by flash 
column chromatography (2% EtOAc in hexanes) provided the vinylisochroman as a clear oil. 
Run 1 (36.1 mg, 75% yield); Run 2 (36.9 mg, 76% yield); Run 3 (37.5 mg, 78% yield).  
O
Br
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Average: 76% Yield. The enantiomeric excess was determined to be 93% by chiral HPLC 
analysis (CHIRALPAK OJ-H column, 1 mL/min, 0.5% isopropanol in hexane, λ = 230.4 nm): 
tR(major) = 6.739 min, tR(minor) = 7.702 min. [α]22D = +19.6o (c = 1, CHCl3); 1H NMR (500 
MHz, Chloroform-d) δ 7.31 – 7.27 (m, 2H), 6.92 (d, J = 8.8 Hz, 1H), 5.93 (ddd, J = 16.8, 10.2, 
7.3 Hz, 1H), 5.40 – 5.34 (m, 2H), 5.08 (d, J = 7.3 Hz, 1H), 4.13 (dt, J = 11.4, 4.9 Hz, 1H), 3.83 
(ddd, J = 11.4, 8.8, 4.1 Hz, 1H), 2.95 (ddd, J = 16.7, 8.8, 5.4 Hz, 1H), 2.73 (dt, J = 16.5, 4.3 Hz, 
1H); 13C NMR (126 MHz, CDCl3) δ 137.71, 136.15, 135.31, 131.86, 129.33, 128.13, 120.68, 




(S)-7-fluoro-1-vinylisochromane (12f): 2-(2-allyl-4-fluorophenyl)ethan-1-ol (11f) (36.0 mg, 
0.20 mmol) was reacted according to the general procedure for 10 hours at 45˚C. Purification by 
flash column chromatography (10% EtOAc in hexanes) provided the vinylisochroman as a clear 
oil. Run 1 (24.0 mg, 67% yield); Run 2 (21.6 mg, 61% yield); Run 3 (20.4 mg, 57% yield). 
Average: 61% Yield. The enantiomeric excess was determined to be 91% by chiral GC analysis 
(Cyclosil-B, 100˚C isothermal, tR(major) = 38.54 min, tR(minor) = 42.72 min.) [α]22D = +10.28 (c 
= 0.25, CH2Cl2). 1H NMR (500MHz, CDCl3) δ 7.12 (dd, J = 8.3, 6.5 Hz, 1H), 6.93 (dt, J = 8.5, 
2.3 Hz, 1H), 6.81 (dd, J = 9.5, 2.4 Hz, 1H), 5.98 (ddd, J = 17.6, 10.3, 7.6 Hz, 1H), 5.44 (dt, J = 
17.1, 1.5 Hz, 1H), 5.42 (d, J = 10.3 Hz, 1H), 5.14 (d, J = 7.3 Hz, 1H), 4.20 (ddd, J = 11.5, 5.4, 
4.4 Hz, 1H), 3.88 (ddd, J = 11.5, 9.0, 4.2 Hz, 1H), 2.98 (ddd, J = 15.9, 9.0, 5.4 Hz, 1H), 2.76 (dt, 
J = 16.1, 3.9 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 161.3 (d, J = 242.8 Hz), 138.2 (d, J = 6.5 
OF
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Hz), 137.6, 130.5 (d, J = 7.3 Hz) 129.3 (d, J = 2.8 Hz), 119.4, 114.1 (d, J = 22.0 Hz), 112.9 (d, J 
= 22.0 Hz), 78.3, 63.5, 28.2; 19F NMR (470 MHz, CDCl3) δ -116.6; HRMS (EI) m/z calc’d for 
C11H11OF [M]+: 178.0794; found 178.0790. 
 
 
(S)-5-fluoro-1-vinylisochromane (12g): 2-(2-allyl-6-fluorophenyl)ethan-1-ol (11g) (36.0 mg, 
0.20 mmol) was reacted according to the general procedure. Purification by flash column 
chromatography (10% EtOAc in hexanes) provided the vinylisochroman as a clear oil. Run 1 
(22.1 mg, 62% yield); Run 2 (23.9 mg, 67% yield); Run 3 (22.9 mg, 64% yield). Average: 64% 
Yield. The enantiomeric excess was determined to be 92% by chiral GC analysis (Cyclosil-B, 
100˚C isothermal, tR(major) = 34.44 min, tR(minor) = 37.65 min.) [α]23D = +2.37 (c = 0.25, 
CH2Cl2). 1H NMR (500MHz, CDCl3) δ 7.20-7.14 (m, 1H), 6.94 (t, J = 9.0 Hz, 1H), 6.88 (d, J = 
7.8 Hz, 1H), 5.99 (ddd, J = 17.1, 10.3, 7.1 Hz, 1H), 5.41 (d, J = 18.3 Hz, 1H), 5.40 (d, J = 10.3 
Hz, 1H), 5.17 (d, J = 7.1 Hz, 1H), 4.21 (dt, J = 11.5, 5.4 Hz, 1H), 3.89 (ddd, J = 11.5, 8.3, 4.4 
Hz, 1H), 2.89 (ddd, J = 13.7, 8.3, 5.6 Hz, 1H), 2.82 (dt, J = 17.3, 4.4 Hz, 1H); 13C NMR (125 
MHz, CDCl3) δ 160.7 (d, J = 243.6 Hz), 138.6 (d, J = 5.5 Hz), 137.7, 126.9 (d, J = 8.3 Hz), 
121.7 (d, J = 3.6 Hz), 121.5 (d, J = 19.1 Hz), 119.3, 113.2 (d, J = 21.1 Hz), 77.9, 62.6, 22.2; 19F 
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(S)-6-chloro-1-vinylisochromane (12h): 2-(2-allyl-5-chlorophenyl)ethan-1-ol (11h) (39.3 mg, 
0.20 mmol) was reacted according to the general procedure for 10 hours at 45˚C. Purification by 
flash column chromatography (10% EtOAc in hexanes) provided the vinylisochroman as a clear 
oil. Run 1 (20.2 mg, 52% yield); Run 2 (22.2 mg, 57% yield) Run 3 (22.1 mg, 57% yield). 
Average: 55% Yield. The enantiomeric excess was determined to be 92% by chiral GC analysis 
(Cyclosil-B, 120˚C isothermal, tR(major) = 49.51 min, tR(minor) = 54.03 min.) [α]22D = +16.95 (c 
= 0.25, CH2Cl2).1H NMR (500MHz, CDCl3) δ 7.20-7.15 (m, 2H), 7.01 (d, J = 8.1 Hz, 1H), 5.98 
(ddd, J = 17.6, 9.8, 7.3 Hz, 1H), 5.41 (d, J = 17.1 Hz, 1H), 5.40 (d, J = 10.7 Hz, 1H), 5.15 (d, J = 
7.1 Hz, 1H), 4.18 (dt, J = 11.5, 4.9 Hz, 1H), 3.80 (ddd, J = 11.5, 8.8, 4.1 Hz, 1H), 2.99 (ddd, J = 
16.6, 8.5, 5.1 Hz, 1H), 2.78 (dt, J = 16.3, 4.2 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 137.8, 
135.8, 134.8, 132.6, 128.9, 127.8, 126.4, 119.2, 78.0, 63.0, 28.8; HRMS (EI) m/z calc’d for 
C11H11OCl [M]+: 194.0498; found 194.0499. 
 
 
(S)-7-(trifluoromethyl)-1-vinylisochromane (12i):  Reaction proceeded according to a 
modified procedure:  To a ½ dram vial was added ligand (S,R) CF3-ArSOX (8.3 mg, 0.02 
mmol) and Pd(OAc)2 (4.4 mg, 0.02 mmol). Toluene (0.4 mL) was added, and the vial was 
capped and heated to 45˚C until all solids had dissolved. Separately, to a 1 dram vial with stir bar 
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diphenylphosphinic acid (4.4 mg, 0.02 mmol). The catalyst solution was subsequently added to 
the reaction flask, and toluene was used to rinse up to 1.3 mL toluene. The 1 dram vial was 
sealed with a Teflon cap, and allowed to stir for 48 hours at 45˚C. Afterward, the vial was 
allowed to cool to room temperature. The majority of the toluene was removed under reduced 
pressure, and the remaining mixture was directly subjected to flash column chromatography 
(10% EtOAc in hexanes) to provide the vinylisochroman as a clear oil.  Run 1 (½ scale) (14.3 
mg, 62% yield); Run 2 (24.9 mg, 55% yield); Run 3 (23.6 mg, 52% yield). Average: 56% 
Yield. The enantiomeric excess was determined to be 92% by chiral GC analysis (Cyclosil-B, 
120˚C isothermal, tR(major) = 15.19 min, tR(minor) = 16.62 min.) [α]22D = +7.32 (c = 0.25, 
CH2Cl2). 1H NMR (500MHz, CDCl3) δ 7.43 (d, J = 7.7 Hz, 1H), 7.31-7.22 (m, 2H), 5.96 (ddd, J 
= 17.4, 9.9, 7.5 Hz, 1H), 5.42 (d, J = 15.0 Hz, 1H), 5.41 (d, J = 10.7 Hz, 1H), 5.16 (d, J = 7.5 Hz, 
1H), 4.19 (dt, J = 11.4, 5.4 Hz, 1H), 3.87 (ddd, J = 11.4, 8.8, 3.9 Hz, 1H), 3.06-2.98 (m, 1H), 
2.82 (d, J = 16.7 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 138.0, 137.3, 137.1, 129.6, 128.6 (q, J 
= 32.9 Hz), 124.4 (q, J = 271.0 Hz), 123.6 (q, J = 3.6 Hz), 123.3 (q, J = 3.6 Hz), 119.9, 78.3, 
63.1, 28.9; 19F NMR (470 MHz, CDCl3) δ -62.8; HRMS (EI) m/z calc’d for C12H10OF3 [M-H]+: 
227.0684; found 227.0685. 
 
 
(S)-4-vinyl-1,4-dihydro-2H-benzo[f]isochromene (12j): 2-(2-allylnaphthalen-1-yl)ethan-1-ol 
(11j) (42.5 mg, 0.20 mmol) was reacted according to the general procedure. Purification by flash 
column chromatography (10% EtOAc in hexanes) provided the vinylisochroman as a clear oil. 
O
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Run 1 (34.5 mg, 80% yield); Run 2 (30.7 mg, 73% yield); Run 3 (29.9 mg, 71% yield). 
Average: 75% Yield. The enantiomeric excess was determined to be 93% by chiral GC analysis 
(Cyclosil-B, 160˚C isothermal, tR(major) = 45.98 min, tR(minor) = 48.09 min.) [α]23D = +74.03 (c 
= 0.25, CH2Cl2). 1H NMR (500MHz, CDCl3) δ 7.99 (d, J = 8.5 Hz, 1H), 7.87 (d, J = 8.1 Hz, 1H), 
7.73 (d, J = 8.5 Hz, 1H), 7.59 (td, J = 8.3, 1.2 Hz, 1H), 7.54 (td, J = 8.1, 1.0 Hz, 1H), 7.24 (d, J = 
8.5 Hz, 1H), 6.08 (ddd, J = 17.3, 10.3, 7.3 Hz, 1H), 5.47 (d, J = 17.3 Hz, 1H), 5.44 (d, J = 11.7 
Hz, 1H), 5.36 (d, J = 7.3 Hz, 1H), 4.37 (dt, J = 11.5, 5.1 Hz, 1H), 4.07 (ddd, J = 11.5, 7.8, 4.6 
Hz, 1H), 3.00 (dt, J = 16.6, 6.3 Hz, 1H), 3.19 (dt, J = 16.6, 4.6 Hz, 1H); 13C NMR (125 MHz, 
CDCl3) δ 138.2, 133.1, 132.5, 132.2, 129.3, 128.8, 126.5, 126.4, 125.8, 124.5, 123.1, 119.2, 78.3, 
62.8, 25.6; HRMS (EI) m/z calc’d for C15H14O [M]+: 210.1045; found 210.1042. 
 
 
Catalyst influence on chiral substrates  
         
 
Table 2.6, Entry 1: 
To a 1 dram vial with stir bar was added (R)-1-(2-allylphenyl)propan-2-ol 13 (35.3 mg, 0.20 
mmol, 1 equiv), 2,6-dimethylbenzoquinone (30 mg, 0.22 mmol, 1.1 equiv), diphenylphosphinic 














meso - 1,2-bis(phenylsulfinyl)ethane (L14)
(S,R)  (L7) tBu-ArSOX











Table 2.6: Catalyst vs. substrate diastereocontrol  
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mmol, 0.1 equiv) and Pd(OAc)2 (4.4 mg, 0.02 mmol, 0.1 equiv). Toluene (0.4 mL) was added, 
and the vial was sealed with a Teflon cap and allowed to stir for 72 hours at 45˚C.  Afterward, 
the vial was allowed to cool to room temperature, and the solvent was removed under reduced 
pressure. A crude HNMR was used for determination of the diastereomer ratio, and crude 
mixture was subjected directly to flash column chromatography (10% EtOAc in hexanes) to 
provide a mixture of cis/trans isomers as a clear oil. Run 1 (7.4 mg, 21% yield); Run 2 (4.5 mg, 
13% yield) Run 3 (5.4 mg, 15% yield). Average: 16% Yield, 1.5:1 cis:trans d.r. 
 
Table 2.6, Entry 2: 
To a ½ dram vial was added ligand (S,R) tBu-ArSOX (8.1 mg, 0.02 mmol, 0.1 equiv) and 
Pd(OAc)2 (4.4 mg, 0.02 mmol, 0.1 equiv). Toluene (0.4 mL) was added, and the vial was capped 
and heated to 45˚C until all solids had dissolved. Separately, to a 1 dram vial with stir bar was 
added (R)-1-(2-allylphenyl)propan-2-ol 13 (35.3 mg, 0.20 mmol, 0.1 equiv), 2,6-
dimethylbenzoquinone (30 mg, 0.22 mmol, 1.1 equiv), and diphenylphosphinic acid (4.4 mg, 
0.02 mmol, 0.1 equiv). The catalyst solution was subsequently added to the reaction flask, and 
toluene was used to rinse up to 1.3 mL toluene. The 1 dram vial was sealed with a Teflon cap, 
and allowed to stir for 15 hours at 45˚C. Afterward, the vial was allowed to cool to room 
temperature, and the solvent was removed under reduced pressure. A crude HNMR was used for 
determination of the diastereomer ratio, and crude mixture was subjected directly to flash column 
chromatography (10% EtOAc in hexanes) to provide cis-vinylisochroman 14a as a clear oil. Run 
1 (21.0 mg, 60% yield); Run 2 (23.0 mg, 66% yield) Run 3 (21.4 mg, 61% yield). Average: 
62% Yield, >20:1 cis:trans d.r. 
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Table 2.6, Entry 3: 
To a ½ dram vial was added ligand (R,S) tBu-ArSOX (8.1 mg, 0.02 mmol, 0.1 equiv) and 
Pd(OAc)2 (4.4 mg, 0.02 mmol, 0.1 equiv). Toluene (0.2 mL) was added, and the vial was capped 
and heated to 45˚C until all solids had dissolved. Separately, to a 1 dram vial with stir bar was 
added (R)-1-(2-allylphenyl)propan-2-ol 13 (35.3 mg, 0.20 mmol, 0.1 equiv), 2,6-
dimethylbenzoquinone (30 mg, 0.22 mmol, 1.1 equiv), and diphenylphosphinic acid (4.4 mg, 
0.02 mmol, 0.1 equiv). The catalyst solution was subsequently added to the reaction flask, and 
toluene was used to rinse up to 0.4 mL toluene. The 1 dram vial was sealed with a Teflon cap, 
and allowed to stir for 48 hours at 45˚C. Afterward, the vial was allowed to cool to room 
temperature, and the solvent was removed under reduced pressure. A crude HNMR was used for 
determination of the diastereomer ratio, and crude mixture was subjected directly to flash column 
chromatography (10% EtOAc in hexanes) to provide a mixture of cis/trans isomers as a clear oil. 
Run 1 (½ scale) (9.0 mg, 52% yield); Run 2 (17.0 mg, 48% yield) Run 3 (16.5 mg, 47% yield). 






















meso - 1,2-bis(phenylsulfinyl)ethane (L14)
(S,R)  (L7) tBu-ArSOX





> 20 : 1
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Table 2.7: Catalyst vs. substrate diastereocontrol  
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Table 2.7, Entry 1: 
To a 1 dram vial with stir bar was added (R)-2-(2-allylphenyl)propan-1-ol (15) (35.3 mg, 0.20 
mmol, 1 equiv), 2,6-dimethylbenzoquinone (30 mg, 0.22 mmol, 1.1 equiv), diphenylphosphinic 
acid (4.4 mg, 0.02 mmol, 0.1 equiv), meso-1,2-bis(phenylsulfinyl)ethane (L14) (5.6 mg, 0.02 
mmol, 0.1 equiv) and Pd(OAc)2 (4.4 mg, 0.02 mmol, 0.1 equiv). Toluene (1.3 mL) was added, 
and the vial was sealed with a Teflon cap and allowed to stir for 72 hours at 45˚C.  Afterward, 
the vial was allowed to cool to room temperature, and the solvent was removed under reduced 
pressure. The crude mixture was subjected directly to flash column chromatography (10% 
EtOAc in hexanes) to provide a mixture of cis/trans isomers as a clear oil. Run 1 (21.7 mg, 62% 
yield); Run 2 (21.6 mg, 62% yield) Run 3 (19.9 mg, 57% yield). Average: 60% Yield, 3.6:1 
cis:trans d.r. 
 
Table 2.7, Entry 2: 
To a ½ dram vial was added ligand (S,R) tBu-ArSOX (8.1 mg, 0.02 mmol, 0.1 equiv) and 
Pd(OAc)2 (4.4 mg, 0.02 mmol, 0.1 equiv). Toluene (0.4 mL) was added, and the vial was capped 
and heated to 45˚C until all solids had dissolved. Separately, to a 1 dram vial with stir bar was 
added (R)-2-(2-allylphenyl)propan-1-ol 15 (35.3 mg, 0.20 mmol, 0.1 equiv), 2,6-
dimethylbenzoquinone (30 mg, 0.22 mmol, 1.1 equiv), and diphenylphosphinic acid (4.4 mg, 
0.02 mmol, 0.1 equiv). The catalyst solution was subsequently added to the reaction flask, and 
toluene was used to rinse up to 1.3 mL toluene. The 1 dram vial was sealed with a Teflon cap, 
and allowed to stir for 3 hours at 45˚C. Afterward, the vial was allowed to cool to room 
temperature, and the solvent was removed under reduced pressure. The crude mixture was 
subjected directly to flash column chromatography (10% EtOAc in hexanes) to provide cis-
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vinylisochroman 16a as a clear oil. Run 1 (23.7 mg, 68% yield); Run 2 (22.8 mg, 65% yield) 
Run 3 (23.5 mg, 67% yield). Average: 67% Yield, >20:1 cis:trans d.r. 
 
Table 2.7, Entry 3: 
To a ½ dram vial was added ligand (R,S) tBu-ArSOX (8.1 mg, 0.02 mmol, 0.1 equiv) and 
Pd(OAc)2 (4.4 mg, 0.02 mmol, 0.1 equiv). Toluene (0.4 mL) was added, and the vial was capped 
and heated to 45˚C until all solids had dissolved. Separately, to a 1 dram vial with stir bar was 
added (R)-2-(2-allylphenyl)propan-1-ol 15 (35.3 mg, 0.20 mmol, 0.1 equiv), 2,6-
dimethylbenzoquinone (30 mg, 0.22 mmol, 1.1 equiv), and diphenylphosphinic acid (4.4 mg, 
0.02 mmol, 0.1 equiv). The catalyst solution was subsequently added to the reaction flask, and 
toluene was used to rinse up to 1.3 mL. The 1 dram vial was sealed with a Teflon cap, and 
allowed to stir for 8 hours at 45˚C. Afterward, the vial was allowed to cool to room temperature, 
and the solvent was removed under reduced pressure. The crude mixture was subjected directly 
to flash column chromatography (10% EtOAc in hexanes) to provide a mixture of cis/trans 
isomers as a clear oil. Run 1 (23.0 mg, 66% yield); Run 2 (22.9 mg, 66% yield) Run 3 (24.7 mg, 
71% yield). Average: 68% Yield, 1:1.4 cis:trans d.r. 
 
 
(1S,3R)-3-methyl-1-vinylisochromane (14a): 1H NMR (500MHz, CDCl3) δ 7.23-7.20 (m, 2H), 
7.15-7.10 (m, 2H), 5.95 (ddd, J = 17.1, 10.3, 8.3 Hz, 1H), 5.52 (dd, J = 17.1, 1.7 Hz, 1H), 5.42 
(dd, J = 10.0, 1.7 Hz, 1H), 5.20 (d, J = 8.1 Hz, 1H), 3.95 (m, 1H), 2.81 (dd, J = 16.1, 10.7 Hz, 
1H), 2.74 (dd, J = 16.1, 2.9 Hz, 1H), 1.43 (d, J = 6.1 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 
O
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138.2, 136.5, 134.1, 128.9, 126.9, 126.3, 125.9, 119.2, 80.2, 70.8, 36.6, 22.1; [α]23D = –34.28˚ (c 
= 0.25, CH2Cl2); HRMS (EI) m/z calc’d for C12H14O [M]+: 174.1045; found 174.1045.  Cis-ring 
geometry was established by 1D 1HNOE spectral data: 
 
 
nOe Assignment of 14a. 
 
(500 MHz, CDCl3) The ethereal proton peak at δ 3.95 (Hb) was irradiated, and the resulting 
observed relationship is illustrated above. 14a gave a characteristic nOe between the pseudo-
axial ethereal proton Hb and the pseudo-axial ethereal proton Ha (δ 5.20), indicating a cis-
relationship between Ha and Hb for 14a. 
 
(1S,4R)-4-methyl-1-vinylisochromane (16a): 1H NMR (500MHz, CDCl3) δ 7.25-7.17 (m, 3H), 
7.07 (d, J = 7.5 Hz, 1H), 6.00 (ddd, J = 17.6, 9.9, 7.9 Hz, 1H), 5.44 (d, J = 17.2 Hz, 1H), 5.38 (d, 
J = 10.3 Hz, 1H), 5.15 (d, J = 7.5 Hz, 1H), 3.95  3.89 (ABq d, JAB = 11.4 Hz, Jd = 3.6 Hz, 2H), 
2.90-2.84 (m, 1H), 1.38 (d, J = 7.1 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 139.4, 138.4, 135.8, 
128.5, 127.1, 126.2, 126.1, 118.9, 78.9, 69.4, 32.8, 21.0; [α]23D = +37.49˚ (c = 0.25, CH2Cl2); 
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established by comparison with similar structures in the literature124, and by 1D NOE spectral 
data of the trans-diastereomer 16b: 
nOe Assignment of 16b. 
  
(500 MHz, CDCl3) Unfortunately, no useful nOe data was able to be gained from 16a. 
Therefore, nOe data was obtained from using the inseparable mixture of 16a and 16b, and 
selectively irradiating protons of the trans-isomer 16b. The ethereal proton peak at δ 3.58 (Hc) 
was irradiated, and the resulting observed relationship is illustrated above. 16b gave a 
characteristic nOe between the pseudo-axial ethereal proton Hc and the pseudo-axial ethereal 
proton Ha (δ 5.22), indicating a cis-relationship between Hc and Ha for 16b. Hc also gave an nOe 
with the geminal ethereal proton Hb (δ 4.18), and the protons on the methyl group (δ 1.33).  The 
ethereal proton peak at δ 4.18 (Hb) was irradiated, and did not give an nOe with Ha but instead 
gave an nOe with the geminal ethereal proton Hc (δ 3.58), the methyl protons (δ 1.33) and the 























	   129	  
 
(R)-1-(2-allylphenyl)propan-2-ol (13): Product is a clear oil. 1H NMR (500 MHz, Chloroform-
d) δ 7.20 (s, 4H), 5.98 (ddt, J = 16.6, 10.0, 6.2 Hz, 1H), 5.09 (dt, J = 10.0, 1.4 Hz, 1H), 5.00 (dt, J 
= 17.1, 1.7 Hz, 1H), 4.08 – 3.96 (m, 1H), 3.45 (ddd, J = 6.1, 4.0, 2.1 Hz, 2H), 2.86 – 2.71 (m, 
2H), 1.98 – 1.75 (br, 1H), 1.27 (d, J = 6.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 138.59, 
137.52, 137.04, 130.73, 130.23, 127.03, 126.71, 116.10, 68.64, 42.69, 37.40, 23.30; [α]26D = -
41.8o (c = 1.00, CHCl3) HRMS (EI) m/z calc’d for C12H16O [M]+: 176.1201; found 176.1204. 
 
Synthesis of 13. 
 
 
To a flamed-dried 50 mL RBF fitted with oven-dried condenser was added magnesium turnings 
(130 mg, 5.34 mmol, 1.2 equiv.). 0.5 mL of dry THF was added followed by the addition of a 
small portion of 2-bromoallylbenzene (877 mg, 4.45 mmol, 1.0 equiv.) dissolved in 3 mL of dry 
THF. A few crystals of iodine were added, and the deep purple solution was heated by a heat 
gun. Upon disappearance of the color, the rest of THF solution  was added slowly, after which 
the reaction was heated at 70oC for 45 min. Then the reaction was cooled in ice bath, followed by 
the addition of a solution of R-(+)-propylene oxide (570 mg, 9.8 mmol, 2.0 equiv.) in 3 mL of 
dry THF. The reaction was allowed to stir at r. t. for 90 min, followed by quenching with sat. 
NH4Cl solution (10 mL). The layers were separated and the aqueous layer was further extracted 
with ethyl acetate (2 x 10 mL). All the organic layers were combined and dried over anhydrous 
MgSO4. The solution was filtered and the solvent was removed under reduced pressure. The 
OH
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crude was purified twice via silica column chromatography (5% acetone/hexane). A colorless oil 
(240 mg, 1.4 mmol, 31% yield) was obtained as the final product. 
 
 
(R)-2-(2-allylphenyl)propan-1-ol (15): Product is a clear oil. 1H NMR (500MHz, CDCl3) δ 
7.26-7.24 (m, 2H), 7.19-7.16 (m, 2H), 5.99 (ddt, J = 16.3, 10.3, 6.2 Hz, 1H), 5.06 (d, J = 10.1 
Hz, 1H), 5.96 (d, J = 17.2 Hz, 1H), 3.71 (m, 2H), 3.52 (dd, J = 16.1, 6.4 Hz, 1H), 3.42 (dd, J = 
15.9, 6.0 Hz, 1H), 3.27 (sex, J = 6.6 Hz, 1H), 1.31 (app. t, J = 6.4 Hz, 1H), 1.23 (d, J = 7.1 Hz, 
3H); 13C NMR (125 MHz, CDCl3) δ 142.2, 138.4, 138.0, 130.5, 127.2, 126.8, 126.2, 116.0, 68.8, 
37.6, 37.1, 18.4; [α]23D = +4.52˚ (c = 0.25, CH2Cl2); HRMS (TOF MS AP+) m/z calc’d for 
C12H17O [M+H]: 177.1279; found 177.1281.   
 
Synthesis of 15. 
 
Under the conditions of Yu123, to a dried RBF was added PhI(OAc)2 (0.75 equiv) and I2 (0.75 
equiv). The flask was wrapped in aluminum foil to protect it from light, and DMF (0.16 M) was 
added. The reaction was capped and stirred for 5 minutes, and then Pd(OAc)2 (0.05 equiv) and (-
)-(R)-2-Phenylpropionic acid starting material (1.0 equiv) were added quickly. The flask was 
sealed with a glass stopper and the seal was wrapped in Teflon tape and parafilm and 
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solvent was subsequently evaporated under reduced pressure with the assistance of a high-
vacuum, and the residue was dissolved in ether. The organic layer was extracted with sat. aq. 
NaHCO3 (x 3), and the combined aqueous layers were acidified with HCl. CH2Cl2 was added, 
and the aqueous layer was extracted with CH2Cl2 (x 2) and EtOAc (x 1). The combined organic 
layers were dried over anhydrous MgSO4, filtered, and concentrated under reduced pressure to 
afford the iodinated product that was taken on directly to the next step.  
To a dried RBF was added the iodinated starting material and anhydrous MeOH (0.3 M). 
Concentrated Sulfuric acid (5 mol%) was added, and the reaction was refluxed for three hours. 
After cooling to room temperature, the volatiles were evaporated under reduced pressure, and the 
remaining mixture was dissolved in EtOAc. The organics were washed with sat. aq. NaHCO3 (x 
3), and the organic layer was dried over anhydrous MgSO4, filtered, and concentrated under 
reduced pressure. The mixture was purified by column chromatography to afford the desired 
methyl ester (54% over two steps). 
 To a dried RBF in a glove box was added Pd(PPh3)4 (0.05 equiv), CsF (2.0 equiv), CuI 
(0.1 equiv), and the flask was sealed and taken out of the glovebox. DMF (0.33 M) was added 
followed by the corresponding methyl ester substrate (1.0 equiv) and allyltributylstannane (1.2 
equiv) via syringe. The reaction was stirred at 45˚C for 6 hours under argon. After complete 
conversion of the starting material was observed by TLC, the flask was cooled to 0˚C and diluted 
slowly with water. The mixture was diluted with ether, and the layers were separated. The 
organic layer was washed with water (x 2). The organic layer was dried over anhydrous MgSO4, 
filtered, and concentrated under reduced pressure. The mixture was purified by column 
chromatography to afford the desired allylated methyl ester (81% yield). 
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 To a dried RBF was added LiAlH4 (95%, 1 equiv) under argon. THF (0.1 M) was added, 
and the flask was cooled to 0˚C. To the mixture was added the allylated methyl ester dissolved in 
THF (1 M) dropwise, and the mixture was warmed to room temperature and stirred for 2 hours 
under argon. After complete conversion of the starting material was observed by TLC, the 
reaction flask was cooled to 0˚C, and the reaction was quenched by dropwise addition of sat. aq. 
Rochelle’s salt. The reaction was diluted with ether, and the biphasic mixture was stirred until 
both layers became homogeneous (typically 2 hours to overnight). The layers were separated, 
and the aqueous layer was extracted with ether (x 3). The combined organic layers were washed 
once with brine, and dried over anhydrous MgSO4, filtered, and concentrated under reduced 






To a ½ dram vial was added ligand (S,R) tBu-ArSOX (4.1 mg, 0.01 mmol, 0.1 equiv) and 
Pd(OAc)2 (2.2 mg, 0.01 mmol, 0.1 equiv). Toluene (0.2 mL) was added, and the vial was capped 
and allowed to stand at 45˚C until all solids had dissolved. Separately, to a ½ dram vial with stir 
bar was added 11a-d (16.3 mg, 0.1 mmol, 1 equiv), 2,6-dimethylbenzoquinone (15 mg, 0.11 
mmol, 1.1 equiv), and diphenylphosphinic acid (2.2 mg, 0.01 mmol, 0.1 equiv.). The catalyst 
solution was subsequently added to the reaction flask, and toluene was used to rinse up to 0.65 
2,6-DMBQ (1.1 equiv.)











1:1 ratio of isomers
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mL toluene. The ½ dram vial was sealed with a Teflon cap, and allowed to stir for 8 hours at 
45˚C.  Afterward, the vial was allowed to cool to room temperature. The majority of the toluene 
was removed under reduced pressure, and the remaining mixture was directly subjected to flash 
column chromatography (10% EtOAc in hexanes) to provide the vinylisochroman as a clear oil: 
11.0 mg, 68% yield, 92% ee. Product is a 1:1 mixture of cis:trans deuterated olefin isomers. 
 
Deuterium stereochemistry for 11a-d was determined to be >95% by 1H NMR. 
 
11a-d  1H NMR (500MHz, CDCl3) δ 7.26-7.21 (m, 4H), 6.01 (dt, J = 17.1, 6.1 Hz, 1H), 5.02 (dt, 
J = 17.1, 1.7 Hz, 1H), 3.89 (q, J = 6.8 Hz, 2H), 3.48 (dd, J = 6.3, 1.7 Hz, 2H), 2.96 (t, J = 6.8 Hz, 
2H), 1.42 (t, J = 5.9 Hz, 1H). 
 
Comparison of Synthetic Routes for Compound 22 
 
 
11a: A three-necked RBF with stirbar was charged with Mg (80 mg, 3.3 mmol, 1.3 equiv) and I2 































































1.) 2.) 3.) 4.)
Transformation 4: TenBrink, R.E. et al. J. Med Chem. 1996. 39, 2435.
Transformations 1-4: TenBrink, R.E. et al. J. Med Chem. 1996. 39, 2435.
OH
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setup was flame-dried and placed under argon atmosphere. To the addition funnel was added a 
solution of 2-allylbromobenzene (0.5 g, 2.54 mmol, 1 equiv) and THF (0.5 M). About 1/4th of 
the solution was added to the flask, and the reaction was stirred with heating until the start of the 
Grignard reaction, after which the remaining solution was added dropwise to the reaction. The 
reaction was stirred at reflux for 1 hour. The reaction was then cooled to 0˚C and ethylene oxide 
(5.07 mmol, 2.5 M solution in THF) was added dropwise to the reaction. The reaction was stirred 
at 0˚C for 30 minutes, and then at room temperature for one hour. Afterward, the reaction was 
cooled to 0˚C and quenched with sat. aq. NH4Cl.  The mixture was diluted with 30 mL ether and 
the layers were separated, and the aqueous layer was extracted with ethyl acetate (2 x 20 mL). 
The combined organic layers were dried over anhydrous MgSO4, filtered, and concentrated 
under reduced pressure. The crude product was purified by column chromatography (10% è 20% 
EtOAc in hexanes) to afford 11a. (284 mg, 69% yield). 
 
 
(S)-2-(isochroman-1-yl)ethan-1-ol (21): To a dried 15 mL flask was added 1-vinylisochromane 
(12a) (55 mg, 0.33 mmol, 1 equiv). The flask was placed under argon, and THF (6 mL) was 
added. To the stirring solution was added 9-BBN (0.99 mL, 0.5M in THF, 1.5 equiv) via syringe 
dropwise. The solution was stirred for 3 hours until consumption of the starting olefin was 
observed by TLC. The solution was cooled to 0˚C, and water (4 mL) was added slowly, followed 
by sodium perborate tetrahydrate (254 mg, 1.65 mmol, 5 equiv), and the white suspension was 
warmed to room temperature and stirred overnight. Afterward, the white suspension was diluted 
with ether, and decanted into a separatory funnel. The remaining white particulates were washed 
O
OH
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twice with 1:1 ether:water and transferred to the separatory funnel. The layers were separated, 
and the aqueous layer was extracted twice with ether. The combined organic phases were washed 
with brine, dried over anhydrous MgSO4, filtered, and concentrated under reduced pressure. 
Purification by flash column chromatography (10% è 20% EtOAc in hexanes) provided the 
alcohol as a clear oil: (47.3 mg, 0.265 mmol, 80% Yield). The enantiomeric excess was 
determined to be 92% by chiral GC analysis (Cyclosil-B, 150˚C isothermal, tR(major) = 23.82 
min, tR(minor) = 25.39 min.) [α]21D = –134.2˚ (c = 0.2, CH2Cl2);  1H NMR (500MHz, CDCl3) δ 
7.23-7.18 (m, 2H), 7.16-7.12 (m, 1H), 7.10-7.05 (m, 1H), 5.02 (d, J = 7.3 Hz, 1H), 4.21 (ddd, J = 
11.1, 5.4, 3.0 Hz, 1H), 3.90-3.84 (m, 1H), 3.80 (td, J = 10.9, 3.4 Hz, 1H), 3.07 (ddd, J = 16.1, 
10.1, 5.4 Hz, 1H), 2.81 (t, J = 4.5 Hz, 1H), 2.71 (dt, J = 16.3, 3.0 Hz, 1H), 2.26 (ddt, J = 14.8, 
6.6, 3.6 Hz, 1H), 2.08 (dddd, J = 15.7, 8.8, 7.1, 4.1 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 
137.6, 134.0, 129.3, 126.7, 126.5, 124.8, 76.8, 64.0, 61.4, 37.8, 29.3; HRMS (TOF MS EI+) m/z 
calc’d for C11H14O [M]+: 178.0994; found 178.0990.  A rotation of [α]21D = +71.4˚ (c = 0.2, 
CH2Cl2) is reported in the literature for the R-enantiomer.90 All other spectral data is consistent 
with data in previous literature. 
 
 
methyl acryloyl-L-valinate (42) was prepared according to literature precedent, and spectral 
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methyl ((E)-3-((S)-isochroman-1-yl)acryloyl)-L-valinate (19): According to the method of 
Grubbs107, to a flame-dried 15 mL round-bottom flask was added 2nd generation Hoveyda-
Grubbs catalyst (15.3 mg, 0.024 mmol, 0.075 equiv) and CH2Cl2 (2 mL) under argon. To a 
separate dried flask was added 12a (52 mg, 0.325 mmol, 1 equiv) and 4214 (120 mg, 0.65 mmol, 
2 equiv), and the flask was placed under argon. The mixture was dissolved with CH2Cl2 (4 mL), 
and was cannulated to the reaction vessel. A reflux condenser was quickly added, and the 
reaction was stirred 48 hours at reflux.  The flask was cooled to room temperature, and the 
solvent was evaporated under reduced pressure. Purification by flash column chromatography 
(20% è 50% EtOAc/hexanes) provided 19 as an off-white solid. (75 mg, 0.24 mmol, 73% Yield) 
[α]22D = –31.97˚ (c = 0.25, CH2Cl2); 1H NMR (500MHz, CDCl3) δ 7.23-7.19 (m, 2H), 7.18-7.14 
(m, 1H), 7.13-7.09 (m, 1H), 7.06 (dd, J = 15.7, 5.6 Hz, 1H), 6.15 (d, J = 15.2 Hz, 1H), 6.09 (d, J 
= 7.5 Hz, 1H), 5.41 (d, J = 4.9 Hz, 1H), 4.67 (dd, J = 8.6, 4.7 Hz, 1H), 4.13 (dt, J = 11.6, 5.4 Hz, 
1H), 3.93 (ddd, J = 11.6, 7.3, 4.3 Hz, 1H), 3.75 (s, 3H), 2.93  2.84 (ABq t, JAB = 17.6 Hz, Jt = 5.4 
Hz, 2H), 2.20 (o, J = 7.3 Hz, 1H), 0.97 (d, J = 6.9 Hz, 3H), 0.93 (d, J = 6.9 Hz, 3H); 13C NMR 
(125 MHz, CDCl3) δ 172.7, 165.4, 143.6, 134.9, 133.8, 129.4, 127.2, 126.5, 126.1, 124.7, 75.2, 
63.1, 57.3, 52.5, 31.7, 28.9, 19.2, 18.1; HRMS (TOF MS ES+) m/z calc’d for C18H24NO4 
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(S)-N,N-dibenzyl-2-(isochroman-1-yl)ethan-1-amine (20): According to the method of 
Buchwald108, in a glove box, to a dried 8 mL dram vial with stir bar was added Cu(OAc)2 (2.7 
mg, 0.0147 mmol, 0.04 equiv) and (R)-DTBM-SEGPHOS (19.1 mg, 0.0162 mmol, 0.044 equiv). 
The vial was taken out of the glove box, and THF (0.2 mL) was added under argon. The mixture 
was stirred for 15 minutes, and then diethoxymethylsilane (0.12 mL, 0.736 mmol, 2 equiv) was 
added via syringe, and the solution was stirred for 10 minutes. A mixture of 12a (59 mg, 0.368 
mmol, 1 equiv) and O-benzoyl-N,N-dibenzylhydroxylamine (140 mg, 0.442 mmol, 1.2 equiv) 
dissolved in THF (0.6 mL) was added via syringe. The reaction was stirred at 40˚C for 36 hours. 
After cooling to room temperature, the reaction was diluted with EtOAc and quenched with 2 
mL Na2CO3 solution. The layers were separated, and the aqueous layer extracted with EtOAc (3 
x 6 mL). The combined organic layers were dried over anhydrous MgSO4, filtered, and 
concentrated under reduced pressure. Purification by flash column chromatography (10% è 20% 
EtOAc/hexanes) provided the amine as a clear oil: (85.7 mg, 0.24 mmol, 65% Yield). The 
enantiomeric excess was determined to be 92% by chiral HPLC analysis (CHIRALPAK OJ-H 
column, 1 mL/min, 2% isopropanol in hexane, λ = 214.4 nm): tR(minor) = 8.93 min, tR(major) = 
10.53 min. [α]22D = –55.95˚ (c = 0.25, CH2Cl2); 1H NMR (500MHz, CDCl3) δ 7.39 (d, J = 7.9 
Hz, 4H), 7.32 (t, J = 7.3 Hz, 4H), 7.25 (t, J = 7.1 Hz, 2H), 7.16-7.08 (m, 3H), 6.95 (d, J = 6.4 Hz, 
1H), 4.81 (d, J = 8.8 Hz, 1H), 4.01 (dt, J = 15.0, 3.9 Hz, 1H), 3.71 (d, J = 13.7 Hz, 2H), 3.70-
3.64 (m, 1H), 3.55 (d, J = 13.9 Hz, 2H), 2.93 (ddd, J = 15.4, 10.6, 6.0 Hz, 1H), 2.80 (dt, J = 13.1, 
7.1 Hz, 1H), 2.67 (d, J = 15.6 Hz, 1H), 2.61 (ddd, J = 12.9, 8.6, 4.5 Hz, 1H), 2.17-2.10 (m, 1H), 
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127.0, 126.3, 126.3, 124.9, 74.4, 63.2, 58.9, 50.4, 34.0, 29.3; HRMS (TOF MS ES+) m/z calc’d 
















































































































































Complete C-H Oxidation Route
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2-(5-bromo-2-methoxyphenethoxy)tetrahydro-2H-pyran (43) 
To a 200 mL flamed-dried RBF, fitted with an oven-dried condenser, was added 2-(5-bromo-2-
methoxyphenyl)acetic acid (5 g, 20.4 mmol, 1 equiv) and 50 mL dry Et2O under N2. The solution 
was stirred at 0℃ and LiAlH4 (0.78 g, 20.4 mmol, 1 equiv) was added in 5 portions over 5 
minutes (CAUTION: gas evolution!). Then, the reaction was heated at 45℃ to reflux for 1 hour. 
After the solution was cooled to 0℃, 0.78 mL of water was added, followed by 0.78 mL of 15% 
NaOH aqueous solution and at last 2.4 mL of H2O. After the slurry was stirred for 30 minutes at 
RT, several spatulas of anhydrous MgSO4 were added and stirred for 30 minutes. The solid was 
filtered off and the solvent was removed under reduced pressure. The crude was continued to 
next step without purification. 
To a 100 mL flame-dried RBF was added the above crude starting material, a few crystals of p-
toluenesulfonic acid monohydrate, and 20 mL dry THF. After cooling to 0℃, 3,4-Dihydro-2H-
pyran (1.95 mL, 21.4 mmol, 1.05 equiv) was added dropwise. After the reaction was stirred at 
RT overnight, all the volatiles were removed under reduced pressure and the crude was applied 
directly to silica column chromatography (10% EtOAc in hexanes). A colorless oil (5.91 g, 18.7 
mmol, 94% yield) was obtained. 1H NMR (500 MHz, Chloroform-d) δ 7.32 (d, J = 2.5 Hz, 1H), 
7.29 – 7.24 (m, 1H), 6.70 (d, J = 8.7 Hz, 1H), 4.60 (t, J = 3.7 Hz, 1H), 3.88 (dt, J = 9.7, 7.2 Hz, 
1H), 3.83 – 3.72 (m, 4H), 3.59 (dt, J = 9.7, 7.0 Hz, 1H), 3.46 (ddd, J = 12.7, 7.1, 3.4 Hz, 1H), 
2.89 (t, J = 7.1 Hz, 2H), 1.82 (dtd, J = 15.7, 8.1, 7.4, 3.6 Hz, 1H), 1.70 (ddt, J = 13.0, 9.7, 3.4 Hz, 
1H), 1.63 – 1.44 (m, 4H); 13C NMR (126 MHz, CDCl3) δ 156.94, 133.55, 130.19, 129.93, 
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for C14H19O3BrNa [M+Na]+: 337.0415; found 337.0414. Spectral data is consistent with data in 




To a 100 mL RBF fitted with a condenser was added magnesium turnings (0.28 g, 11.57 mmol, 
1.2 equiv). The apparatus was flamed-dried under vacuum with vigorous stirring for 20 minutes. 
After cooling to RT, 2 mL of dry THF was added followed by the addition of a small portion of 
43 (3.04 g, 9.64 mmol, 1 equiv) dissolved in 8 mL of dry THF under N2. A few crystals of iodine 
were added, and the deep purple solution was heated by a heat gun. Upon disappearance of the 
color, the rest of the THF solution was added slowly, after which the reaction was heated to 
70℃ with vigorous stirring for 2 hours. The color of the solution was changed from light yellow 
to dark brown. Then, the reaction was cooled to 0℃, after which methyl isocyanate (500 mg, 
8.76 mmol, 0.91 equiv) dissolved in 24 mL of dry Et2O was added dropwise. (NOTE: A fresh 
new bottle of methyl isocyanate was opened and used immediately.) After the reaction was 
stirred at RT for 30 mins, 30 mL of saturated NH4Cl solution was added to quench the reaction 
and the resulting solution was partitioned in a 150 mL separatory funnel. The aqueous layer was 
extracted with EtOAc (50 mL x 3). The organic layers were combined and dried over anhydrous 
Na2SO4. The solid was filtered off and the solvent was removed under reduced pressure. The 
crude was purified via silica column chromatography (40%→50% EtOAc in hexanes). A 
colorless oil (2.46 g, 8.39 mmol, 87% yield) was obtained. 1H NMR (500 MHz, Chloroform-d) 
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Hz, 1H), 3.89 (dt, J = 9.5, 7.4 Hz, 1H), 3.82 (s, 3H), 3.76 (ddd, J = 11.1, 8.0, 3.3 Hz, 1H), 3.60 
(dt, J = 9.5, 7.1 Hz, 1H), 3.47 – 3.40 (m, 1H), 2.96 (d, J = 4.8 Hz, 3H), 2.91 (t, J = 7.2 Hz, 2H), 
1.84 – 1.73 (m, 1H), 1.67 (ddt, J = 12.3, 8.8, 3.2 Hz, 1H), 1.58 – 1.42 (m, 4H); 13C NMR (126 
MHz, CDCl3) δ 168.16, 160.33, 129.47, 127.49, 127.12, 126.66, 109.96, 99.09, 66.78, 62.68, 
55.70, 30.98, 30.83, 27.02, 25.70, 19.92; HRMS (ESI) m/z calc’d for C16H23NO4Na [M+Na]+: 





To a 200 ml flamed-dried RBF was added NaH (200 mg, 8.36 mmol, 1.1 equiv) and 9 mL dry 
DMF under N2. After the solution was cooled to 0℃, ethanethiol (0.66 mL, 9.12 mmol, 1.2 
equiv) in 9 mL dry DMF was added dropwise. The reaction was stirred at RT for 20 mins to 
result in a homogeneous solution. Then 44 (2.23 g, 7.60 mmol, 1 equiv) dissolved in 19 mL dry 
DMF was added to the above solution. The flask was fitted with an oven-dried condenser and 
heated in 110℃ oil bath for 6 hours under N2. After cooling down to RT, the reaction was 
quenched with 20 mL of saturated NH4Cl solution and transferred to a 150 mL separatory funnel. 
The aqueous layer was extracted with EtOAc (80 mL x 4), and all the organic layers were 
combined and dried over Na2SO4. The solid was filtered off and the volatiles were removed 
under reduced pressure including most of the residual DMF. A sticky yellow oil (2 g) was 
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To a 100 mL flamed-dried RBF was added the above crude, 22 mL dry DCM, triethylamine (3 
mL, 21.5 mmol) and 4-dimethylaminopyridine (87.5 mg, 0.72 mmol). The solution was stirred at 
RT and then N-phenyl-bis(trifluoromethanesulfonimide) (3.8 g, 10.7 mmol) was added in one 
portion. The reaction was stirred at RT for 80 mins under N2, after which all the solution was 
directly loaded onto a silica column flushed with acetone/hexane (10%→15%→20%). The 
product (2.8 g, 6.81 mmol, 90% yield) was isolated as a pale yellow oil. 1H NMR (500 MHz, 
Chloroform-d) δ 7.90 (d, J = 2.3 Hz, 1H), 7.69 (dd, J = 8.6, 2.3 Hz, 1H), 7.28 (d, J = 8.6 Hz, 
1H), 6.58 (d, J = 7.7 Hz, 1H), 4.55 (dd, J = 4.6, 2.5 Hz, 1H), 3.97 (dt, J = 9.7, 6.8 Hz, 1H), 3.69 
(ddt, J = 22.3, 12.6, 5.0 Hz, 2H), 3.45 (ddd, J = 9.6, 5.2, 2.9 Hz, 1H), 3.07 – 2.92 (m, 5H), 1.76 
(dq, J = 10.8, 4.6, 3.4 Hz, 1H), 1.70 – 1.62 (m, 1H), 1.58 – 1.41 (m, 4H); 13C NMR (126 MHz, 
CDCl3) δ 166.95, 150.06, 134.71, 132.83, 130.88, 127.11, 121.57, 118.74 (q, J = 320.1 Hz), 
99.36, 66.19, 62.84, 30.83, 30.27, 27.17, 25.60, 19.82; 19F NMR (470 MHz, CDCl3) δ -74.18; 




To a 300 mL flamed-dried RBF was added 45 (2.8 g, 6.81 mmol, 1 equiv), lithium chloride (1.44 
g, 34 mmol, 5 equiv), 70 mL of dry THF and finally allyltributylstannane (2.3 mL, 7.49 mmol, 
1.1 equiv). The solution was stirred and degassed under dry argon for 15 mins. Then, Pd(PPh3)4  
(0.79 g, 0.68 mmol, 0.1 equiv) was added as a solid and the reaction flask was fitted with an 
oven-dried condenser. The reaction was heated in 80℃ oil bath for 22 hours under argon. After 
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a 150 mL separatory funnel. The aqueous layer was extracted with EtOAc (3 x 50 mL). The 
organic layers were combined and dried over anhydrous Na2SO4. The solid was filtered off and 
the solvent was removed under reduced pressure. The crude was purified via silica column 
chromatography (10%→15%→20% acetone/hexane). A colorless oil (1.90 g, 6.25 mmol, 92% 
yield) was obtained. 1H NMR (500 MHz, Chloroform-d) δ 7.65 (d, J = 2.1 Hz, 1H), 7.54 (dd, J = 
7.9, 2.0 Hz, 1H), 7.15 (d, J = 7.9 Hz, 1H), 6.54 (s, 1H), 5.91 (ddt, J = 16.6, 10.1, 6.2 Hz, 1H), 
5.04 (dd, J = 10.1, 1.7 Hz, 1H), 4.94 (dd, J = 17.1, 1.8 Hz, 1H), 4.53 (dd, J = 4.5, 2.7 Hz, 1H), 
3.90 (dt, J = 9.7, 7.3 Hz, 1H), 3.71 (ddd, J = 11.3, 8.1, 3.2 Hz, 1H), 3.57 (dt, J = 9.7, 7.2 Hz, 1H), 
3.47 – 3.38 (m, 3H), 2.95 (d, J = 4.8 Hz, 3H), 2.91 (t, J = 7.3 Hz, 2H), 1.76 (dddd, J = 15.7, 12.1, 
7.2, 3.4 Hz, 1H), 1.66 (ddt, J = 12.1, 8.7, 3.2 Hz, 1H), 1.59 – 1.38 (m, 4H); 13C NMR (126 MHz, 
CDCl3) δ 168.44, 142.05, 137.75, 136.69, 132.82, 129.96, 128.67, 125.14, 116.46, 99.19, 67.81, 
62.64, 37.21, 33.06, 30.90, 27.01, 25.64, 19.85; HRMS (ESI) m/z calc’d for C18H25NO3Na 
[M+Na]+: 326.1732; found 326.17302. 
 
 
Tert-butyl (4-allyl-3-(2-hydroxyethyl)benzoyl)(methyl)carbamate (11k) 
To a 25 mL flame-dried RBF was added 46 (1.90 g, 6.25 mmol, 1 equiv), 6.3 mL of dry DCM, 
Et3N (0.88 mL, 6.25 mmol, 1 equiv) and (Boc)2O (4.3 mL, 18.8 mmol, 3 equiv) under N2. Then, 
DMAP (1.53 g, 12.5 mmol, 2 equiv) was added as a solid in one portion. After the reaction was 
stirred at RT for 6 h, another portion of (Boc)2O (2.2 mL, 9.58 mmol) was added. After stirring 
for 8 more hours, another portion of (Boc)2O (2.2 mL, 9.58 mmol) was further added and the 
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pressure and the resulting crude was flushed through a silica gel plug with 10% EtOAc/Hexane. 
After removal of the solvents under reduced pressure, the oil obtained was diluted with 35 mL of 
EtOH, followed by the addition of pyridinium p-toluenesulfonate (150 mg, 0.6 mmol, 0.1 equiv). 
The solution was stirred in a 45℃ oil bath for 24 hours. All the volatiles were removed by 
reduced pressure and the crude was applied directly to silica column chromatography 
(10%→15%→20%→25%→30% EtOAc in hexanes). A colorless oil (1.89 g, 5.92 mmol, 95% 
yield) was obtained as pure product. 1H NMR (500 MHz, Chloroform-d) δ 7.34 (d, J = 1.9 Hz, 
1H), 7.31 (dd, J = 7.9, 1.9 Hz, 1H), 7.18 (d, J = 7.9 Hz, 1H), 5.91 (ddt, J = 16.5, 10.0, 6.2 Hz, 
1H), 5.06 (dd, J = 10.3, 1.7 Hz, 1H), 4.97 (dd, J = 17.1, 1.8 Hz, 1H), 3.78 (t, J = 6.9 Hz, 2H), 
3.44 (d, J = 6.1 Hz, 2H), 3.27 (s, 3H), 2.88 (t, J = 6.9 Hz, 2H), 2.00 (br, 1H), 1.18 (s, 9H); 13C 
NMR (126 MHz, CDCl3) δ 173.84, 153.90, 141.88, 136.79, 136.74, 135.99, 129.82, 129.32, 
126.14, 116.49, 83.17, 63.11, 37.27, 35.91, 32.89, 27.72; HRMS (ESI) m/z calc’d for 
C18H25NO4Na [M+Na]+: 342.1681; found 342.1678. 
 
 
(S)-tert-butyl methyl(1-vinylisochromane-6-carbonyl)carbamate (12k): tert-butyl (4-allyl-3-
(2-hydroxyethyl)benzoyl)(methyl)carbamate (11k) (640 mg, 2.0 mmol) was reacted according to 
the general procedure for 7 hours. Purification by flash column chromatography (5%→8% 
EtOAc in hexanes) provided the vinylisochroman as a clear oil. Run 1 (440 mg, 70% yield); Run 
2 (0.4 mmol scale, 85.7 mg, 68% yield); Run 3 (0.73 mmol scale, 165.6 mg, 71% yield). 
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analysis (CHIRALPAK AD-RH column, 0.5 mL/min, 50% MeCN in H2O, λ = 254.4 nm): 
tR(major) = 10.882 min, tR(minor) = 14.043 min. [α]26D = +13.2o (c = 0.84, CHCl3); 1H NMR 
(500 MHz, Chloroform-d) δ 7.32 – 7.27 (m, 2H), 7.06 (d, J = 8.0 Hz, 1H), 5.92 (ddd, J = 17.3, 
10.2, 7.3 Hz, 1H), 5.40 – 5.33 (m, 2H), 5.16 (dd, J = 7.2, 1.5 Hz, 1H), 4.14 (dt, J = 11.4, 4.9 Hz, 
1H), 3.84 (ddd, J = 11.4, 8.7, 4.1 Hz, 1H), 3.28 (s, 3H), 2.95 (dddd, J = 15.3, 9.1, 5.5, 1.3 Hz, 
1H), 2.76 (dt, J = 16.4, 4.3 Hz, 1H), 1.17 (s, 9H); 13C NMR (126 MHz, CDCl3) δ 173.53, 153.82, 
139.36, 137.67, 136.39, 133.68, 128.22, 126.10, 125.34, 119.32, 83.17, 78.23, 63.15, 32.81, 




Tert-butyl (1-(2-hydroxyethyl)isochromane-6-carbonyl)(methyl)carbamate (17) 
To an oven-dried 2 dram vial, fitted with PTFE/silicone septum and screw cap, was added 9-
BBN (1.44 mL, 0.72 mmol, 0.5 M in THF, fresh new bottle, 1.2 equiv) under argon. The solution 
was cooled to 0℃, after which 12k (190 mg, 0.6 mmol, 1 equiv) dissolved in 0.85 mL of dry 
THF was added dropwise. The reaction was stirred at 0℃ under argon for 12 hours. Then, 1.44 
mL of H2O was added, followed by the addition of sodium perborate tetrahydrate (462 mg, 3 
mmol, 5 equiv). The reaction was warmed to RT and stirred overnight. The white suspension 
was transferred to a 60 mL separatory funnel by 10 mL of H2O and 20 mL of EtOAc. The 
aqueous layer was separated and extracted carefully with EtOAc (10 mL x 4). The organic layers 
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solvent was removed under reduced pressure. The crude was purified via silica column 
chromatography (30% EtOAc in hexanes). A sticky colorless oil (162 mg, 0.48 mmol, 80% 
yield) was obtained. [α]26D = -50.6o (c = 1.00, CHCl3)  1H NMR (500 MHz, Chloroform-d) δ 
7.31 (dd, J = 8.1, 1.8 Hz, 1H), 7.26 (s, 1H), 7.07 (d, J = 8.0 Hz, 1H), 5.00 – 4.95 (m, 1H), 4.16 
(ddd, J = 11.4, 5.5, 3.2 Hz, 1H), 3.82 (td, J = 5.1, 4.3, 1.4 Hz, 2H), 3.74 (ddd, J = 11.3, 10.1, 3.6 
Hz, 1H), 3.27 (s, 3H), 3.06 – 2.96 (m, 1H), 2.80 (br. s, 1H), 2.69 (dt, J = 16.5, 3.5 Hz, 1H), 2.21 
(dddd, J = 14.7, 6.8, 5.1, 3.3 Hz, 1H), 2.07 – 1.94 (m, 1H), 1.17 (s, 9H); 13C NMR (126 MHz, 
CDCl3) δ 173.45, 153.79, 140.87, 136.20, 133.83, 128.29, 125.66, 124.56, 83.21, 76.17, 63.72, 
60.89, 37.94, 32.81, 29.16, 27.68. HRMS (ESI) m/z calc’d for C18H25NO5Na [M+Na]+: 





(NOTE: MsCl was distilled over P2O5 under high vacuum prior to use) 
To an oven-dried ½ dram vial, fitted with PTFE/silicone septum and screw cap, was added 17 
(68 mg, 0.2 mmol, 1 equiv), DMAP (1.2 mg, 0.01 mmol, 0.05 equiv), DIPEA (88 µL, 0.51 
mmol, 2.5 equiv) and 0.23 mL of dry THF under N2. After the reaction was cooled to 0℃, MsCl 
(17 µL, 0.21 mmol, 1.05 equiv) was added slowly under N2. The reaction was stirred at 0℃ for 
35 minutes, after which 1-(4-methoxyphenyl)piperazine (55 mg, 0.29 mmol, 1.5 equiv) and 0.23 









	   147	  
THF was distilled off under N2. After 12 h reaction, 0.5 mL of water was added to the reaction. 
By using 2 mL of water and 4 mL of DCM, the solution was transferred to a 10 mL test tube, 
where extraction of the layers was performed. The mixing of layers was carefully performed by 
Pasteur pipette with bulb and the aqueous layer was extracted with DCM (4 mL x 5). The 
organic layers were combined and dried over anhydrous Na2SO4. The solid was filtered off and 
the solvent was removed under reduced pressure. The crude was purified via silica column 
chromatography (1%%→2%→5% MeOH in DCM). A sticky colorless oil (45 mg, 0.11 mmol, 
54% yield) was obtained initially. Upon trituration with Et2O, a white solid was obtained as pure 
product. [α]23D = -44.7o (c = 0.93, MeOH/CHCl3 = 1:1). The enantiomeric excess was determined 
to be 93% by correlating optical rotation to the literature reported value of [α]D = -48˚ (c = 0.93, 
MeOH:CHCl3 = 1:1) for enantiopure product.105 1H NMR (500 MHz, Chloroform-d) δ 7.57 – 
7.51 (m, 2H), 7.13 (d, J = 8.4 Hz, 1H), 6.88 (d, J = 9.1 Hz, 2H), 6.82 (d, J = 9.1 Hz, 2H), 6.36 (d, 
J = 5.3 Hz, 1H), 4.84 (dd, J = 8.5, 3.2 Hz, 1H), 4.11 (ddd, J = 11.5, 5.3, 3.7 Hz, 1H), 3.74 (s, 
3H), 3.74 (dd, J = 20.7, 3.8 Hz, 1H), 3.09 (t, J = 5.0 Hz, 4H), 2.98 (d, J = 4.9 Hz, 3H), 3.02 - 
2.92 (m, 1H), 2.75 – 2.59 (m, 6H), 2.54 (ddd, J = 12.4, 10.3, 4.9 Hz, 1H), 2.23 – 2.11 (m, 1H), 
2.02 (tq, J = 13.9, 4.8 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 168.24, 154.01, 145.87, 141.73, 
134.64, 132.89, 127.93, 125.20, 124.70, 118.40, 114.65, 74.73, 63.19, 55.80, 54.89, 53.70, 50.78, 
33.30, 29.27, 27.08. HRMS (EI) m/z calc’d for C24H32N3O3 [M]+: 410.2444; found 410.2437. 
The spectral data is consistent with the literature.105 
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Resubjection of racemic 12a to the reaction. 
 
  
To a ½ dram vial was added ligand (S,R) tBu-ArSOX (8.1 mg, 0.02 mmol, 0.1 equiv) and 
Pd(OAc)2 (4.4 mg, 0.02 mmol, 0.1 equiv). Toluene-d8 (0.3 mL) was added, and the vial was 
capped and allowed to stand at 45˚C until all solids had dissolved. Separately, to a 1 dram vial 
with stir bar was added racemic 12a (16.2 mg, 0.1 mmol, 0.5 equiv), 11f (18mg, 0.1 mmol, 0.5 
equiv) , 2,6-dimethylbenzoquinone (30 mg, 0.22 mmol, 1.1 equiv), diphenylphosphinic acid (4.4 
mg, 0.02 mmol, 0.1 equiv.) and nitrobenzene (4.1 µL, 0.04 mmol). The catalyst solution was 
subsequently added to the reaction flask, and toluene was used to rinse up to 1.3 mL toluene-d8. 
The 1 dram vial was sealed with a Teflon cap, and allowed to stir for 2 hours at 45˚C, at which 
point an aliquot was taken and passed through a silica gel plug with ether as an eluent before 
being subjected to chiral GC analysis. The enantiomeric excess for 12f was determined to be 
91% (Cyclosil-B, 100˚C isothermal, tR(major) = 37.13 min, tR(minor) = 41.06 min.) and the 
enantiomeric excess for 12a was determined to be 0% (Cyclosil-B, 100˚C isothermal, tR = 32.55 
min, tR = 34.03 min.). A separate aliquot was taken from the reaction flask at the same time, and 
diluted with CDCl3 to determine the conversion of 12f versus the nitrobenzene internal standard 


















	   149	  
Enantiomeric excess over time 
 
To a ½ dram vial was added ligand (S,R) tBu-ArSOX (8.1 mg, 0.02 mmol, 0.1 equiv) and 
Pd(OAc)2 (4.4 mg, 0.02 mmol, 0.1 equiv). Toluene (0.3 mL) was added, and the vial was capped 
and allowed to stand at 45˚C until all solids had dissolved. Separately, to a 1 dram vial with stir 
bar was added 11a (32.4 mg, 0.2 mmol, 1 equiv), 2,6-dimethylbenzoquinone (30 mg, 0.22 mmol, 
1.1 equiv), and diphenylphosphinic acid (4.4 mg, 0.02 mmol, 0.1 equiv.). The catalyst solution 
was subsequently added to the reaction flask, and toluene was used to rinse up to 1.3 mL toluene. 
The 1 dram vial was sealed with a Teflon cap, and allowed to stir at 45˚C. Aliquots were taken 




















%ee vs. time 
Figure 2.6: Enantiomeric excess over time  
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To a ½ dram vial was added ligand (S,R) tBu-ArSOX (4.1 mg, 0.01 mmol, 0.1 equiv) and 
Pd(OAc)2 (2.2 mg, 0.01 mmol, 0.1 equiv). Toluene (0.2 mL) was added, and the vial was capped 
and allowed to stand at 45˚C until all solids had dissolved. Separately, to a ½ dram vial with stir 
bar was added 23 (16.2 mg, 0.1 mmol, 1 equiv), 2,6-dimethylbenzoquinone (15 mg, 0.11 mmol, 
1.1 equiv), and diphenylphosphinic acid (2.2 mg, 0.01 mmol, 0.1 equiv.). The catalyst solution 
was subsequently added to the reaction flask, and toluene was used to rinse up to 0.65 mL 
toluene. The vial was sealed with a Teflon cap, and allowed to stir for 8 hours at 45˚C. The vial 
was allowed to cool to room temperature, and solvent was evaporated under reduced pressure.  
The crude residue was examined by 1HNMR, and 12a was not observed. 
 
 
23  1H NMR (500MHz, CDCl3) δ  7.45 (dd, J = 8.4, 1.7 Hz, 1H) 7.24-7.17 (m, 3H), 6.68 (dd, J = 
15.7, 1.7 Hz, 1H), 6.14 (dq, J = 15.6, 6.6 Hz, 1H), 3.84 (t, J = 6.9 Hz, 2H), 2.98 (t, J = 6.9 Hz, 
2H), 1.93 (dd, J = 6.6, 1.7 Hz, 3H), 1.5 (br. s, 1H); 13C NMR (125MHz, CDCl3) δ  137.6, 135.2, 
130.5, 128.6, 128.2, 127.2, 127.1, 126.5, 63.4, 36.7, 19.1; HRMS (EI) m/z calc’d for C11H14O 
[M]+: 162.1045; found 162.1047.  
2,6-DMBQ (1.1 equiv.)









	   151	  
Aliphatic olefin study 
 
 
Table 2.8, Entry 1: 
To a ½ dram vial was added ligand (R,S) tBu-ArSOX (4.1 mg, 0.01 mmol, 0.1 equiv) and 
Pd(OAc)2 (2.2 mg, 0.01 mmol, 0.1 equiv). Toluene-d8 (0.2 mL) was added, and the vial was 
capped and heated to 45˚C until all solids had dissolved. Separately, to a ½ dram vial with stir 
bar was added (S)-3-methylhept-6-en-1-ol (24) (12.8 mg, 0.10 mmol, 1 equiv), 2,6-
dimethylbenzoquinone (15 mg, 0.11 mmol, 1.1 equiv), and diphenylphosphinic acid (2.2 mg, 
0.01 mmol, 0.1 equiv). The catalyst solution was subsequently added to the reaction flask, and 
toluene-d8 was used to rinse up to 0.65 mL. The ½ dram vial was sealed with a Teflon cap, and 
allowed to stir for 48 hours at 45˚C. Afterward, the vial was allowed to cool to room 
temperature, and nitrobenzene (4.1 µL, 0.04 mmol, 0.4 equiv) was added as an internal standard. 
The diasteromeric ratio (19:1 cis:trans) was determined by subjecting a crude aliquot to GC 
analysis (HP-5 (5%-Phenyl)-methylpolysiloxane column (30m, 0.32mm, 0.25mm). Because of 
the low boiling point of 25, the yield was determined by 1HNMR, compared to the nitrobenzene 
internal standard. The yield was determined to be 78%. For purposes of isolation, the reaction 
mixture was directly subjected to column chromatography (97:3 pentane : Et2O), and the 






meso - 1,2-bis(phenylsulfinyl)ethane (L14)





Ligand % Yield d.r. (cis:trans)










Table 2.8: Catalyst vs. substrate diastereocontrol on aliphatic olefin  
	   152	  
Table 2.8, Entry 2: 
To a ½ dram vial with stir bar was added (S)-3-methylhept-6-en-1-ol (24) (12.8 mg, 0.10 mmol, 
1 equiv), 2,6-dimethylbenzoquinone (15 mg, 0.11 mmol, 1.1 equiv), diphenylphosphinic acid 
(2.2 mg, 0.01 mmol, 0.1 equiv), meso-1,2-bis(phenylsulfinyl)ethane (L14) (2.8 mg, 0.01 mmol, 
0.1 equiv) and Pd(OAc)2 (2.2 mg, 0.01 mmol, 0.1 equiv). Toluene-d8 (0.65 mL) was added, and 
the vial was sealed with a Teflon cap and allowed to stir for 24 hours at 45˚C.  Afterward, the 
vial was allowed to cool to room temperature, and nitrobenzene (4.1 µL, 0.04 mmol, 0.4 equiv) 
was added as an internal standard. The diasteromeric ratio (8:1 cis:trans) was determined by 
subjecting a crude aliquot to GC analysis. The yield was determined by 1HNMR, compared to 
the nitrobenzene internal standard. The yield was determined to be 76%.  
Table 2.8, Entry 3: 
To a ½ dram vial was added ligand (S,R) tBu-ArSOX (4.1 mg, 0.01 mmol, 0.1 equiv) and 
Pd(OAc)2 (2.2 mg, 0.01 mmol, 0.1 equiv). Toluene-d8 (0.2 mL) was added, and the vial was 
capped and heated to 45˚C until all solids had dissolved. Separately, to a ½ dram vial with stir 
bar was added (S)-3-methylhept-6-en-1-ol (24) (12.8 mg, 0.10 mmol, 1 equiv), 2,6-
dimethylbenzoquinone (15 mg, 0.11 mmol, 1.1 equiv), and diphenylphosphinic acid (2.2 mg, 
0.01 mmol, 0.1 equiv). The catalyst solution was subsequently added to the reaction flask, and 
toluene-d8 was used to rinse up to 0.65 mL. The ½ dram vial was sealed with a Teflon cap, and 
allowed to stir for 48 hours at 45˚C. Afterward, the vial was allowed to cool to room 
temperature, and nitrobenzene (4.1 µL, 0.04 mmol, 0.4 equiv) was added as an internal standard. 
The diasteromeric ratio (1.3:1 cis:trans) was determined by subjecting a crude aliquot to GC 
analysis. The yield was determined by 1HNMR, compared to the nitrobenzene internal standard. 
The yield was determined to be 85%.   
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(S)-3-methylhept-6-en-1-ol (24): 1H NMR (500MHz, CDCl3) δ 5.83 (ddt, J = 16.7, 10.1, 6.6 
Hz, 1H), 5.02 (d, J = 17.1, 1H), 4.96 (d, J = 10.3 Hz 1H), 3.78-3.68 (m, 2H), 2.16-2.02 (m, 2H), 
1.69-1.59 (m, 2H), 1.48-1.38 (m, 2H), 1.30-1.23 (m, 1H), 0.93 (d, J = 6.4 Hz, 3H); 13C NMR 
(125MHz, CDCl3) δ  139.3, 114.5, 61.4, 40.1, 36.5, 31.5, 29.2, 19.7; [α]23D = –4.06˚ (c = 0.45, 
hexane); HRMS (EI+) m/z calc’d for C8H15 [M–OH]+: 111.1174; found 111.1178. Spectral data 
is consistent with previous literature.127  
 
 
(2S,4R)-4-methyl-2-vinyltetrahydro-2H-pyran (cis-25): Product is a clear oil. 1H NMR 
(500MHz, CDCl3) δ 5.89 (ddd, J = 16.4, 10.7, 5.6 Hz, 1H), 5.27 (d, J = 17.3 Hz, 1H), 5.12 (d, J 
= 10.7 Hz, 1H), 4.07 (ddd, J = 11.5, 4.6, 1.2 Hz, 1H), 3.81 (ddd, J = 11.0, 5.4, 1.0 Hz, 1H), 3.51 
(td, J = 12.2, 2.2 Hz, 1H), 1.74-1.65 (m, 2H), 1.60-1.55 (m, 1H) 1.32-1.22 (m, 1H), 1.10-1.02 
(m, 1H), 0.99 (d, J = 6.3 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 139.6, 114.7, 78.3, 68.2, 40.7, 
34.6, 30.5, 22.5; [α]23D = –19.88˚ (c = 0.2, CH2Cl2); HRMS (EI+) m/z calc’d for C8H14O [M]+: 
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nOe Assignment of cis-25. 
 
       
 
(500 MHz, CDCl3) The ethereal proton peak at δ 4.07 (Ha) was irradiated, and the resulting 
observed relationship is illustrated above. cis-25 gave a characteristic nOe between the axial 
ethereal proton Ha, and both the axial proton Hc (δ 1.27, multiplet) and the axial ethereal proton 
Hb (δ 3.51). Additionally, the ethereal proton peak at δ 3.51 (Hb) was irradiated, and an nOe 
between the axial ethereal proton Hb, and both the and axial ethereal proton Ha (δ 4.07) and the 
axial proton Hc (δ 1.27, multiplet) was observed. This indicates a cis-relationship between Ha, 
Hb, and Hc for cis-25. 
 
 
Observation of side product 
Under the optimized reaction conditions, small amounts (approx. 10%) of an adduct from the 
reaction of the isochroman product (12a) and the 2,6-dimethylquinone oxidant were isolated as a 
side product. The quantity of this side product (47) was observed to increase if the reaction was 
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47: 1H NMR (500MHz, CDCl3) δ 7.39 (d, J = 7.9 Hz, 1H), 7.31-7.27 (m, 2H), 7.21 (d, J = 7.7 
Hz, 1H), 6.57 (s, 1H), 4.28 (br. s, 1H), 4.16 (t, J = 11.6 Hz, 1H), 3.93 (dd, J = 11.1, 6.0 Hz, 1H), 
3.21-3.10 (m, 1H), 2.99-2.90 (m, 1H), 2.76 (dd, J = 16.1, 6.0 Hz, 1H), 2.68 (d, J = 15.9 Hz, 1H), 
2.40 (td, J = 13.1, 6.2 Hz, 1H), 2.22 (s, 3H), 2.20 (s, 3H), 2.13 (dd, J = 13.5, 6.6 Hz, 1H); 13C 
NMR (125 MHz, CDCl3) δ 146.6, 146.2, 137.2, 134.8, 128.9, 128.4, 127.0, 126.8, 122.2, 122.0, 
119.5, 116.6, 95.8, 59.4, 32.3, 29.1, 20.5, 16.3, 11.7; HRMS (EI+) m/z calc’d for C19H20O3 
[M]+: 296.1413; found 296.1419. 
A (racemic) crystal structure was obtained of 47, produced from a reaction run with racemic 
ligand 41. This crystal was spectroscopically identical (1HNMR) to 47 produced from reactions 
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Crystal data and structure refinement for 47. 
Identification code  cd89zsa 
Empirical formula  C19 H20 O3 
Formula weight  296.35 
Temperature  100(2) K 
Wavelength  1.54178 Å 
Crystal system  Monoclinic 
Space group  P21/n 
Unit cell dimensions a = 7.6306(2) Å a= 90°. 
 b = 7.6652(2) Å b= 90.5414(12)°. 
 c = 24.7258(8) Å g = 90°. 
Volume 1446.15(7) Å3 
Z 4 
Density (calculated) 1.361 Mg/m3 
Absorption coefficient 0.728 mm-1 
F(000) 632 
Crystal size 0.287 x 0.153 x 0.114 mm3 
Theta range for data collection 3.575 to 68.369°. 
Index ranges -9<=h<=9, -8<=k<=9, -29<=l<=28 
Reflections collected 39068 
Independent reflections 2633 [R(int) = 0.0434] 
Completeness to theta = 67.679° 99.7 %  
Absorption correction Integration 
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Max. and min. transmission 0.95969 and 0.91376 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2633 / 0 / 204 
Goodness-of-fit on F2 1.080 
Final R indices [I>2sigma(I)] R1 = 0.0382, wR2 = 0.0941 
R indices (all data) R1 = 0.0439, wR2 = 0.0978 
Extinction coefficient n/a 
Largest diff. peak and hole 0.218 and -0.283 e.Å-3 
 
 
Alkylation: General Nucleophile Synthetic Scheme A: 
 
 To a flame-dried round bottom flask was added methyl 3-oxopentanoate (1 equiv.) and 
CH3CN (0.4 M). 4-Acetamidobenzenesulfonyl azide (1.1 equiv.) was added, and the reaction 
was cooled to 0˚C. Et3N (1.2 equiv) was added, and the reaction was stirred at 0˚C for 30 
minutes before warming to room temperature. The reaction was stirred overnight. Afterward, the 
suspension was filtered through celite and rinsed with EtOAc. The mixture was concentrated 
under reduced pressure and purified by silica gel column chromatography (20% Et2O in 
petroleum ether) to afford the diazo ester which was taken on to the next step. 
 To a flame-dried RBF under argon was added the diazo ester (1 equiv.) and CH2Cl2 (0.1 
M), and the reaction was cooled to –78˚C. Et3N (1.1 equiv.) was added, followed by TiCl4 
dropwise (1M solution in CH2Cl2, 1.1 equiv), and the reaction was stirred at –78˚C for two 
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reaction was stirred for 1 hour at –78˚C. After complete conversion of the starting material was 
observed by TLC, NH4Cl (sat. aq.) was added dropwise at –78˚C, and the reaction was allowed 
to warm to room temperature. The quenched reaction mixture was then extracted with CH2Cl2 
(3x) and the combined organic layers were dried over MgSO4, filtered, and concentrated under 
reduced pressure. The crude mixture was purified by silica gel column chromatography (20% ! 
30% EtOAc in hexanes) to afford the alcohol product that was taken on to the next step. 
 To a flame-dried RBF equipped with a reflux condenser was added the alcohol substrate 
(1 equiv.) and CH3CN (0.1 M) under argon. Freshly-prepared IBX (1.5 equiv.) was added, and 
the reaction was stirred for 2 hours at 80˚C. After the flask was cooled, cold Et2O was added, and 
the suspension was filtered through celite and rinsed with cold Et2O. The filtrate was 
concentrated under reduced pressure, and the crude mixture was purified by silica gel column 
chromatography (20% ! 30% EtOAc in hexanes) to afford the ketone product that was taken on 
to the next step. 
 To a flame-dried RBF in a glove box was added a catalytic amount of Rh2OAc4. The 
flask was sealed with a septum and taken out of the glove box, after which an argon balloon was 
added. Toluene (0.1M) was added, and the mixture was heated to 80˚C. A 1M solution of the 
ketone substrate in toluene was added, and the reaction was stirred for ten minutes. Evolution of 
nitrogen gas was observed. The reaction was subsequently rapidly cooled in an ice bath, and 
filtered through celite (rinsing with EtOAc) to remove the majority of the catalyst. The crude 
mixture was concentrated under reduced pressure and was purified by silica gel column 
chromatography (20% EtOAc in hexanes) to afford the beta-ketoester product. NOTE: The 
products were moderately unstable to silica gel, so the column purification was performed in a 
rapid manner. Additionally the beta-ketoester products were observed to decompose after 
	   159	  
prolonged exposure to the atmosphere, however they were stable when stored either under 
vacuum, or in a glovebox freezer under argon atmosphere. 
Alkylation: General Nucleophile Synthetic Scheme B: 
 
 To a flame-dried round bottom flask equipped with a reflux condenser was added 
dimethyl 3-oxoglutarate (1 equiv.), isopropanol (2.5 equiv.), toluene (0.8 M) and DMAP (0.1 
equiv.). The mixture was refluxed for 24 hours. Afterward, the mixture was cooled and 
concentrated under reduced pressure. The crude mixture was purified by silica gel column 
chromatography (5% EtOAc in hexanes) to afford the isopropyl ester product. 
To a flame-dried round bottom flask was added the isopropyl ester substrate (1 equiv.) 
and CH3CN (0.1 M). Et3N (1.5 equiv) was added, and the reaction was cooled to 0˚C. 4-
Acetamidobenzenesulfonyl azide (1.0 equiv.) was added, and the reaction was warmed to room 
temperature and stirred 4 hours. Afterward, the suspension was filtered through celite and rinsed 
with EtOAc. The mixture was concentrated under reduced pressure and purified by silica gel 
column chromatography (20% EtOAc in hexanes) to afford the diazo ester which was taken on 
to the next step. 
 To a flame-dried RBF in a glove box was added a catalytic amount of Rh2OAc4. The 
flask was sealed with a septum and taken out of the glove box, after which an argon balloon was 
added. Benzene (0.1M) was added, and the mixture was heated to 50˚C. A 1M solution of the 
ketone substrate in benzene was added under slow addition conditions, and the reaction was 
stirred for 1 hour after completion of addition. Evolution of nitrogen gas was observed. The 
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EtOAc) to remove the majority of the catalyst. The crude mixture was concentrated under 
reduced pressure and was purified by silica gel column chromatography (20% ! 30%  ! 50%  
EtOAc in hexanes) to afford the beta-ketoester product. NOTE: The product was moderately 
unstable to silica gel, so the column purification was performed in a rapid manner. Additionally 
the beta-ketoester product was observed to decompose after prolonged exposure to the 
atmosphere, however it was stable when stored either under vacuum, or in a glovebox freezer 
under argon atmosphere. 
 
	  
Isopropyl 5-isopropoxy-3-oxo-2,3-dihydrofuran-2-carboxylate: 1H NMR (500MHz, CDCl3) δ 
5.13 (hept, J = 6.2 Hz, 1H), 5.04 (s, 1H), 4.80 (hept, J = 6.2 Hz, 1H), 4.74 (s, 1H), 1.45 (dd, J = 
6.6, 1.9 Hz, 6H), 1.32 (dd, J = 6.3, 2.5 Hz, 6H); 13C NMR (125 MHz, CDCl3) δ 191.2, 185.2, 
163.3, 82.7, 79.6, 77.6, 77.4, 77.2, 76.9, 70.8, 22.0, 21.8, 21.8, 21.8; HRMS (ESI) m/z calc’d for 
C11H17O5 [M+H]: 229.1076; found 229.1079.  
	  
Isopropyl 2-cinnamyl-5-isopropoxy-3-oxo-2,3-dihydrofuran-2-carboxylate: 1H NMR 
(500MHz, CDCl3) enol-tautomer: δ 7.95-7.50 (br. s, 1H), 7.44 (d, J = 3.2 Hz, 1H), 7.40 (d, J = 
4.8 Hz, 1H), 7.12 (dd, J = 5.0, 3.6 Hz, 1H), 3.94 (s, 3H), 2.19 (s, 3H); keto-tautomer: δ 3.94 (s, 
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125.8, 124.1, 109.0, 81.3, 51.7, 7.5; HRMS (EI) m/z calc’d for C11H11O4S [M+H]: 239.0378; 
found 239.0382.  
 
Methyl 5'-ethyl-3-methyl-4-oxo-4,5-dihydro-[2,2'-bifuran]-5-carboxylate: product exists in 
solution as an approx. 10:1 enol:keto-tautomeric mixture: 1H NMR (500MHz, CDCl3) enol-
tautomer δ 8.11 – 7.36 (br. s, 1H), 6.65 (d, J = 3.4 Hz, 1H), 6.10 (d, J = 3.4 Hz, 1H), 3.93 (s, 
3H), 2.72 (q, J = 7.6 Hz, 2H), 2.18 (s, 3H), 1.27 (t, J = 7.5 Hz, 3H); keto-tautomer δ 7.09 (d, J = 
3.6 Hz, 1H), 6.26 (d, J = 3.5 Hz, 1H), 3.86 (s, 3H), 2.00 (s, 3H); 13C NMR (125 MHz, CDCl3) 
(enol:keto-tautomeric mixture) δ 164.6, 163.7, 159.3, 144.3, 123.9, 117.9, 110.2, 108.4, 107.8, 
106.4, 81.1, 53.3, 51.6, 21.9, 21.6, 12.1, 11.9, 6.9, 6.3; HRMS (ESI) m/z calc’d for C13H15O5 
[M+H]: 251.0919; found 251.0921. 	  
	  
3-allylphenyl diethyl phosphate: To a flame-dried RBF under argon was added 3-allylphenol 
(350 mg, 2.5 mmol, 1 equiv.), anhydrous THF (8 mL), and DABCO (420 mg, 3.75 mmol, 1.5 
equiv.) at room temperature. To this mixture was added diethylchlorophosphate (540 mg, 3.75 
mmol, 1.5 equiv.) dissolved in THF (2 mL) dropwise via syringe. The reaction was stirred at 
room temperature overnight. Afterward, the reaction was poured into CH2Cl2 and washed with 
HCl (5% aq.), NaHCO3 (sat. aq.), and brine. The organic layer was dried over MgSO4, filtered, 
and concentrated under reduced pressure. The crude mixture was purified by silica gel 
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(450 mg, 67% yield). 1H NMR (500MHz, CDCl3) δ 7.33 – 7.19 (m, 2H), 7.09 – 7.02 (m, 2H), 
7.00 (d, J = 7.7 Hz, 1H), 6.03 – 5.86 (m, 1H), 5.14 – 5.02 (m, 2H), 4.26 – 4.17 (m, 4H), 3.38 (d, 
J = 6.7 Hz, 2H), 1.36 (t, J = 7.1 Hz, 6H); 13C NMR (125 MHz, CDCl3) δ 150.9 (d, JP = 7.5 Hz), 
142.3, 136.8, 129.7, 125.4, 120.3 (d, JP = 5.0 Hz) 117.7 (d, JP = 5.0 Hz), 116.5, 64.7 (d, JP = 6.3 
Hz), 40.0, 16.2 (d, JP = 6.3 Hz); 31P NMR (202MHz, CDCl3) δ –5.2; HRMS (ESI) m/z calc’d for 
C13H20O4P [M+H]: 271.1099; found 271.1105.  
Alkylation: Synthesis of L15: 
	  
	  
(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl (S)-4-bromobenzenesulfinate: To a mixture of 4-
bromosulfonyl chloride (5 g, 19.5 mmol, 1.01 equiv.) and (–)menthol (3.02 g, 19.3 mmol, 1 
equiv.) in CH2Cl2 (50 mL) at 0˚C under argon was added Et3N (26.9 mL, 193 mmol, 10 equiv.), 
and the reaction was stirred 15 minutes at 0˚C. A solution of triphenylphosphine (5.06 g, 19.3 
mmol, 1 equiv.) in CH2Cl2 (10 mL) was added dropwise at 0˚C, and the reaction was stirred 3 
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organic layer was dried over MgSO4, filtered, and concentrated under reduced pressure. The 
crude mixture was purified by silica gel column chromatography (10% EtOAc in hexanes) to 
afford the product as a mixture of diastereomers.  The diastereomeric mixture was dissolved in a 
minimal amount of acetone and one drop of HCl (conc.) was added. Recrystallization at 0˚C 
afforded the product as a single diastereomer (2.3 g, 6.4 mmol, 33% yield).    [α]23D = –151.98 (c 
= 0.76, CHCl3).  1H NMR (500MHz, CDCl3) δ 7.66 (d, J = 8.5 Hz, 2H), 7.58 (d, J = 8.5 Hz, 2H), 
4.13 (td, J = 10.7, 4.5 Hz, 1H), 2.32 – 2.22 (m, 1H), 2.10 (qd, J = 7.4, 4.9 Hz, 1H), 1.76 – 1.58 
(m, 2H), 1.56 – 1.43 (m, 1H), 1.41 – 1.30 (m, 1H), 1.22 (q, J = 11.8 Hz, 1H), 1.12 – 0.99 (m, 
1H), 0.96 (d, J = 6.5 Hz, 3H), 0.93 – 0.81 (m, 4H), 0.72 (d, J = 6.9 Hz, 3H); 13C NMR (125 
MHz, CDCl3) δ 145.3, 132.3, 126.8, 126.8, 80.8, 48.0, 43.0, 34.1, 31.9, 25.4, 23.3, 22.2, 21.0, 
15.6; HRMS (ESI) m/z calc’d for C16H124O2SBr [M+H]: 359.0680; found 359.0685.  
	  
Isopropyl 2-cinnamyl-5-isopropoxy-3-oxo-2,3-dihydrofuran-2-carboxylate: To a round 
bottom flask with a reflux condenser was added the sulfinate (1.2 g, 3.34 mmol, 1 equiv.), 9-
anthraceneboronic acid (1.11 g, 5.01 mmol, 1.5 equiv.), Pd(dppf)Cl2 (366 mg, 0.5 mmol, 0.15 
equiv.), and Na2CO3 (1.42 g, 13.36 mmol, 4 equiv.). The atmosphere in the flask was replaced 
with argon, and a mixture of degassed 1:1:1 CH3CN : H2O : toluene (45 mL) was added to the 
flask. The reaction was stirred at 80˚C for 18 hours. After cooling to room temperature, the 
mixture was partitioned with EtOAc (100 mL) and H2O (100 mL), and the layers were separated. 
The aqueous layer was extracted with EtOAc (2x 100 mL), and the combined organic layers 
OS
O
	   164	  
were dried over MgSO4, filtered, and concentrated under reduced pressure. The crude material 
was purified by silica gel chromatography (5%  ! 10% EtOAc in hexanes) to afford the product 
as an off-white solid (1.2 g, 79 % yield). [α]23D = –103.60 (c = 0.275, CHCl3).  1H NMR 
(500MHz, CDCl3) δ 8.54 (s, 1H), 8.06 (d, J = 8.5 Hz, 2H), 7.95 (d, J = 8.2 Hz, 2H), 7.65 – 7.55 
(m, 4H), 7.48 (t, J = 7.0 Hz, 2H), 7.37 (t, J = 7.7 Hz, 2H), 4.28 (td, J = 10.8, 4.5 Hz, 1H), 2.44 – 
2.34 (m, 1H), 2.28 (tt, J = 9.5, 4.6 Hz, 1H), 1.82 – 1.69 (m, 2H), 1.63 – 1.41 (m, 2H), 1.35 (q, J = 
11.8 Hz, 1H), 1.12 (qd, J = 13.0, 3.6 Hz, 1H), 1.01 (d, J = 6.5 Hz, 3H), 0.98 – 0.88 (m, 4H), 0.83 
(d, J = 7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 145.5, 143.1, 135.4, 132.1, 131.4, 130.1, 
128.6, 127.4, 126.5, 125.9, 125.5, 125.36, 80.9, 48.1, 43.2, 34.2, 32.0, 25.4, 23.3, 22.3, 21.1, 
15.7; HRMS (ESI) m/z calc’d for C30H33O2S [M+H]: 457.2201; found 457.2197.  
	  
(S)-2-(2-((S)-(4-(anthracen-9-yl)phenyl)sulfinyl)phenyl)-4-(3,4,5-trimethoxyphenyl)-4,5-
dihydrooxazole (L15): To a dried flask under argon was added the 2-bromophenyloxazoline 
(280 mg, 0.71 mmol, 1 equiv), THF (10 mL), and TMEDA (0.11 mL, 0.78 mmol, 1.1 equiv). 
The reaction was cooled to –78˚C with stirring, and n-butyllithium (1.6M in hexane, 0.44 mL, 
0.71 mmol 1 equiv) was added via syringe dropwise. The reaction was stirred 5 minutes at –
78˚C. Subsequently, the sulfinate (652 mg, 1.43 mmol, 2 equiv) was added as a solution in THF 
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then overnight at room temperature. The reaction was subsequently cooled to 0˚C, and quenched 
with water. The mixture was diluted with CH2Cl2, and the layers were separated. The aqueous 
layer was extracted with CH2Cl2. The combined organic layers were dried over anhydrous 
MgSO4, filtered, and concentrated under reduced pressure. The crude residue was purified via 
column chromatography (20 ! 30% EtOAc in hexanes) to afford the desired product as an off-
white solid (95 mg, 22 % yield). [α]21D = –229.29 (c = 0.2, CHCl3).  1H NMR (500MHz, CDCl3) 
δ 8.55 – 8.46 (m, 2H), 8.10 (d, J = 7.8 Hz, 1H), 8.03 (d, J = 8.5 Hz, 2H), 7.98 (d, J = 7.5 Hz, 
2H), 7.85 (t, J = 7.7 Hz, 1H), 7.63 (t, J = 7.6 Hz, 1H, 7.50 – 7.40 (m, 4H), 7.36 (d, J = 7.7 Hz, 
2H), 7.31 (d, J = 7.5 Hz, 2H), 6.51 (s 2H), 5.46 (t, J = 9.7 Hz, 1H), 4.84 (d, J = 9.6 Hz, 1H), 4.31 
(t, J = 9.0 Hz, 1H), 3.73 (s, 6H), 3.68 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 162.4, 153.7, 
147.8, 146.0, 141.6, 137.6, 137.1, 135.4, 132.8, 131.8, 131.4, 130.7, 130.1, 130.0, 128.6, 127.3, 
126.7, 126.4, 125.8, 125.4, 125.3, 125.2, 103.9, 74.8, 71.2, 60.9, 56.3; HRMS (ESI) m/z calc’d 
for C38H32NO5S [M+H]: 614.2015; found 614.2010.  
 
Isopropyl 2-cinnamyl-5-isopropoxy-3-oxo-2,3-dihydrofuran-2-carboxylate (26): To a ½ 
dram vial was added ligand L15 (6.1 mg, 0.01 mmol) and Pd(OAc)2 (2.2 mg, 0.01 mmol). 
Dioxane (0.3 mL) was added, and the vial was capped and heated to 45˚C until all solids had 
dissolved. Separately, to a second ½ dram vial with stir bar was added nucleophile (45 mg, 0.20 
mmol), 2,6-dimethylbenzoquinone (20.8 mg, 0.15 mmol), and zinc acetate dihydrate (11 mg, 
0.05 mmol). The catalyst solution was subsequently added to the reaction flask, and dioxane was 
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cold room for 10 min. Allylbenzene (13 µL, 0.1 mmol) was added via syringe, and the reaction 
vial was again capped and stirred for 72 hours at 5˚C.  Subsequently, the reaction mixture was 
directly subjected to flash column chromatography (10% ! 20%  ! 30%  ! 50%  EtOAc in 
hexanes) to provide the alkylated product as a clear oil. Run 1 (19.9 mg, 58% yield); Run 2 (24.4 
mg, 71% yield); Run 3 (23.8 mg, 69% yield). Average: 66% Yield. The enantiomeric excess 
was determined to be 90% by chiral HPLC analysis (CHIRALPAK OJ-H column, 0.5 mL/min, 
5% isopropanol in hexane, λ = 254 nm,  tR(minor) = 14.34 min, tR(major) = 15.56 min.) [α]22D = 
+99.22 (c = 0.26, CHCl3).  1H NMR (500MHz, CDCl3) δ 7.39 – 7.19 (m, 5H), 6.57 (d, J = 15.8 
Hz, 1H), 6.09 (td, J = 14.9, 6.3 Hz, 1H), 5.10 (hept, J = 6.6 Hz, 1H), 4.81 (hept, J = 6.3 Hz, 1H), 
4.73 (s, 1H), 3.12 (dd, J = 14.7, 8.1 Hz, 1H), 2.97 (dd, J = 14.8, 6.7 Hz, 1H), 1.43 (dd, J = 11.6, 
6.2 Hz, 6H), 1.30 (dd, J = 6.3 Hz, 6H); 13C NMR (125 MHz, CDCl3) δ 193.3, 184.2, 164.7, 
137.0, 135.4, 128.6, 127.7, 126.4, 121.1, 92.1, 79.6, 77.2, 70.7, 36.9, 21.9, 21.8, 21.75; HRMS 
(ESI) m/z calc’d for C20H25O5 [M+H]: 345.1702; found 345.1692.  
 
Methyl 2-cinnamyl-4-methyl-3-oxo-5-(thiophen-2-yl)-2,3-dihydrofuran-2-carboxylate (27): 
To a ½ dram vial was added ligand L15 (6.1 mg, 0.01 mmol) and Pd(OAc)2 (2.2 mg, 0.01 
mmol). Dioxane (0.3 mL) was added, and the vial was capped and heated to 45˚C until all solids 
had dissolved. Separately, to a 1 dram vial with stir bar was added nucleophile (24 mg, 0.10 
mmol), 2,6-dimethylbenzoquinone (20.8 mg, 0.15 mmol), and zinc acetate dihydrate (11 mg, 
0.05 mmol). The catalyst solution was subsequently added to the reaction flask, and dioxane was 
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cold room for 10 min. Allylbenzene (13 µL, 0.1 mmol) was added via syringe, and the reaction 
vial was again capped and stirred for 72 hours at 5˚C.  Subsequently, the reaction mixture was 
warmed until all solvent in the flask had melted, and immediately subjected to flash column 
chromatography (10% ! 20%  ! 30%  ! 50%  EtOAc in hexanes) to provide the alkylated 
product as a clear oil. Run 1 (29.1 mg, 82% yield); Run 2 (28.6 mg, 81% yield); Run 3 (30.1 mg, 
85% yield). Average: 83% Yield. The enantiomeric excess was determined to be 91% by chiral 
HPLC analysis (CHIRALPAK IB-3 column, 0.5 mL/min, 10% isopropanol in hexane, λ = 254 
nm, tR(minor) = 9.52 min, tR(major) = 10.04 min.) [α]22D = +93.19 (c = 0.13, CHCl3).  1H NMR 
(500MHz, CDCl3) δ 7.82 (dd, J = 3.9, 1.2 Hz, 1H), 7.73 (dd, J = 5.1, 1.2 Hz, 1H), 7.37 – 7.18 
(m, 6H), 6.58 (d, J = 15.8 Hz, 1H), 6.09 (dt, J = 15.2, 7.3 Hz, 1H), 3.80 (s, 3H), 3.22 (dd, J = 
15.4, 7.4 Hz, 1H), 2.97 (dd, J = 14.6, 7.2 Hz, 1H), 2.02 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 
198.0, 174.9, 166.1, 137.1, 135.4, 132.1, 132.0, 131.1, 128.6, 128.5, 127.7, 126.5, 121.3, 107.9, 
89.8, 53.5, 37.9, 7.2; HRMS (ESI) m/z calc’d for C20H19O4S [M+H]: 355.1004; found 355.0998.  
	  
Methyl 5-cinnamyl-5'-ethyl-3-methyl-4-oxo-4,5-dihydro-[2,2'-bifuran]-5-carboxylate (28): 
To a ½ dram vial was added ligand L15 (6.1 mg, 0.01 mmol) and Pd(OAc)2 (2.2 mg, 0.01 
mmol). Dioxane (0.3 mL) was added, and the vial was capped and heated to 45˚C until all solids 
had dissolved. Separately, to a second ½ dram vial with stir bar was added nucleophile (25 mg, 
0.10 mmol), 2,6-dimethylbenzoquinone (20.8 mg, 0.15 mmol), and zinc acetate dihydrate (11 
mg, 0.05 mmol). The catalyst solution was subsequently added to the reaction flask, and dioxane 
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a cold room for 10 min. Allylbenzene (13 µL, 0.1 mmol) was added via syringe, and the reaction 
vial was again capped and stirred for 72 hours at 5˚C.  Subsequently, the reaction mixture was 
directly subjected to flash column chromatography (10% ! 20%  ! 30%  ! 50%  EtOAc in 
hexanes) to provide the alkylated product as a clear oil. Run 1 (23.2 mg, 63% yield); Run 2 (24.5 
mg, 67% yield); Run 3 (25.6 mg, 70% yield). Average: 67% Yield. The enantiomeric excess 
was determined to be 93% by chiral HPLC analysis (CHIRALPAK OJ-H column, 0.5 mL/min, 
5% isopropanol in hexane, λ = 230 nm,  tR(minor) = 10.82 min, tR(major) = 12.83 min.) [α]22D = 
+135.15 (c = 0.11, CHCl3).  1H NMR (500MHz, CDCl3) δ 7.35 – 7.26 (m, 4H), 7.26 – 7.18 (m, 
1H), 7.13 (d, J = 3.5 Hz, 1H), 6.56 (d, J = 15.8 Hz, 1H), 6.27 (d, J = 3.4 Hz, 1H), 6.08 (dt, J = 
15.2, 7.3 Hz, 1H), 3.79 (s, 3H), 3.19 (ddd, J = 14.7, 7.5, 1.4 Hz, 1H), 2.96 (ddd, J = 14.4, 7.2, 1.4 
Hz, 1H), 2.79 (q, J = 7.6 Hz, 2H), 2.01 (s, 3H), 1.32 (t, J = 7.6 Hz, 3H); 13C NMR (125 MHz, 
CDCl3) δ 197.8, 170.8, 166.2, 163.6, 143.9, 137.1, 135.2, 128.6, 127.6, 126.5, 121.4, 117.7, 
107.7, 107.2, 89.6, 53.4, 37.9, 21.9, 11.9, 6.4; HRMS (ESI) m/z calc’d for C22H23O5 [M+H]: 
367.1545; found 367.1541.  
	  
Methyl (E)-5-(3-(benzo[d][1,3]dioxol-5-yl)allyl)-5'-ethyl-3-methyl-4-oxo-4,5-dihydro-[2,2'-
bifuran]-5-carboxylate (29): To a ½ dram vial was added ligand L15 (6.1 mg, 0.01 mmol) and 
Pd(OAc)2 (2.2 mg, 0.01 mmol). Dioxane (0.3 mL) was added, and the vial was capped and 
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was added nucleophile (25 mg, 0.10 mmol), 2,6-dimethylbenzoquinone (20.8 mg, 0.15 mmol), 
and zinc acetate dihydrate (11 mg, 0.05 mmol). The catalyst solution was subsequently added to 
the reaction flask, and dioxane was used to rinse up to 0.6 mL toluene. The vial was sealed with 
a Teflon cap, cooled to 5˚C in a cold room for 10 min. Saffrole (14.8 mg, 0.1 mmol) was added, 
and the reaction vial was again capped and stirred for 72 hours at 5˚C.  Subsequently, the 
reaction mixture was directly subjected to flash column chromatography (10% ! 20%  ! 30%  
! 50%  EtOAc in hexanes) to provide the alkylated product as a clear oil. Run 1 (37.8 mg, 92% 
yield); Run 2 (35.7 mg, 87% yield); Run 3 (37.3 mg, 91% yield). Average: 90% Yield. The 
enantiomeric excess was determined to be 91% by chiral HPLC analysis (CHIRALPAK OJ-H 
column, 0.5 mL/min, 40% isopropanol in hexane, λ = 260 nm,  tR(major) = 12.82 min, tR(minor) 
= 16.11 min.) [α]23D = +113.49 (c = 0.23, CHCl3).  1H NMR (500MHz, CDCl3) δ 7.10 (d, J = 3.5 
Hz, 1H), 6.82 (s, 1H), 6.76 – 6.67 (m, 2H), 6.44 (d, J = 15.6 Hz, 1H), 6.25 (d, J = 3.2 Hz, 1H), 
5.92 (s, 2H), 5.87 (dt, J = 15.9, 7.3 Hz, 1H), 3.76 (s, 3H), 3.13 (dd, J = 14.7, 7.5 Hz, 1H), 2.91 (t, 
J = 14.6, 7.2 Hz, 1H), 2.77 (q, J = 7.6 Hz, 2H), 1.98 (s, 3H), 1.30 (t, J = 7.6 Hz, 3H); 13C NMR 
(125 MHz, CDCl3) δ 197.8, 170.8, 166.2, 163.6, 148.0, 147.2, 143.9, 134.8, 131.6, 121.1, 119.5, 
117.7, 108.3, 107.7, 107.2, 105.8, 101.1, 89.6, 53.4, 37.8, 21.9, 11.9, 6.4; HRMS (ESI) m/z 
calc’d for C22H23O7 [M+H]: 411.1444; found 411.1443.  
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Methyl (E)-5-(3-(3-((diethoxyphosphoryl)oxy)phenyl)allyl)-5'-ethyl-3-methyl-4-oxo-4,5-
dihydro-[2,2'-bifuran]-5-carboxylate (30): To a ½ dram vial was added ligand L15 (6.1 mg, 
0.01 mmol) and Pd(OAc)2 (2.2 mg, 0.01 mmol). Dioxane (0.3 mL) was added, and the vial was 
capped and heated to 45˚C until all solids had dissolved. Separately, to a second ½ dram vial 
with stir bar was added nucleophile (25 mg, 0.10 mmol), 2,6-dimethylbenzoquinone (20.8 mg, 
0.15 mmol), and zinc acetate dihydrate (11 mg, 0.05 mmol). The catalyst solution was 
subsequently added to the reaction flask, and dioxane was used to rinse up to 0.6 mL toluene. 
The vial was sealed with a Teflon cap, cooled to 5˚C in a cold room for 10 min. Olefin (27 mg, 
0.1 mmol) was added, and the reaction vial was again capped and stirred for 72 hours at 5˚C.  
Subsequently, the reaction mixture was directly subjected to flash column chromatography (10% 
! 20%  ! 30%  ! 50%  EtOAc in hexanes) to provide the alkylated product as a clear oil. 
Run 1 (39.1 mg, 78% yield); Run 2 (37.2 mg, 72% yield); Run 3 (38.8 mg, 75% yield). 
Average: 75% Yield. The enantiomeric excess was determined to be 93% by chiral HPLC 
analysis (CHIRALPAK IB-3 column, 0.5 mL/min, 5% isopropanol in hexane, λ = 254 nm,  
tR(minor) = 36.87 min, tR(major) = 38.83 min.) [α]23D = +121.00 (c = 0.10, CHCl3).  1H NMR 
(500MHz, CDCl3) δ 7.22 (t, J = 7.9 Hz, 1H), 7.13 – 7.05 (m, 4H), 6.50 (d, J = 15.7 Hz, 1H), 6.25 
(d, J = 3.4 Hz, 1H), 6.06 (dt, J = 15.2, 7.3 Hz, 1H), 4.27 – 4.14 (m, 4H), 3.76 (s, 3H), 3.15 (dd, J 
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(t, J = 7.3 Hz, 6H), 1.29 (t, J = 9.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 197.6, 170.8, 166.2, 
163.7, 151.0 (d, JP = 6.3 Hz), 143.8, 139.0, 134.3, 129.7, 123.2, 122.7, 119.0 (d, JP = 5.0 Hz), 
117.8 (d, JP = 5.0 Hz), 117.8, 107.7, 107.1, 89.4, 64.7 (d, JP = 6.3 Hz), 53.4, 37.8, 21.9, 16.2 (d, 
JP = 5.0 Hz), 11.9, 6.4; 31P NMR (202MHz, CDCl3) δ –5.2; HRMS (ESI) m/z calc’d for 
C26H32O9P [M+H]: 519.1784; found 519.1786.  
	  
Tert-butyl (E)-3-(3-(5'-ethyl-5-(methoxycarbonyl)-3-methyl-4-oxo-4,5-dihydro-[2,2'-
bifuran]-5-yl)prop-1-en-1-yl)-1H-indole-1-carboxylate (31): To a ½ dram vial was added 
ligand XX (6.1 mg, 0.01 mmol) and Pd(OAc)2 (2.2 mg, 0.01 mmol). Dioxane (0.3 mL) was 
added, and the vial was capped and heated to 45˚C until all solids had dissolved. Separately, to a 
second ½ dram vial with stir bar was added nucleophile (25 mg, 0.10 mmol), 2,6-
dimethylbenzoquinone (20.8 mg, 0.15 mmol), and zinc acetate dihydrate (11 mg, 0.05 mmol). 
The catalyst solution was subsequently added to the reaction flask, and dioxane was used to rinse 
up to 0.6 mL toluene. The vial was sealed with a Teflon cap, cooled to 5˚C in a cold room for 10 
min. Olefin (25.7 mg, 0.1 mmol) was added, and the reaction vial was again capped and stirred 
for 72 hours at 5˚C.  Subsequently, the reaction mixture was directly subjected to flash column 
chromatography (10% ! 20%  ! 30%  ! 50%  EtOAc in hexanes) to provide the alkylated 
product as a clear oil. Run 1 (29.0 mg, 57% yield); Run 2 (28.3 mg, 56% yield); Run 3 (30.8 mg, 
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HPLC analysis (CHIRALPAK IA-3 column, 0.5 mL/min, 10% isopropanol in hexane, λ = 330 
nm,  tR(major) = 3.76 min, tR(minor) = 4.48 min.) [α]23D = +109.85 (c = 0.31, CHCl3).  1H NMR 
(500MHz, CDCl3) δ 8.12 (s, 1H), 7.59 (d, J = 7.9 Hz, 1H), 7.51 (s, 1H), 7.30 (d, J = 8.4 Hz, 1H), 
7.19 (d, J = 8.9 Hz, 1H), 7.12 (d, J = 3.5 Hz, 1H), 6.63 (d, J = 16.0 Hz, 1H), 6.25 (d, J = 3.5 Hz, 
1H), 6.10 (dt, J = 15.3, 7.3 Hz, 1H), 3.78 (s, 3H), 3.19 (dd, J = 14.7, 7.5 Hz, 1H), 3.02 (dd, J = 
14.3, 6.9 Hz, 1H), 2.77 (q, J = 7.6 Hz, 2H), 1.99 (s, 3H), 1.65 (s, 9H), 1.29 (t, J = 7.6 Hz, 3H); 
13C NMR (125 MHz, CDCl3) δ 197.9, 170.8, 166.3, 163.6, 149.7, 143.9, 135.9, 128.8, 126.4, 
124.7, 123.7, 122.9, 121.9, 119.9, 118.6, 117.7, 115.4, 107.7, 107.3, 89.6, 84.0, 53.4, 38.4, 28.3, 
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